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Summary 
This report, written following EMCDDA (European Monitoring Centre for Drugs and 
Drug Addiction) guidelines,1 is divided into two parts. The first part (Part A) provides an 
overview of new developments and trends in the drugs area in Ireland for 2004 and, in 
some cases, for the first six months of 2005. These are covered under the following 
headings: 
1. National policies and context 
2. Drug use in the population 
3. Prevention 
4. Problem drug use 
5. Drug-related treatment 
6. Health correlates and consequences 
7. Responses to health correlates and consequences 
8. Social correlates and consequences 
9. Responses to social correlates and consequences 
10. Drug markets 
 
The second part (Part B) examines three specific issues considered to be important at 
an EU level. The three issues are: 
1. Gender differences 
2. European drug policies: extended beyond illicit drugs? 
3. Developments in drug use within recreational settings 
 
The following new developments and key findings in the drugs area in Ireland occurred 
or were made available during 2004 and the first six months of 2005: 
 
• The National Drugs Strategy 2001–2008 was the subject of a mid-term review, 
which was completed in June 2005. The review recommends adjustments to 
‘refocus’ and ‘re-energise’ the National Drugs Strategy. 
 
• ‘Refocusing’ of the National Drugs Strategy is recommended in order to meet 
emerging trends, identified particularly in the treatment area, including an 
increased prevalence of polydrug use, including cocaine; an increased 
incidence of hepatitis C as well as the ongoing prevalence of HIV; and the need 
to strengthen and expand rehabilitation provisions, in light of the significant and 
ongoing expansion in treatment provision in recent years. 
 
• ‘Re-energising’ of the National Drugs Strategy is recommended under all four 
pillars (Supply Reduction, Prevention, Treatment and Research), including 
measures such as the provision of additional resources, extending the reach 
and availability and accelerating the roll-out of certain programmes, increased 
training, establishing guidelines and models of best practice, and further 
monitoring of initiatives. 
 
• Recognising that a measure of the expenditure on drugs is vital in gauging the 
cost-effectiveness of the different elements in the National Drugs Strategy, the 
mid-term review proposes that expenditure directly attributable to drugs 
programmes should be measured. Although this would not capture the overall 
resources devoted to addressing the direct and indirect costs of drug use, the 
                                                
1 A copy of the EMCDDA guidelines is available from the EMCDDA’s website at www.emcdda.eu.int 
The guidelines require each Focal Point to write their National Report in a prescribed format using 
standard headings and covering each topic using a check list of items. This helps to ensure comparability 
of reporting across the EU. 
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review suggests that it would give ‘an indication as to the overall budget 
priorities’ accorded to the illicit drugs issue. 
 
• In mid-2005 the government issued Prison Rules, 2005, which includes specific 
provision for mandatory drug testing of prisoners. Later in 2005 the Irish Prison 
Service is expected to commence implementation of a new strategy of 
mandatory drug testing, addiction counselling and treatment, and to implement 
extra measures to prevent drug use and provide a more complete system of 
rehabilitation of prisoners with drug misuse problems. 
 
• To counteract the limitations of drug-related data sources with regard to heroin 
use in the regions, the National Advisory Committee on Drugs (NACD) is 
developing a Drug Trend Monitoring System (DTMS). This system will collect 
primary data as well as analyse secondary data on a range of drug-use 
indicators in order to identify nationwide trends in drug use, including the spread 
of heroin use outside of Dublin. A report on the pilot DTMS will be submitted to 
the Cabinet Committee on Social Inclusion for consideration later in 2005. 
 
• Parliament and civil society have undertaken a number of initiatives which have 
led to, or influenced, government decisions in the area of drugs policy, including 
family support services and support for family networks, services for members 
of vulnerable minorities affected by drugs, the needs of service users, 
community policing, and the treatment of cocaine addiction. 
 
• The third European School Survey Project on Alcohol and Other Drugs 
(ESPAD) was published in December 2004. For school-going children aged 15–
16 years there was a notable increase in lifetime use of any illicit drug between 
1999 (32%) and 2003 (40%), up 8%. This increase followed a drop between 
1995 and 1999.  
 
• Ireland ranked joint third after the Czech Republic (44%) and Switzerland (41%) 
for lifetime experience of any illicit drug in 2003. The average for the 35 ESPAD 
countries in 2003 was 22%. 
 
• The majority of those who have tried any illicit drug have used cannabis 
(marijuana or hashish). The lifetime prevalence rates for cannabis use are thus 
similar to those for use of any illicit drug and reflect the same trend. Lifetime use 
of inhalants dropped slightly between 1999 (22%) and 2003 (18%) but remains 
high. The average for the 35 ESPAD countries in 2003 was 10%. 
 
• The results of a national survey of third-level students were published in April 
2005. Cannabis was the most common illicit drug used by students, with over 
one-third (37%) reporting that they had used it in the past 12 months. Ecstasy 
was the second most used illicit drug, followed by cocaine, magic mushrooms 
and amphetamines. For all drugs, the levels of use were higher among students 
than among those of a similar age group (15–24 years) in the general 
population. The use of solvents (inhalants) was particularly high. 
 
• The mid-term review of the National Drugs Strategy 2001–2008 recommends 
four new key performance indicators (KPIs) under the prevention pillar: (i) a 
reduction of 5% by 2007 in estimated prevalence of opiate use based on 2001 
data; (ii) a reduction of 5% by 2007 in prevalence rate of recent and current use 
of illicit drugs in the general population based on the 2002/2003 rate; (iii) 
substance use policies in place in 100% of schools; and  (iv) early school 
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leaving in local drugs task force areas reduced by 10% based on the 2005/06 
rate.  
 
• The mid-term review recommends that a new cross-pillar on Family Support 
services in drug prevention be included in the National Drugs Strategy.  
 
• The mid-term review recommends that a working group be established to 
examine the area of prevention programmes in non-school settings, with the 
aim of developing guidelines on models of best practice to assist in the 
implementation of non-school setting interventions (selective and indicated 
prevention).  
 
• A new fund to tackle emerging needs in the local drugs task force areas has 
been launched and is currently being used to fund the piloting of four 
interventions aimed at tackling cocaine use in communities.  
 
• The number of treated cases in Ireland reported to the National Drug Treatment 
Reporting System (NDTRS) has increased steadily, from 6,048 in 1998 to 9,084 
in 2003.  This increase is explained by a combination of factors: a true increase 
in drug use, an increase in access to treatment services, and an increase in the 
number of centres reporting cases to the NDTRS.   
 
• The numbers treated for problem drug use and residing in the Health Service 
Executive (HSE) Eastern Region (Dublin, Kildare, Wicklow) increased by 23% 
between 1998 and 2003, while the numbers treated for problem drug use and 
residing in the seven HSE areas outside the Eastern Region increased by 
197% during the same period 
 
• The profile of main problem drugs reported by treated cases differed by place of 
residence.  Overall, 94% of treated cases residing in the HSE Eastern Region 
reported that an opiate was their main problem drug, while almost 20% of 
treated cases residing outside the HSE Eastern Region area reported an opiate 
as their main problem drug.  Just under 3% of treated cases residing in the HSE 
Eastern Region reported that cannabis was their main problem drug, while just 
over 55% of treated cases residing outside the HSE Eastern Region reported 
this as their main problem drug.   
 
• Drug use exists among new migrants to Ireland.  The majority of problem users 
have used drugs prior to their arrival but a considerable number commence 
drug use in Ireland.  According to the migrants, drugs are used to help deal with 
social exclusion and post traumatic stress disorder. 
 
• On 1 January 2005, the ten health boards managing the health services in 
Ireland were replaced by a single entity, the Health Service Executive (HSE), 
which will manage Ireland’s public health sector. 
 
• In March 2005, the HSE published its National Service Plan (NSP) for 2005.  
The plan emphasises that responses to the needs of those dependent on drugs 
or alcohol require a partnership approach across organisational boundaries, 
together with clear strategies to prevent and reduce levels of drug or alcohol 
misuse and harm.  The management of all addiction services will be under the 
remit of the Primary, Community and Continuing Care service delivery unit, 
which will oversee a number of national care groups.   
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• In 2001, the National Drugs Strategy identified seven key performance 
indicators to measure progress under the treatment pillar.  In 2005, the mid-
term review recommended that these be replaced by four new indicators to 
reflect the diversity of drug types and the number of drugs used by those 
seeking treatment, and to monitor the availability of harm reduction 
interventions.   
 
• The total number of drug treatment services available in Ireland increased 
between 1998 and 2003. The largest increase was in outpatient treatment 
services and general practitioner services. 
 
• A working group to examine the extent of problem drug use among those aged 
under 18 years was established in October 2001 and reported in September 
2005. The group reviewed the extent of the problem and noted that 
‘attendances by children account for a substantial proportion of the workload of 
the addiction services in Ireland’.  The group examined the issue of informed 
consent.  The group recommended that: where possible, the family be involved 
in treatment as this leads to better outcomes; substitution treatment should not 
be initiated outside a specialist context and a four-tiered model which would 
ensure that the services provided would be based on the specific needs of the 
child and their family.   
 
• Smyth et al. (2005b)examined the medium-term follow-up outcomes of 109 
patients attending an inpatient opiate detoxification programme between July 
1995 and December 1996.  Of the 109 patients interviewed, 25 (23%) reported 
neither using opiates nor prescribed methadone recently.  After controlling for 
confounding factors, opiate abstinence was found to be significantly associated 
with completion of an inpatient treatment programme, persistence with aftercare 
and the absence of a family history of substance misuse.   
 
• In 2002, the Methadone Prescribing Implementation Committee was requested 
to review the Methadone Protocol that was introduced in October 1998. There 
were 19 recommendations in the Methadone Protocol, of which 12 were 
completely implemented by the end of 2004, four were almost completely 
implemented and the remaining three required some further work. The three 
requiring further work related to service provision, including the range of 
services, the link between treatment services and general practitioners, and 
pharmacists’ contracts. 
 
• In June 2005, the Health Research Board published an overview of drug-related 
deaths in Ireland.  According to data from the General Mortality Register, almost 
all drug-related deaths between 1991 and 1994 occurred in Dublin.  Between 
1995 and 2000, there was a substantial increase in drug-related deaths in 
Dublin, from 39 to 90, and a steady increase outside the Dublin area, from 4 to 
29. In 2001, there was a sharp decrease in the number of drug-related deaths 
in Dublin (to 55) and a continued increase outside Dublin (to 33 in 2001 and 35 
in 2002).  A National Drug-Related Deaths Index is to be set up in Ireland so as 
to comply with Action 67 of 'Building on Experience: National Drugs Strategy 
2001–2008.   
 
• In 2004, there were 365 newly diagnosed cases of HIV infection reported to the 
Health Protection Surveillance Centre, of which 71 (20%) were infected through 
injecting drug use. This represents an increase on the numbers of new HIV 
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cases among injecting drug users in 2002 (50) and 2003 (49).  Of the 64 cases 
for whom place of residence was known, 60 lived in the HSE Eastern Region. 
 
• Two studies estimated the prevalence of blood-borne viruses among treated 
opiate users.  Between 66% and 72% of drug users tested positive for hepatitis 
C; 17% for hepatitis B core antigen, and 11% to 12% for HIV in two areas of 
Dublin.  These results are in line with results from a study in a similar setting.   
 
• Cullen et al. (2005) examined, by means of in-depth interviews, the experiences 
of heroin users attending general practice with respect to risk practices for 
hepatitis C.  Twenty-two participants said that they had tested positive for 
hepatitis C, of whom 15 had consumed alcohol in the week prior to the study.  
Nine consumed more than the recommended amount for their gender.  Those 
respondents who reduced their alcohol intake did so because they were 
concerned about their health, while those who increased their alcohol intake did 
so to substitute for heroin.   
 
• Moore et al. (2004) at Dublin City University profiled harm-reduction services in 
Ireland. All service providers in the Eastern Region reported that methadone 
maintenance and one-for-one needle-exchange facilities were available in their 
areas. With the exception of filters, all other types of injecting equipment were 
provided to clients attending these services. Half of the service providers in the 
Eastern Region area reported that filters were not available at their service. In 
contrast, service providers outside the ERHA area stated that methadone 
maintenance was the mainstay of their harm-reduction services and that no 
injecting equipment was distributed. Pipes were not provided at any service in 
Ireland.  
 
• In Ireland, hepatitis B vaccine is recommended for several high-risk groups, 
including prisoners and injecting drug users.  Grogan et al. (2005) reported that 
81% of 316 clients attending methadone treatment in an area of Dublin had 
commenced a course of this vaccine and 177 (56%) had completed at least 
three doses of the vaccine.  O’Sullivan (2004) reported that 86 per cent of those 
for whom the vaccine was indicated tested positive for anti-HBs, which indicates 
in this case a vaccine-induced immunity.   
 
• On 9 August 2005, the Minister of State at the Department of Health and 
Children introduced a new Statutory Instrument, the ‘Medical Products 
(Prescription and Control of Supply) (Amendment) Regulations 2005’.  This 
permits the supply and administration of a number of medicinal products 
(including naloxone, for the management of respiratory depression secondary 
to a known or suspected narcotic overdose) by pre-hospital emergency care 
providers in specific circumstances.   
 
• A team at Dublin City University explored the management of individuals with a 
combination of mental illness and substance misuse in Ireland (McGabhann et 
al. 2004). The team reported that there is a need to: formalise referral 
procedures between the mental health services and the addiction services; 
reconsider exclusion criteria; use valid assessment tools; develop and expand 
the small number of evidence-based dual diagnosis services in existence.  
 
• The first drug-prevalence study among the homeless population in Ireland 
revealed that drug use is a major contributory factor to becoming and remaining 
homeless. 
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• The mid-term review of the National Drugs Strategy recommends that a fifth 
pillar – rehabilitation –  be included in the strategy to assist drug users to move 
towards social reintegration.  
 
• A review of a major state-sponsored vocational training and employment-
support scheme reports a conflict between the aims of the scheme according to 
the sponsors, FÁS (National Training and Employment Authority), and the 
perceptions of participants. On the one hand, the sponsors aims are to enhance 
labour market opportunities for stabilised drug users, whereas on the other 
hand, participants perceive the scheme as assisting them in relapse prevention 
and rehabilitation, with the option of labour market participation a remote 
possibility. 
 
• The review of the FÁS scheme also reports that twice as many females (67.7%) 
as males (32.3%) participated in the scheme. Data from 2002 show that males 
accounted for 71% of cases living in and treated for problematic drug use in 
Ireland. This would suggest that males are not well disposed to accessing the 
FÁS support scheme.  
 
• A model of good practice in inter-agency work has been developed to co-
ordinate an approach to providing quality supports and services to drug users. 
The Blanchardstown EQUAL Inter-agency Initiative contains protocols on 
confidentiality and lead agency work.  
 
• The total number of drug offences where criminal proceedings commenced 
decreased by just over 10% in 2003, to 7,150 offences. However, a larger 
proportion of these (25%) were for drug dealing than in the previous year 
(19%). In 2003, 67% of the offences where criminal proceedings commenced 
were for simple possession.  In 2002, 76% of offences were for possession. 
 
• In 2003, cannabis-related prosecutions accounted for 57.6% of the total number 
of drug-related prosecutions. There has been a steady increase in cannabis-
related prosecutions since 1996, despite a brief downturn in 1998. Cannabis-
related prosecutions decreased in 2003. 
 
• In 2003, heroin-related prosecutions accounted for 10.6% of the total number of 
prosecutions. Prosecutions related to cannabis, heroin, ecstasy and 
amphetamines all declined during 2003. 
 
• In late 2003 the Garda Research Unit published a study which examined the 
link between opiate use and criminal activity in Ireland (Furey and Browne 
2003). Among the findings were: of 131 drug users surveyed, 110 had looked 
for drug treatment and 100 had received it; 64 respondents reported an 
association between the receipt of treatment and engagement in crime and 49 
of these respondents reported doing ‘a lot less’ crime. 
 
• With regard to drug treatment in prison, a number of positive developments are 
reported, such as the introduction of evidence-based methadone treatment 
services that can be accessed by the majority of opiate-dependent prisoners. 
Attempts have also been made to vaccinate a significant minority of prisoners 
against hepatitis B, something very few prisons, nor, indeed, community health 
services, have managed. The employment of registered nurses facilitated the 
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separation of disciplinary and healthcare roles. There has also been an 
increase in the availability of drug-free units. 
 
• In 2004 divisional drug policing plans were posted on the Garda website. 
 
• The Garda Síochána Act 2005 provides for the development of joint policing 
committees at local-authority level and for the establishment of local policing 
fora in designated areas under the umbrella of such committees. These bodies 
are to act as fora where matters relating to local issues of policing and crime, 
including drug-related issues, can be discussed and where strategies and 
recommendations for dealing with issues locally can be formulated. 
 
• Along with traditional supply-prevention measures, Mountjoy Prison has 
introduced  new visiting arrangements to prevent drug smuggling which involve 
prior nomination and identification of visitors. The Irish Prison Service has also 
installed nets over a number of prison yards to prevent drugs being propelled 
over prison walls. 
 
• An evaluation of a pilot juvenile arrest referral programme in Dublin’s north 
inner city has  recommended that the pilot phase of the scheme be extended, 
with additional resources in terms of staff, programme development and 
monitoring. 
 
• The Customs Service report that, although the number and quantity of cannabis 
resin seizures has been showing signs of decline in recent years, indications 
are that this trend is reversing. 
 
• Following a generally consistent increase in cannabis-related prosecutions in all 
Garda regions between 1995 and 2002, there was a decrease in such 
prosecutions in all Garda regions in 2003. 
 
• In 2003, ecstasy-related prosecutions declined in all Garda regions. 
 
• Since 1995, there has been a steady increase in heroin-related prosecutions in 
the Garda Eastern Region, from zero prosecutions in 1995 to 75 in 2003. While 
the trends in the other regions are more sporadic, it is clear that, although 
heroin remains predominantly a Dublin-based phenomenon, it is no longer 
exclusively based in the capital. 
 
• Although cocaine-related prosecutions in the Dublin Metropolitan Region have 
continued to rise each year, since 1999, the proportion of the total number of 
such prosecutions which are not Dublin-based has also continued to grow. 
While there was a slight decrease in cocaine-related prosecutions in the 
Southern Region in 2003, there was a 167% increase in such prosecutions in 
the Eastern Region. Increases were also recorded in the Northern, South 
Eastern and Western Regions. 
 
• In 2003, supply offences decreased in all Garda regions except for the Dublin 
Metropolitan and the Eastern regions. 
 
• With regard to perceived availability of certain drugs,  Ireland ranks first among 
the 35 ESPAD countries in the case of inhalants, crack, cocaine and ecstasy. 
These findings suggest an exaggerated perception of drug availability in 
Ireland. 
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• The ESPAD survey found that, of the 40% of students who had used illicit 
drugs, 19% had received the drug for the first time from a friend or sibling, and 
15% had shared it in a group. 
 
• Arising from the mid-term review of the National Drugs Strategy, a new key 
performance indicator relates to the monitoring of the number, as distinct from 
the quantity, of seizures. 
 
• The total number of drug seizures recorded in the annual reports of the Garda 
Síochána decreased by 17.2% between 2000 and 2003, down from 7,706 to 
6,377 seizures. Seizures made by customs decreased by approximately 18.7% 
during this period, down from 961 seizures in 2000 to 781 in 2003. 
 
• Heroin seizures have decreased by just under 18% since 2001, down from 802 
in 2001 to 660 in 2003. 
 
• Cocaine seizures increased steadily to a total of 213 in 1999, dropped slightly in 
2000, and increased sharply to a total of 566 seizures in 2003. 
 
• Ecstasy is the second most commonly seized drug in Ireland. Following a sharp 
increase in the number of ecstasy seizures, from 347 in 1997 to 1,864 in 2000, 
there was a decrease to 1,027 seizures in 2002 and then a slight increase to a 
total off 1,083 seizures in 2003. 
 
• Cannabis remains the principal drug seized in Ireland, accounting for 58 per 
cent of total drug seizures in 2003. In 2003, the number of cannabis seizures 
increased to a total of 3,705. 
 
• The total quantity of cocaine seized in 2003 was 107.5 kg. This represents a 
500% increase on the amount seized in 1995. 
 
• The volume of heroin seized has remained relatively consistent over the past 
few years, while the volume of cocaine seized has increased. This suggests 
that, contrary to speculation in the media and elsewhere, the increased 
availability and use of cocaine might not be displacing that of heroin. 
 
• The most recent Garda drug price estimates saw a reduction in the street price 
of cocaine from approximately €100 to €70 per gram in 2004. 
 
• According to the Forensic Science Laboratory, drug purity levels have remained 
fairly constant, with heroin purity ranging from 30% to 40% and that of cocaine 
ranging from 9% to 25%. 
 
Ireland – National Report 2004  12
 
Part A: New Developments and Trends 
 
1. National Policies and Context 
1.1 Overview 
This chapter provides an overview of new developments in the legal and policy areas 
for 2004 and the first half of 2005. Seven pieces of legislation with implications for the 
drugs issue were enacted and two further legislative items were initiated. The mid-term 
review of the National Drugs Strategy 2001–2008 was completed during this period 
and has led to a 'refocusing' of priorities and a 're-energising' of the roll-out of various 
actions in the Strategy. Parliament and civil society were active in contributing to the 
debate and development of drug-related policy. 
 
1.2 Legal framework 
This section describes a number of legislative measures enacted or in preparation 
during the reporting period. 
 
The purpose of the Criminal Justice (Joint Investigations Teams) Act 2004 is to give 
effect to the EU Council Framework Decision of 13 June 2002 on Joint Investigation 
Teams. These may be established for a specific purpose and limited period, by mutual 
agreement of the competent authorities of two or more member states, in order to carry 
out criminal investigations with a cross-border dimension in one or more of the member 
states setting up the team. Such investigations may involve investigations into 
organised crime, which may include drug trafficking. 
 
The Intoxicating Liquor Act 2004 amends the Intoxicating Liquor Act 1988 to provide a 
clear statutory basis for the holding of alcohol-free events for persons under the age of 
18 years in licensed premises (e.g. a nightclub) or a part of licensed premises (e.g. a 
function room in a hotel) at a time when intoxicating liquor is not being sold, supplied or 
consumed and any bar counter there is securely closed. 
 
Section 36 of the Road Traffic Act 2004 makes a number of technical amendments to 
section 36 of the Taxi Regulation Act 2003 (see National Report 2004). Section 36 of 
the Road Traffic Act, 2004 provides, inter alia, that a person convicted summarily, 
where a penalty other than a term of imprisonment (that the person serves in whole or 
in part) is imposed by the Court, is disqualified from holding a licence for a period of 12 
months and, accordingly, the licence stands suspended for that period. 
 
The Proceeds of Crime (Amendment) Act 2005 makes further provision in relation to 
the recovery and disposal of proceeds of crime and for that purpose amends the 
Proceeds of Crime Act 1996, the Criminal Assets Bureau Act 1996, the Criminal 
Justice Act 1994  and the Prevention of Corruption (Amendment) Act 2001. The Act 
does not make specific reference to drug legislation. However, proceeds of crime 
legislation has been directed against those involved in organised crime involving drug 
trafficking. The Act also allows proof of criminality to include criminality outside the 
State. 
 
Section 28 of the Maritime Safety Act 2005 introduces prohibitions on the operation of 
vessels in Irish waters while under the influence of alcohol or drugs to such an extent 
as to be incapable of properly controlling or operating the vessel. Section 29, inter alia, 
entitles the person in command of a vessel to refuse permission to board a vessel to a 
person who is under the influence of alcohol or drugs to such an extent that they 
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misconduct themselves or cause offence or annoyance to persons on the vessel. 
Section 31 introduces controls and penalties in relation to the consumption of alcohol 
or drugs on board vessels.  
 
Section 13 of the Safety, Health and Welfare at Work Act 2005 provides for drug 
testing in the workplace. The legislation obliges the employee to ensure that he or she 
is not under the influence of an intoxicant to the extent that he or she is in such a state 
as to endanger his or her own safety, health or welfare at work or that of any other 
person.  Also, if reasonably required by his or her employer, the employee must submit 
to any appropriate, reasonable and proportionate tests, by or under the supervision of a 
registered medical practitioner who is a competent person, as may be prescribed. An 
employer may require an employee to undergo an assessment by a registered medical 
practitioner, nominated by the employer, of his or her fitness to perform work activities. 
Regulations have not yet been finalised. The NACD has commissioned research to 
assist in the preparation of the necessary regulations. This research is to consider such 
issues as:  
• Information on drug impairment in the workplace 
• Right to privacy on health issues in the workplace 
• Information on substance use in the workplace 
• Literature search on drug testing issues in the workplace 
 
The Garda Síochána Act 2005 was passed into law in July 2005. In March 2005, the 
Joint Oireachtas Committee on Justice, Equality, Defence and Women’s Rights 
conducted a review of community policing in Ireland in light of proposals contained in 
Chapter 4 of the Garda Síochána Bill 2004 to establish new local policing structures. 
Many of the recommendations of the Joint Committee have been incorporated into the 
Act (Oireachtas Joint Committee on Justice Equality Defence and Women's Rights 
2005). 
 
An important amendment to the original Bill was the inclusion of the Minister of State at 
the Department of Community, Rural and Gaeltacht Affairs with responsibility for drugs 
strategy in the preparation of guidelines concerning the establishment and 
maintenance of joint policing committees (JPCs) by local authorities and the Garda 
Commissioner. The Act also provides for the inclusion on the JPCs of ‘persons 
representing local community interests’. Another important tier in the new local policing 
structures is the establishment of local policing fora. The Act provides for the 
establishment of such fora by JPCs in consultation with the local Garda superintendent 
‘as the committee considers necessary’. The steering group which oversaw the mid-
term review of the National Drugs Strategy highlighted concerns raised during its 
consultation process about the pace at which community policing fora were developing 
in drugs task force areas. In light of these concerns, and developments with regard to 
the Garda Síochána Act 2005, a new Action has been incorporated into the Strategy: 
‘Taking into account the provisions of the Garda Síochána Bill 2004 (enacted as of 
June 2005), Community Policing Fora should be extended to all Local Drugs Task 
Force areas and to other areas experiencing problems of drug misuse.’ 
The Irish Medicines Board (Miscellaneous Provisions) Bill 2005 provides for a number 
of amendments to the Misuse of Drugs Act 1977. These include provisions: 
• to extend the powers available to the Minister to give a direction, following a 
conviction for an offence under the Misuse of Drugs Acts or the Customs Acts, 
prohibiting bodies corporate involved in the practice of community pharmacy, 
and their officials, from having such controlled drugs as may be specified; 
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• to enable the Irish Medicines Board to issue licences and permits in respect of 
controlled drugs for various purposes; 
• to limit the prohibition of the cultivation of poppies to that of poppies cultivated 
for the production of opium. 
A number of amendments to the Criminal Justice Bill 2004 are being proposed by the 
Minister for Justice, Equality and Law Reform. The Bill is currently being considered by 
the Joint Oireachtas Committee on Justice, Equality, Defence and Women’s Rights. 
Among the proposed amendments are: 
• provisions for creating criminal offences in relation to participation in criminal 
organisations 
• proposals to strengthen the provisions on the imposition of the 10-year 
mandatory minimum sentence for drug trafficking 
• new offences of supplying drugs to prisoners 
• provisions in relation to a Drug Offenders Register 
• new provisions to deal with anti-social behaviour, such as anti-social behaviour 
orders 
• provisions to raise the age of criminal responsibility to 10 years. 
 
Other legal developments 
With regard to cannabis, the NACD recently published An overview of scientific and 
other information on cannabis (Morgan 2004). The report draws on relevant research 
from Ireland and abroad, with a view to presenting a balanced account of how this 
illegal but widely used substance affects a range of outcomes. The overview was 
conducted by authors from four different disciplines. Chapter four of the report 
examines  the criminological and sociological consequences of cannabis use (Connolly 
2004a). Many of the negative criminological and sociological consequences related to 
cannabis have been attributed to its legal status, rather than to any properties of the 
drug itself. The debate over cannabis law reform remains one of the most contested 
areas of international drug policy. The legal status of cannabis has come under 
increased scrutiny in recent years in Ireland. The National Crime Forum, established by 
the Minister for Justice, Equality and Law Reform in 1998, heard arguments for and 
against the decriminalisation of cannabis. Chapter four of the NACD report also looks 
at the effect that drug laws have had on educational and employment prospects, 
relationships and travel in a number of countries. Although there is clear evidence of 
violence associated with the drug trade, in the absence of any adequate studies into 
Irish drug markets it is impossible to state with any clarity the extent to which violence 
is associated specifically with the trade in cannabis. The chapter concludes by 
highlighting the need for further research in the drugs–crime area in Ireland. There is a 
particular need for more data describing the way in which laws are being implemented 
in the area of drug markets. 
 
Implementation of legislation 
In its interpretation of Section 8(2) Criminal Justice (Drug Trafficking) Act 1996 the 
Court of Criminal Appeal in the case of the Director of Public Prosecutions v. Peter 
Byrne (30 October 2003, Ref 26/2) defined the circumstances in which a search 
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warrant issued by a Garda superintendent can be utilised (GNDU, personal 
communication, September 2005). In delivering its judgement the court stated: 
 
It is not the case that An Garda Síochána are free to choose whether they will 
apply for a search warrant to a Judge or Peace commissioner or to a 
Superintendent. They must apply to a Judge or Peace Commissioner unless 
the very limited circumstances which permit them to apply to a Superintendent 
are present. These circumstances must be demonstrated to be present for the 
Superintendent’s warrant to be valid. 
 
In Creaven & anor  v. Criminal Assets Bureau & ors [2004] IESC 92, the Supreme 
Court held that a District Judge cannot sit and hear applications outside the district to 
which he/she is assigned. Although the case did not concern a drug-related matter, 
commenting on the decision, the Garda National Drugs Unit (GNDU) stated: 
 
One implication of this decision is that where in the course of conducting an 
operation gardaí wish to apply for search warrants on an urgent basis, and the 
premises to be searched relate to a number of District Court Districts, such 
warrants can only be obtained from district Judges assigned to, and then sitting 
in, the relevant Districts. (GNDU, personal communication, September 2005) 
 
Action 27 of the National Drugs Strategy obliges the Garda Síochána, the health 
boards and vintner representative bodies to ‘prepare guidelines… for publicans and 
night-club owners regarding drug dealing on, or in the vicinity of, their premises. These 
guidelines should set out clearly the actions which the owner of the premises should 
take in response to drug dealing…’ (Department of Tourism Sport and Recreation 
2001: 114). In June 2005 an information booklet, entitled ‘Guidelines regarding drug 
dealing on or in the vicinity of licensed premises’, was launched with the aim of 
addressing Action 27 (An Garda Síochána and others 2005). The guidelines were 
drawn up by An Garda Siochána, with the co-operation of the Licensed Vintners 
Association, the Irish Nightclub Industry Association, the Vintners Federation of Ireland, 
the Department of Health and Children, and the Irish Hotels Federation. The guidelines 
cover such matters as the law in relation to drug issues, the legal conditions and 
appropriate procedures for the conducting of searches of persons entering premises, 
signs of drug misuse by customers, what to do if drugs are found, first aid, and the 
monitoring of queues. 
 
In December 2004, the Oireachtas decided to extend sections 2, 3, 4, 5 and 6 of the 
Criminal Justice (Drug Trafficking) Act 1996 into force until 31 December 2006. These 
sections relate to police detention powers in suspected drug cases. 
 
Part II of the Criminal Justice Act 1999, as amended, provides in section 5 for 
mandatory minimum sentences for possession of drugs with a value of €13,000. The 
Minister for Justice, Equality and Law Reform, Michael McDowell TD, in response to a 
parliamentary question, informed the Oireachtas that, since the provisions came into 
force on 26 May 1999 up until May 2004:  
 
a total of 180 persons had been prosecuted, of whom 12 received a 
sentence of ten years or more. By 29 November of this year, the number of 
persons prosecuted had risen to 229, with 22 persons receiving a sentence 
of ten years or more. (McDowell 2004b) 
 
The European Arrest Warrants Act 2003 came into effect on 1 January 2004. The 
Minister for Justice informed the Oireachtas that this Act: 
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simplifies extradition and surrender procedures between member states of 
the EU for offences such as illicit trafficking in narcotic drugs and 
psychotropic substances. (McDowell 2004a) 
 
 
Crime statistics 
The annual reports of the Garda Síochána are the main source of data on crime in 
Ireland. However, a number of concerns have been raised as to their reliability. Action 
4 of the National Drugs Strategy requires ‘the establishment of a framework to monitor 
numbers of successful prosecutions, arrests and the nature of sentences passed’. 
 
The Expert Group on Crime Statistics, established to consider the compilation and 
reporting of crime statistics, submitted a number of recommendations to the Minister for 
Justice, Equality and Law Reform in July 2004.  Based on these recommendations, the 
Minister has approved the establishment of a Central Crime Statistics Unit. However, 
concerns about existing official data sources remain. A minority report of the Expert 
Group concluded that lack of clarity regarding the collation of information about crimes 
reported to and recorded by An Garda Síochána meant that the Group was unable to 
reach conclusions ‘about the quality, reliability and accuracy of Garda data’ (Expert 
Group on Crime Statistics 2004b; Expert Group on Crime Statistics 2004a).The Expert 
Group has recommended that a special research project be commissioned by the 
Department of Justice, Equality and Law Reform to address this issue. Other important 
recommendations include: 
 crime statistics to be released promptly and to a rigidly set timetable; 
 significant changes in the reporting, categorisation or description of offences to 
be clearly explained; 
 crime reports to contain all relevant information in relation to the methods of 
compilation, including the main counting rules; 
 future changes in crime reports to be implemented after consultation with major 
stakeholders; 
 crime statistics to cover all non-headline offences known or reported; 
 annual crime statistics to be provided by county; 
 greater access to data throughout the criminal justice system to be provided to 
researchers. 
 
Another recent development, which should also enhance our understanding of crime as 
it impacts at a local level, is contained in the Garda Síochána Act 2005. Section 36 of 
the Act provides for the establishment of joint policing committees. One of the functions 
of these committees is to keep under review ‘the levels and patterns of crime, disorder 
and anti-social behaviour in that area (including the patterns and levels of misuse of 
alcohol and drugs)’. It is unclear at this stage how this will be done, whether through 
the use of local surveys or through the increased availability of official data at a local 
level. 
 
 
1.3 Institutional framework, strategies and policies 
 
Since 2001, the National Drugs Strategy 2001–2008 (Department of Tourism, Sport 
and Recreation 2001) has provided the framework for illicit drugs policy in Ireland. In 
March 2005 a Progress Report (Department of Community Rural and Gaeltacht Affairs 
2004) on the implementation of the National Drugs Strategy was published, followed in 
June 2005 by a mid-term review of the Strategy (Steering group for the mid-term 
review of the National Drugs Strategy 2005). As a result of the review process, 
priorities and actions under the National Drugs Strategy have been adjusted. These 
adjustments are reported on below. 
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An update on new initiatives announced in the government’s Agreed Programme for 
Government (Fianna Fáil and the Progressive Democrats 2002), which are in addition 
to the actions identified in the National Drugs Strategy, are also described in this 
section. 
 
Co-ordination arrangements 
With over 20 statutory agencies involved in delivering the National Drugs Strategy, as 
well as multiple service providers and community and voluntary groups, a hierarchy of 
‘interagency mechanisms’ is in place to co-ordinate policy and activities in pursuit of the 
strategic objectives, as summarised below. 
 
Level Inter-Agency Co-ordinating Mechanism 
National Cabinet Committee on Social Inclusion 
 Inter-Departmental Group on Drugs (IDG) 
 National Drugs Strategy Team (NDST) 
Regional Regional Drugs Task Forces (RDTFs)
Local Local Drugs Task Forces (LDTFs) 
 
A dedicated institutional framework – the National Drugs Strategy Unit in the 
Department of Community, Rural and Gaeltacht Affairs (DCRGA) – co-ordinates the 
overall implementation of the National Drugs Strategy and interacts closely with all the 
statutory and non-statutory agencies involved in delivering the Strategy. 
 
The mid-term review makes a number of recommendations to strengthen the co-
ordination and integration of activities at national level.  
 
• The Inter-Departmental Group (IDG) is not perceived to have fulfilled the role 
envisaged for it, as an advisory group to the Cabinet Committee on Social 
Inclusion. To strengthen its ability to anticipate and respond to implementation 
issues and/or new trends emerging that may affect the Strategy and its decision-
making role, it is recommended that the IDG be reconstituted and its membership 
expanded to include representatives of additional state agencies and of the 
community and voluntary sectors. Departmental officials should be given the 
authority to make decisions on the issues being discussed by the IDG. It is also 
anticipated that this reconstituted IDG will provide an opportunity for feedback and 
discussion on issues relating to drug misuse as they arise at EU and international 
fora. 
• The National Drugs Strategy Team (NDST) is considered to be in a unique position 
to identify service gaps and best practice approaches as well as trends and 
developments on the ground and bring these to the attention of the IDG and the 
government. To ensure that it can continue to fulfil this role, membership of the 
NDST is to be reviewed to ensure adequate representation of the community and 
voluntary sectors, and a periodic review of resourcing levels is to be instigated to 
ensure its ongoing effectiveness. 
• The role of the National Drugs Strategy Unit in the Department of Community, Rural 
and Gaeltacht Affairs (DCRGA) is clearly articulated in the mid-term review for the 
first time. It includes not only co-ordination of and monitoring and reporting on the 
National Drugs Strategy and advice and support to the Minister of State with 
responsibility for the Drugs Strategy, but also the operation and management of, or 
financial accountability for, a range of drug-related funds and state agencies. The 
Unit also represents Ireland at EU meetings of national drug co-ordinators. 
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National plan and/or strategies 
The mid-term review of the National Drugs Strategy (Steering group for the mid-term 
review of the National Drugs Strategy 2005) which was based on a wide and thorough 
public consultation process and analysis of key national and EU data to assess 
progress and impacts, as well as emerging trends and gaps, recommends adjustments 
to the Strategy in order to ‘refocus’ priorities and ‘re-energise’ the roll-out and 
implementation of various key actions during the remaining period of the Strategy. 
‘Refocusing’ is recommended in order to meet emerging trends, identified particularly in 
the treatment area, including an increased prevalence of polydrug use, including 
cocaine; an increased incidence of hepatitis C as well as the ongoing prevalence of 
HIV; and the need to strengthen and expand rehabilitation provisions, in light of the 
significant and ongoing expansion in treatment provision in recent years. ‘Re-
energising’ is recommended under all four pillars, including measures such as the 
provision of additional resources, extending the reach and availability and accelerating 
the roll-out of certain programmes, more training, establishing guidelines and models of 
best practice, and further monitoring.  
  
Details of the adjustments and innovations recommended under each of the pillars, 
including the new, fifth pillar, Rehabilitation, are outlined below. In total, 17 of the 100 
actions are replaced or amended, and eight new actions are identified.  
 
Supply Reduction: under this pillar, the review notes progress on most of the 21 
actions. Recommendations are made with regard to three key issues. 
• The extra Garda (police) resources allocated to local drugs task force (LDTF) areas 
have not had the expected impact and steps are to be taken to increase resourcing 
and ensure effectiveness in preventing drug dealing on the ground in LDTF areas. 
• Progress in establishing community policing fora in all the LDTF areas has been 
slow and action is to be taken to accelerate roll-out. 
• Options for providing guidance and training for the judiciary in dealing with drug-
related issues are to be explored. 
 
Prevention: under this pillar, 11 of the 16 actions are completed or ongoing and some 
progress has been made with regard to the other five. Recommendations were made in 
relation to five key issues. 
• The introduction of school substance abuse policies has encountered practical 
problems in a number of schools and a mechanism for monitoring the deployment 
of such policies is recommended. 
• The effectiveness of the SPHE (Social Personal and Health Education) 
programme, which is part of the post-primary syllabus and includes a dedicated 
module on preventing substance abuse (including alcohol), has been diminished 
owing to varying standards of delivery and low prioritisation by schools. The review 
recommends enhanced training in prevention education for teachers and student 
teachers, and enhanced support services for schools in LDTF areas in delivering 
the programme, and greater encouragement to all schools to prioritise the 
implementation of school-based prevention programmes within existing timetables. 
• Gaps and inconsistencies in the delivery of non-school-based programmes by 
different agencies were found and it is recommended that a working group be 
formed to develop guidelines and models of best practice for such programmes. 
• Confusion was found to exist in how parents and families access information about 
substance abuse. The review recommends that factual information on prevention 
should be more easily accessible and also that the mandate and resourcing of the 
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Home School Community Liaison Service should be strengthened to help in 
information provision. 
 
Treatment: under this pillar, nine of the 36 actions were considered completed or 
ongoing, while some progress was noted on a further 24, and little progress on just 
three. The review noted that a complicating factor in completing actions under the 
Treatment pillar was the variation in the prevalence of drug misuse across the country, 
which resulted in uneven rollout of services nationwide. Six key issues are identified. 
• Given the increased prevalence of polydrug use, including cocaine, the availability 
and range of treatment options should continue to be increased. 
• Rehabilitation is such an important component in facilitating drug misusers’ ‘moving 
on’ and ultimately reintegrating them into society that it is recommended as a fifth 
pillar of the National Drugs Strategy. 
• While guidelines for the treatment of under-18-year-olds presenting with serious 
drug problems have been developed, in compliance with an action in the National 
Drugs Strategy, it is now essential that these guidelines be fully implemented, with 
priority given to areas of most need. 
• In light of the increase in the incidence of hepatitis C and the ongoing prevalence of 
HIV, higher priority needs to be given to the actions in the Strategy relating to harm-
reduction approaches, including needle-exchange and exchange of other injecting 
paraphernalia, and ensuring wider geographical availability and availability at 
evenings and weekends. 
• While the review recognises that there have been significant improvements in 
treatment provision in recent years, in the remaining phase of the Strategy the 
concentration should be on providing appropriate treatment no later than one 
month after assessment.  
• Difficulties in recruiting new pharmacists and general practitioners into the 
methadone protocol resulted in recommendations to continue to increase general 
practitioner and pharmacist participation in the provision of methadone treatment, 
and to examine the issue of the voluntary and community services employing 
medical staff directly. 
 
Research: under this pillar, the review noted that just one out of five actions have been 
completed and varying progress reported on the other four. As well as discussing the 
need to improve the management of drug-related research, including maintaining the 
standard of local and regional research, promoting inter-agency co-operation and 
coherence, ensuring regular reporting, and encouraging information sharing, the review 
identifies two new key issues. 
• There is no mechanism in place to track progress in implementing the 
recommendations arising from the research reports carried out by the NACD and 
the review recommends establishing a process to monitor the implementation 
of the recommendations.  
• The Central Methadone Treatment List should be developed by the provision of 
further information regarding entry and re-entry of clients and the length of time in 
treatment and this additional information should be made available on an annual 
basis. 
 
Rehabilitation: with regard to this proposed new pillar, the review recommends that a 
working group be set up to develop an integrated rehabilitation provision. The group, to 
be chaired by the Department of Community, Rural and Gaeltacht Affairs, is due to 
report to the IDG and the Cabinet Committee on Social Inclusion by the end of 2005.  
 
In June 2002 the incoming Fianna Fáil–Progressive Democrat government published 
an Agreed Programme for Government (Fianna Fáil and the Progressive Democrats 
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2002), setting out its priorities for 2002–2007. The Agreed Programme broadly 
endorses the Supply Reduction, Prevention and Treatment pillars of the National Drugs 
Strategy. It also identifies five new initiatives, designed to contribute to: 
o achieving drug-free prisons, 
o reducing drug supply, and  
o improving information in respect of the drug situation. 
 
The new initiatives and recent progress in relation to them, as outlined in the 
government’s annual progress report for 2005 (Fianna Fáil and the Progressive 
Democrats 2005), are set out below.  
 
We will provide for compulsory drugs testing of prisoners where appropriate.  
In mid-2005 new prison rules were published, including specific provision for 
mandatory drug testing. Later in 2005 the Irish Prison Service is expected to 
commence implementation of a new strategy of mandatory drug testing, addiction 
counselling and treatment, and to implement extra measures to prevent drug use and 
provide a more complete system of rehabilitation (see also Section 9.3). 
 
Where a person has been found to be involved in the supply of drugs to a 
prisoner we will introduce a stiffer penalty. 
The Criminal Justice Bill 2004 will create a new offence of supplying drugs to prisoners. 
It is expected that this Bill will be enacted during 2005. 
 
We will require convicted drug dealers to register with the gardaí after leaving 
prison. 
The Criminal Justice Bill 2004 will also provide for the establishment of a drug dealers 
register. This register will be based on the same principles as the sex offenders register 
and will enable the movements of convicted drug dealers to be recorded in a similar 
fashion, covering changes of address and movements in and out of the State. 
 
We will ensure that an early warning system, involving all key agencies, is in 
place to track the potential spread of heroin into new areas.  
To counteract the limitations of drug-related data sources with regard to heroin use in 
the regions, the NACD is developing a Drug Trend Monitoring System (DTMS). This 
system will collect primary data as well as analyse secondary data on a range of drug 
use indicators in order to identify nationwide trends in drug use, including the spread of 
heroin use outside of Dublin. A report on the pilot DTMS will be submitted to the 
Cabinet Committee on Social Inclusion for consideration later in 2005.  
 
We will continue to prioritise heroin and cocaine for intervention, and will 
publish separate national targets for supply reduction for each major type of 
drug. 
In reporting on this initiative, the government refers to a key performance indicator, 
already included in the National Drugs Strategy, which identifies one aggregate target 
for the volume of all drugs seized in Ireland: ‘A key indicator in the Strategy is to 
increase the volume of opiates and all other drugs seized by 25% by end of 2004 and 
by 50% by end 2008, using 2000 seizures as a base.’ No breakdown of this target for 
‘each major type of drug’ is provided. 
 
 
Implementation of policies and strategies 
One major structural change has occurred, with implications for the implementation of 
actions under the Prevention and Treatment pillars of the National Drugs Strategy. On 
1 January 2005 the Health Service Executive (HSE) was established to manage 
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Ireland’s public health sector as a single national entity. It replaced the former regional 
health boards, which had responsibility for 23 actions in the National Drugs Strategy, 
and joint responsibility for a further 11 actions. Responsibility for these actions has 
transferred across to the HSE (see Section 5.2).  
 
 
Impact of policies and strategies 
The mid-term review sought to assess the impact and direction of the National Drugs 
Strategy at the mid-point. As such, it represents a stock-take of progress, when the 
implementation of some of the actions is still ongoing, and does not seek to assess 
overall impacts. It concentrates on examining the progress and impact of the Strategy 
under each of the four pillars in relation to the objectives set for each pillar. It concludes 
that the Strategy’s current aims and objectives are ‘fundamentally sound’ and that 
‘progress is being made’ across all four pillars. It reports, moreover, that 49% of actions 
in the National Drugs Strategy have been completed or are ongoing, action is under 
way on a further 45%, and just 6% require ‘considerably more progress’. Finally, it 
proposes new and revised key performance indicators (KPIs) under each pillar, 
reflecting both lessons learned in the course of the review and developments in the 
collection and availability of research and data since the Strategy was first published. 
 
By reprioritising actions for the second phase of the National Drugs Strategy up to 2008 
and by proposing new and revised key performance indicators, the mid-term review 
expresses the belief that the Strategy will better deliver the aims and objectives set out 
for the period 2001–2008. 
 
1.4 Budget and public expenditure 
Up-to-date information on budgetary provisions and public expenditure on the illicit 
drugs issue in Ireland is not available. 
 
The mid-term review of the National Drugs Strategy, published in June 2005, 
recognises that ‘a measure of the expenditure is vital to gauge the cost effectiveness of 
the different elements of the Strategy’. The review proposes that only expenditure that 
is directly attributable to drugs programmes (e.g. drugs services of the Health Services, 
cost of Garda (police) drug units, drugs-specific training of prison officers) should be 
measured. Although this would not capture the overall resources devoted to addressing 
the direct and indirect costs of drug use, the review suggests that it would give ‘an 
indication as to the overall budget priorities’ accorded to the illicit drugs issue. The 
review recommends that the IDG should consider how best this issue should be 
progressed and that the estimates should be produced on an annual basis. No 
timeframe is set for implementing this recommendation. 
 
The GNDU reports that ‘work will commence shortly on highlighting expenditure by An 
Garda Síochána specifically on drug law enforcement’ (GNDU, personal 
communication, September 2005). 
 
1.5 Social and cultural context 
Public opinions of drug issues 
Public opinion in Ireland views drug trafficking as an issue in need of urgent action. 
Eurobarometer 63, for which the field work was conducted in May/June 2005, reported 
that, when asked to select the three actions that the EU should follow, in order of 
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priority, from a list of 16 possible actions, respondents in Ireland ranked ‘fighting 
organised crime and drug trafficking’ second, after ‘fighting poverty and social 
exclusion’ (European Commission 2005a). Eurobarometer 62, for which the field work 
was conducted in October/November 2004, reported that on that occasion respondents 
in Ireland reversed the ranking, with ‘fighting organised crime and drug trafficking’ as 
the top priority for action, just ahead of ‘fighting poverty and social exclusion’ 
(European Commission 2005b). 
 
Initiatives in parliament and civil society 
Parliamentary committees, comprising elected representatives from all parties in the 
Oireachtas (Houses of Parliament), and a range of community and voluntary bodies 
have been active in researching drug-related issues and making recommendations to 
improve performance. A notable initiative during the period covered by this National 
Report was the publication of the first four reports funded under the 
Community/Voluntary Sector Research Grant Scheme, administered by the NACD. 
This research fund was established to promote a better understanding of drug-related 
issues in communities; boost the research capacity of the community/voluntary sector 
and, consequently, their capacity to influence policy and the planning of services; and 
facilitate liaison between community/ voluntary organisations, service planners and 
service providers.  
 
A selection of initiatives taken by parliament and civil society that have contributed to 
the development of drug policy during the period covered by this National Report is 
provided below.  
 
Family support 
The public consultation process carried out as part of the mid-term review of the 
National Drugs Strategy highlighted the need to develop supports and guidance for 
parents, as well as children at risk.  During the consultation process, the community-
based CityWide Family Support Network, representing local family support groups, 
independent family members and those working directly with families of drug users, 
published a report Supporting grandparents. . .supporting children (CityWide Family 
Support Network 2004), based on consultation with a number of carers involved in 
family support groups, and campaigned for ‘Family Support’ to be identified as the fifth 
pillar of the National Drugs Strategy.  
 
Although not established as a new ‘pillar’ of the drugs strategy, family support is 
identified as a cross-cutting issue in the mid-term review of the National Drugs Strategy 
(see Section 3.2). The review adopts the recommendations made in a study 
commissioned by the NACD on the role of family support services in drug prevention 
(Watters and Byrne 2004).  
 
Service users  
In 2001 the National Drugs Strategy included an action requiring public drug treatment 
service providers to draft service-user charters. The mid-term review of the Strategy 
calls for service users to be consulted in the drafting or revision of these charters. 
During the life of the National Drugs Strategy there has been a growing awareness and 
recognition of the needs of drug-service users. In 2002 the Irish College of General 
Practitioners published a model service charter for use by general practitioners, and in 
2003  UISCE (a group comprising drug users, ex-users and professionals who seek to 
ensure the voice of the drug user informs drug policy) published a report on service 
users’ experiences and perceptions of methadone substitution treatment service 
provision (UISCE 2003). During 2005 a collaborative piece of community-based action 
research expanded the scope of these discussions, seeking to identify and address 
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issues confronted by drug users in relation not only to drug treatment services but also 
to health services in general (O'Reilly et al. 2005).  
 
Community policing  
The National Drugs Strategy includes an action to extend the Community Policing Fora 
(CPF) initiative to all local drugs task force areas. The mid-term review of the Strategy 
found that, although CPFs are being piloted in a number of areas, progress in 
extending them has been slow.  The review recommends that, taking into account the 
provisions in the Garda Síochána Bill 2004 (see Section 1.2), CPFs should be 
extended to all local drugs task force areas and to other areas experiencing drug 
misuse problems.  
 
During the period covered by this report, several initiatives in civil society and 
parliament contributed to thinking on community policing. In Dublin, the 
Blanchardstown Local Drugs Task Force published a report (Connolly 2004b) which 
made a number of recommendations with regard to the structure and process of a local 
community policing forum.  A public consultation on crime and policing in Dublin City 
(Lord Mayor’s Commission 2005) argued strongly that reducing crime, disorder and 
anti-social behaviour cannot be the sole responsibility of the gardaí and the Courts, and 
that local bodies and communities should share the responsibility. In March 2005, the 
Joint Oireachtas Committee on Justice, Equality, Defence and Women’s Rights (2005) 
conducted a review of community policing in Ireland in ligh t of the proposals contained 
in the Garda Síochána Bill 2004. 
 
Cocaine 
The mid-term review of the National Drugs Strategy noted the increased prominence of 
cocaine, both in terms of supply and the prevalence of cocaine misuse. Early in 2005 a 
series of pilot treatment projects were launched and the mid-term review called for the 
lessons learned from the evaluations of these projects to be implemented in LDTF 
areas. It was in the context of the pilot treatment projects that an Oireachtas Committee 
undertook to investigate the treatment of cocaine addiction, with particular reference to 
the Irish experience (Oireachtas Joint Committee on Arts, Sport, Tourism, Community, 
Rural and Gaeltacht Affairs 2005).  
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2. Drug Use in the Population 
 
2.1 Overview 
This section provides an overview of the new developments and trends in drug use in 
the population in Ireland for 2004 and early 2005. 
 
Drug prevalence surveys in the general population are important in that they can shed 
light on the patterns of drug use, both demographically and geographically and, if 
repeated, can track changes over time. They help to increase our understanding of 
drug use, and to formulate and evaluate drug policies. They also enable informed 
international comparisons, provided countries conduct surveys in a comparable 
manner. 
 
2.2 Drug use in the general population 
No new surveys of drug use in the general population were carried out or published in 
the current reporting period. 
 
In 2005, the NACD published revised prevalence estimates from their national survey 
of drug use in the general population 2002/2003 (National Advisory Committee on 
Drugs and Drug and Alcohol Information and Research Unit 2005). According to the 
NACD, the revisions were necessary due to anomalies discovered in the original 
survey data.    
 
Full details of the revised estimates can be found in the on-line version of Standard 
Table 1. Key findings for Ireland are described below. One in five (18.5%) adults 
reported using an illegal drug in their lifetime (see Table 2.2.1). For young adults (aged 
15–34 years) this rose to one in four (26.0%) people. Twice as many men as women 
reported the use of an illegal drug during the last month or the last year. 
 
Table 2.2.1   Lifetime, last-year and last-month prevalence of illegal drugs in Ireland, 2002/2003 
Ever used an illegal 
drug* 
Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
During lifetime 18.5 24.0 13.1 26.0 
During last year  5.6 7.8 3.4 9.7 
During last month 3.0 4.1 1.7 5.2 
* illegal drugs refer to any use of amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic 
mushrooms, poppers and solvents. 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005) 
 
Cannabis was the most commonly used illegal drug. One in six adults had used 
cannabis in their lifetime and this increased to one in four for young adults (see Table 
2.2.2). 
 
Table 2.2.2   Lifetime, last-year and last-month prevalence of cannabis in Ireland, 2002/2003 
Ever used cannabis Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
During lifetime 17.4 22.4 12.3 24.0 
During last year  5.0 7.2 2.9 8.6 
During last month 2.6 3.4 1.7 4.3 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005) 
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Prevalence of other illegal drugs was lower and confined largely to the younger age 
group. One in fourteen (7.1%) young adults claimed to have tried ecstasy at least once 
in their lifetime (see Table 2.2.3).  
 
Table 2.2.3   Lifetime, last-year and last-month prevalence of ecstasy in Ireland, 2002/2003 
Ever used ecstasy Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
During lifetime 3.7 4.9 2.6 7.1 
During last year  1.1 1.7 0.5 2.0 
During last month 0.3 0.7 - 0.6 
- no respondents in this category 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005) 
 
Cocaine use (including crack) was much higher in men than women for lifetime, current 
and recent use (see Table 2.2.4). 
 
Table 2.2.4   Lifetime, last-year and last-month prevalence of cocaine (including crack) in Ireland, 
2002/2003 
Ever used cocaine 
(including crack) 
Adults 
15–64 years 
% 
Males 
15–64 years 
% 
Females 
15–64 years 
% 
Young adults 
15–34 years 
% 
During lifetime 3.0 4.3 1.6 4.7 
During last year  1.1 1.7 0.5 2.0 
During last month 0.3 0.7 - 0.7 
- no respondents in this category 
Source: (National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005) 
 
2.3 Drug use in the school and youth population 
On 14 December 2004 the Minister of State at the Department of Health and Children, 
Mr Sean Power, announced the publication of the third European School Survey 
Project on Alcohol and Other Drugs (ESPAD) (Hibell et al. 2004). The third ESPAD 
survey was conducted in 35 European countries during 2003 and collected information 
on young people’s alcohol and illicit drug use. The target population was school-going 
children born in 1987. Thus, those surveyed were aged either 15 or 16 years at the 
time of the survey. As in the earlier ESPAD surveys, the 2003 survey was conducted 
with a standardised methodology and a common questionnaire to provide comparable 
European data.  
 
The publication of the results for the 2003 Irish ESPAD survey allows comparisons with 
the previous Irish ESPAD surveys conducted in 1999 (Hibell et al. 2000) and 1995 
(Hibell et al. 1997). Trends in some of the main indicators of drug use over the last 
eight years are reported in Table 2.3.1. There was a notable increase in lifetime use of 
any illicit drug between 1999 (32%) and 2003 (40%), up 8%. This increase followed a 
drop between 1995 and 1999. Ireland ranked joint third after the Czech Republic (44%) 
and Switzerland (41%) for lifetime experience of any illicit drug in 2003. The average 
for the 35 ESPAD countries in 2003 was 22%. 
 
Table 2.3.1   Changes in the proportion of school-going children (15–16 years) in Ireland using 
drugs in the ESPAD surveys of 1995, 1999 and 2003 
Drug use 1995 survey
% 
1999 survey
% 
2003 survey 
% 
Lifetime use of any illicit drug* 37 32 40 
Lifetime use of cannabis 37 32 39 
Lifetime use of inhalants NA 22 18 
*includes cannabis, amphetamines, LSD or other hallucinogens, crack, cocaine, heroin and ecstasy 
NA = Not Available 
Source: (Hibell et al. 1997; Hibell et al. 2000; Hibell et al. 2004) 
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The majority of those who have tried any illicit drug have used cannabis (marijuana or 
hashish). The lifetime prevalence rates for cannabis use are thus similar to those for 
use of any illicit drug and reflect the same trend. The rate of lifetime use of inhalants 
dropped slightly between 1999 (22%) and 2003 (18%) but remains high. The average 
for the 35 ESPAD countries in 2003 was 10%. 
 
The Irish 2003 ESPAD survey was managed by Dr Mark Morgan, St Patrick’s College, 
Dublin, and funded by the Department of Health and Children. The sampling strategy 
involved a two-step process. All secondary schools were divided into three strata 
(single-sex secondary, mixed secondary, and vocational and community schools). In 
the first sampling step, schools were selected within each strata proportionate to the 
number of schools in the sampling frame. A total of 120 schools were selected in this 
manner. In the second sampling step, two grade-five classes were randomly selected 
from these schools. Out of the 120 selected schools, 108 agreed to participate and, out 
of the 216 classes chosen from these schools, 196 participated. Students in these 
classes who were born in 1987 were asked to complete a questionnaire administered 
by a teacher in the school. A special room in each school was provided for this 
purpose. Data collection was carried out during April. A total of 2,407 students 
participated in the survey. The response rate (participating students in participating 
classes) was 96%. No information was available on the students in non-participating 
schools or classes. As indicated above, the desired target population in the ESPAD 
survey was students born in 1987. However, the ESPAD report notes that in Ireland 
grade five accommodates only about 67% of all students born in 1987. Consequently, 
the Irish results cannot be generalised to 1987-born students in other grades. 
 
On 25 April 2005 the Minister of State at the Department of Health and Children, Mr 
Sean Power TD, announced the publication of The Health of Irish Students report 
(Health Promotion Unit 2005a). The report incorporated the results of the College 
Lifestyle and Attitudinal National (CLAN) survey and a qualitative evaluation of the 
College Alcohol Policy Initiative. The aim of the CLAN survey was to establish a 
national student profile of lifestyle habits, including living conditions, general health, 
mental health, dietary habits, exercise habits, accidents and injuries, sexual health and 
substance use – tobacco, alcohol and illicit drugs (Hope et al. 2005). This information 
will be used in planning for student needs and as a baseline in monitoring trends over 
time. 
 
With regard to alcohol use, three out of every four drinking occasions were binge 
drinking occasions for male students, compared to three out of every five for female 
students. Binge drinking is a term used to describe a single occasion of excessive or 
high-risk drinking, defined in this survey as drinking at least four pints of beer or a bottle 
of wine or equivalent at one drinking occasion. These figures indicate that this pattern 
of high-risk drinking is the norm among college students, with more male than female 
binge drinkers. 
 
The likelihood of students experiencing adverse consequences from their own drinking 
increased with more frequent binge drinking episodes. Students who were regular 
binge drinkers, defined as binge drinking at least weekly, were three times more likely 
to have experienced money problems (32% vs. 10%), fights (22% vs. 6%), accidents 
(13% vs. 4%) and unprotected sex (19% vs. 6%) than were students who were binge 
drinking less frequently, or were not binge drinkers. Regular binge drinkers were also 
twice as likely as other student drinkers to be current smokers (38% vs. 18%) and 
recent cannabis users (54% vs. 25%). Regular binge drinking can also interfere with 
academic performance. For example, regular binge drinkers were twice as likely to 
miss classes due to alcohol (61% vs. 27%) and to report that their studies were 
affected (39% vs. 19%).   
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With regard to drug use, cannabis was the most common illicit drug used by students, 
with over one-third (37%) reporting that they had used it in the past 12 months (Table 
2.3.2). Ecstasy was the second most used illicit drug, followed by cocaine, magic 
mushrooms and amphetamines. For all drugs, the levels of use were higher among 
students than among those of a similar age group (15–24 years) in the general 
population. The use of solvents (inhalants) was particularly high. Male students were 
more likely to use illicit drugs than were female students. Significant differences 
(p<0.01) between genders were observed for cannabis, ecstasy, cocaine, magic 
mushrooms and solvents. 
 
Table 2.3.2   Illicit drug use in past 12 months by undergraduate full-time students (CLAN survey) 
compared to those aged 15–24 years in the general population, 2002/2003 
Used in last 12 months CLAN survey 
 
% 
General population* 
(15–24 years) 
% 
Cannabis 37.3 11.0 
Ecstasy 8.0 2.8 
Cocaine 5.8 2.7 
Magic mushrooms 4.9 1.1 
Amphetamines 4.5 1.2 
Solvents 2.2 0.2 
LSD 1.7 0.2 
Heroin 0.4 0.2 
*  National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005) Drug use in 
Ireland & Northern Ireland. Bulletin 1. First results (revised) from the 2002/2003 drug prevalence survey. Dublin: 
National Advisory Committee on Drugs. 
Source: (Hope et al. 2005) 
 
The report recommends ten actions required to ensure that the college environment is 
more conducive to the positive health and well-being of all students. Acknowledging 
that alcohol-related harm was particularly high and of major concern, the report 
recommends the implementation of all five elements of the college alcohol policy 
framework (Health Promotion Unit 2001). In addition, the report recommends that a 
programme of ongoing research should be agreed to allow for monitoring of trends and 
evaluation of programmes and interventions.  
 
The CLAN survey was carried out among undergraduate full-time students in 21 third-
level colleges in Ireland during the academic year 2002/2003. The colleges included 
seven universities, twelve institutes of technology and two colleges of education. A 
national sample size was calculated using a 3% precision and a 95% degree of 
confidence, with a breakdown for the colleges based on each college population. Each 
participating college generated a random sample from its computerised enrolment list 
of full-time undergraduate students, distributed the self-completed survey questionnaire 
by mail to selected students and collected the completed questionnaires by mail or by 
using drop-off points on campus.  
 
A total of 3,259 students responded to the survey, giving a reported response rate of 
50%. No information is given in the report about those who did not respond, so it is not 
possible to tell if they differed in any way from those who did respond. Of those who did 
respond, 38% were male and 62% were female. Based on Department of Education 
and Science figures, the gender breakdown for persons receiving full-time education in 
the academic year 2002/2003 was 46% male and 54% female (Department of 
Education and Science 2004). Thus, there would appear to be a slight over-
representation of female students in the CLAN survey. 
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2.4 Drug use among specific groups 
Lawless and Corr (2005) at Merchants Quay Ireland assessed the nature, extent and 
experience of alcohol and drug use among people who were homeless in four cities in 
Ireland, namely: Cork, Dublin, Galway and Limerick. The report was prepared for the 
NACD and launched in April 2005. ‘Homelessness’ was defined as living in a hostel or 
shelter, a bed and breakfast, or a squat, or living temporarily with family or relatives. In 
Cork, Galway and Limerick the definition was extended to include transitional housing 
or long-term supported housing.   
 
In Dublin, the sample was selected using a quota sampling based on gender, age and 
primary accommodation type, while in Cork, Galway and Limerick the quota sample 
was based on primary accommodation. The majority (247, 70%) of the sample was 
recruited in Dublin and the remainder (108, 30%) in the other three cities. The 355 
participants were recruited from among those in contact with homeless services in the 
four cities. Drug treatment centres and needle-exchange facilities were excluded from 
the list of services so as to avoid over-estimating the prevalence of drug use.   
 
Between June and October 2003, nine field workers interviewed the participants using 
a semi-structured questionnaire, which:   
• Elicited information regarding basic identifiers, personal characteristics, 
accommodation types, experiences of homelessness, income, health, alcohol 
and drug use, risk behaviours, contact with services and current needs;   
• Measured problem alcohol use using a validated tool known as the Alcohol Use 
Disorders Identification Test Screening Instrument (AUDIT);   
• Assessed drug use through three approaches, which included: 
o European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
standard questions on lifetime, recent and current use of various drug 
classifications; 
o A 10-point version of the Drug Abuse Screening Test (DAST) to identify 
problematic drug use; 
o Severity of Dependence Scale to measure the degree of dependence on 
a variety of drugs. 
Each person interviewed was allocated a unique identifier (initials, gender and date of 
birth) and these identifiers were shared between the fieldworkers so as to avoid 
respondents participating more than once.   
 
The prevalence of drug use among the homeless is presented below.  
• Of the 355 participants,  
o 74% reported illicit drug use at some point in their life, 64% reported 
illicit drug use in the year preceding the study and 52% reported illicit 
drug use in the month preceding the study (Table 2.4.1); 
o Cannabis was the most common illicit drug used, with 69% using it at 
some point in their life, followed by heroin (42%), ecstasy (42%), 
cocaine powder (41%), amphetamines (35%), hallucinogens (28%), 
crack cocaine (19%) and solvents (16%); 
o Cannabis was the most common (43%) illicit drug used in the last 
month, followed by heroin (22%), cocaine powder (17%), ecstasy (12%), 
crack cocaine (3%) amphetamines (2%), hallucinogens (1%), and 
solvents (1%); 
o 45% were using more than one drug at the time of the study and this 
represents 72% of current drug users; 
• Using the DAST screening instrument, 36% of the 355 participants were 
classified as problem drug users and 65% of the 183 current drug users were 
problem drug users; 
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• Using the Severity of Dependence Scale, 43% of the scores of the 183 current 
drug users indicated a high level of psychological dependence. 
 
Table 2.4.1   Prevalence of illicit* drug use in the homeless population in Ireland in 2003 
 
Illicit drug use 
Total  
(n=355) 
% 
Dublin  
(n=245) 
% 
Cork  
(n=36) 
% 
Limerick  
(n=36) 
% 
Galway  
(n=36) 
% 
During lifetime 74 80 72 42 64 
During last year 64 72 53 28 50 
During last month 52 59 42 25 36 
*Illicit drugs defined as cannabis, ecstasy, amphetamines, cocaine powder, crack cocaine, heroin, hallucinogens, and 
solvents 
Source (Lawless and Corr 2005) 
 
As expected, drug use is much more common among the homeless population than 
among the general population. The profile of drug use reported by the homeless 
population in 2003 is similar to that reported by the prison population in 1999 (Centre 
for Health Promotion Studies 2000), indicating the high-risk substance use among 
these two populations and, possibly, considerable overlap between the prison and the 
homeless population. 
 
Of the 352 participants for whom frequency of alcohol use was known, 105 (30%) were 
not drinking alcohol at the time of the survey, while 83 (23%) consumed alcohol on four 
or more days per week. Of those reporting alcohol use at the time of the survey and 
who were screened for problem alcohol use (n=247), 73% had an alcohol problem and 
49% of these had a high-level alcohol problem 
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3. Prevention 
3.1 Overview 
 
In June 2005 the mid-term review of the National Drugs Strategy was published 
(Steering group for the mid-term review of the National Drugs Strategy 2005). The 
review considered both the actions and key performance indicators under the 
Prevention pillar of the Strategy. The National Drugs Strategy (Department of Tourism 
Sport and Recreation 2001) set out nine key performance indicators (KPIs) to measure 
progress under the prevention pillar. The mid-term review of the Strategy recommends 
replacing these with four new KPIs:  
 
• The 3 Source Capture-Recapture study estimate of opiate misusers, due to be 
released in 2007, to show a stabilisation in terms of overall numbers and to 
show a reduction of 5% of the prevalence rate based on 2001 figures 
(published in 2003)  
 
• The NACD Drug Prevalence Survey, due to be released in 2007, to show a 
reduction of 5% in the prevalence rate of recent and current use of illicit drugs in 
the overall population based on 2002/03 rate 
 
• Substance use policies in place in 100% of schools; and  
 
• Early school leaving in LDTF areas reduced by 10% based on 2005/06 rate. 
 
The capture-recapture study and the NACD drug-prevalence study have replaced the 
European School Survey Project on Alcohol and Other Drugs (ESPAD) surveys as 
data sources to assess progress in reducing demand for drugs among the target 
populations under the prevention pillar. However, both studies contain limitations for 
measuring a reduction or otherwise in substance use among 15–16-year-olds in the 
school-going population, whereas ESPAD provided a precise measurement for this age 
band. The capture-recapture study estimates the prevalence of opiate use among 15–
64-year-olds. The NACD drug-prevalence survey estimates the prevalence of different 
illicit drugs in the general population. The sample estimates in both studies would need 
to be much larger to provide robust estimates for this two-year age band to be capable 
of being used to measure a reduction in demand for illicit substances among this target 
group. Both studies would also need to establish who among the respondents in the 
15–16-year age band were attending school. Indeed, the research team behind the 
NACD drug-prevalence study concedes that estimates produced in the 2003 study can 
be treated more robustly for the general population than those for sub-groups of the 
population, such as different age groups (National Advisory Committee on Drugs & 
Drugs and Alcohol Information and Research Unit 2003). This is because the sample 
size was calculated to provide a total population estimate.  
 
It is important to assess the demand for illicit substances among the 15–16-year-old 
school-going population as half of the 16 actions under the prevention pillar target 
school-going young people through interventions designed to address educational 
disadvantage and prevention of substance misuse. The replacement of ESPAD 
represents a missed opportunity to capture data specific to the school-going 
population.  
 
The remaining two KPIs have a strong association in that they can both assess 
progress on actions designed to address educational disadvantage. Consistent 
monitoring and implementation of substance use policies in all schools can create a 
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climate where students with substance misuse issues can be supported rather than 
disciplined. This concern was raised during the consultation process of the mid-term 
review of the National Drugs Strategy. An over-emphasis on disciplinary sanctions 
through suspension and expulsion can contribute to early school leaving. In addition, all 
schools now have a legal obligation to report absences and expulsions to the National 
Educational Welfare Board (NEWB), which in turn has been entrusted with prioritising 
LDTF areas in the course of its work. Early identification of substance-related 
absenteeism and expulsions in LDTF schools through this process requires the early 
intervention of educational welfare officers (EWOs) in conjunction with teachers, 
parents and specialised substance-misuse counsellors. This process can contribute to 
supporting the young person to remain in mainstream education. Failure to intervene at 
this stage will almost certainly add to the numbers of early school leavers and lead to 
an experience of alienation and marginalisation on the part of the young person.  
 
The mid-term review of the National Drugs Strategy contains an overview of progress 
on 16 actions under the prevention pillar. Half of the actions relate to school-based 
prevention programmes that can be broadly categorised into (i) programmes to tackle 
educational disadvantage and (ii) programmes to develop personal skills and make 
students more aware of drug-related issues. Eleven actions are listed as either 
completed or ongoing over the lifetime of the strategy. On the remaining five actions, 
while some progress has been made, further work is necessary or under way in order 
to complete their implementation. The review also contains a number of 
recommendations on actions to be replaced, amended and new actions to be included 
(see Section 1.3).  
 
 
3.2 Universal prevention 
 
School 
 
Implementation of substance use policies in schools 
The Steering Group notes that returns to the Department of Education and Science 
indicate that over 50% of all schools had adopted substance use policies by mid-2004.  
The Group recommends setting a new target date for policies to be implemented in 
schools in high-risk areas, the development of a national monitoring system in schools 
and annual reporting of substance misuse policy implementation. The Group 
recommends replacing Action 43 of the National Drugs Strategy with the following new 
actions: 
 
• Substance use policies should be developed and implemented in all Local 
Drugs Task Force (LDTF) schools by the end of 2005/06 academic year. (New 
Action) 
• A mechanism to monitor the development of substance use policies in all 
schools should be put in place and should report annually. (New Action) 
 
Implementation of Social, Personal and Health Education (SPHE) in schools 
 
Social, Personal and Health Education (SPHE) is a curriculum subject in both primary 
and secondary schools up to Junior Certificate. At both levels, SPHE includes 
dedicated modules focusing on substance use prevention. However, the review noted 
that the practice of implementing SPHE varied between schools. As SPHE is not an 
exam subject, it was found to be lacking in priority as a regular timetable subject. The 
Steering Group believes that consistency in the delivery of SPHE modules is vital to 
their successful implementation. In this context, the Group considers that ongoing 
training and support in prevention education should be made available for teachers 
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and, furthermore, that it should be part of the curriculum for student teachers. The 
group recommends amendments to three existing actions in the Drugs Strategy and 
the inclusion of one new action: 
 
• Appropriate and ongoing training and support services should be put in place 
on a nationwide basis for teachers to deliver the SPHE. (Action 31 amended) 
• The supports provided to LDTF area schools through the Walk Tall support 
service should be extended to other areas of disadvantage. (Action 32 
amended) 
• Schools at primary and post-primary levels should further prioritise the 
implementation of school-based prevention programmes within existing 
timetables. (Action 33 amended) 
• Prevention education should be part of the curriculum for student teachers. 
(New Action) 
 
Understanding Substances and Substance Use – A Handbook For Teachers 
A handbook to assist teachers to deliver substance use education in both primary and 
post-primary schools was launched by the Addiction Services and Health Promotions 
Department of the South Western Area Health Board (SWAHB) and Walk Tall: the 
Substance Misuse Prevention programme at the end of 2004 (Keane et al. 2004). The 
handbook contains basic information on how to mainstream drug terminology and the 
use of slang terms in youth culture; a theoretical model from which to understand the 
different stages of drug use; factual information on administration routes; effects of use, 
risks of short- and long-term use and legal status are given for both licit and illicit drugs. 
In addition, the handbook outlines some of the main factors that can contribute to drug 
use and on the other hand looks at some of the protective factors that can reduce the 
risks of engaging with drugs.  
 
The handbook contains a useful exploration of what is termed the 'epidemiological 
triangle of drug use', considering the interaction of different factors that influence the 
effects of a drug. The section is grounded in the theoretical proposition of Zinberg 
(1984). According to Zinberg, there are three key factors in play when drugs are being 
used: the make up and compound of the drug itself (drug), the psychology of the 
person (set) and the social environment (setting). Reference to the framework provides 
for the removal of the temptation to demonise the properties of drugs as solitary effect 
producers, without considering the psychological condition and social context of the 
user. The drug, set and setting framework can be a useful basis of discussion for 
teachers, particularly in secondary-school drug education, as it has the capacity to 
enable teachers to neither deny nor demonise the effects that drugs can produce but 
instead understand such effects through the interaction between users, the drug and 
the environment.  
 
The handbook also addresses the signs and symptoms of drug use and the issue of 
home drug testing. The section highlights the need for teachers and parents to be 
aware that signs and symptoms that may traditionally be linked to drug use, such as 
erratic mood swings, changes in appearance and loss of interest in school, are also 
normative aspects of the experience of adolescence.  
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Family 
 
Support for parents and families  
The Steering Group for the mid-term review of the National Drugs Strategy noted that a 
number of interventions in LDTF areas targeted parents of at-risk young people and 
families of drug users, but also highlighted the continuing gap in support services for 
parents and families outside LDTF areas. It noted that phase two of the National Drugs 
Awareness Campaign had attempted to bridge this gap by focusing on parents by 
means of information on the campaign website and leaflet distribution. The approach 
adopted in this second pahse is as follows: 
 
 Target group Actions Rationale 
Second phase of the 
National Drugs Awareness 
Campaign 
Parents 'Parent orientated' TV and 
radio ads; parents’ 
information booklet; a 
roadshow inviting parents 
nationwide to Q&A 
sessions locally 
To encourage more open 
communication between 
parents and children 
 
However, the Steering Group concluded that, despite the availability of this material, 
confusion existed among parents and families as to how best to access information 
regarding drugs. The group recommended the replacement of Action 35 and the 
inclusion of a new action to support parents and families: 
 
• Factual preventative information for parents and families in dealing with 
substance misuse should be more easily accessible in appropriate locations 
such as Garda Stations, Libraries, Health Centres and other public offices 
(Action 35 replaced). 
• The role of the Home School Community Liaison Scheme (HSCL)2 should be 
further strengthened through the provision of additional resources; in particular, 
there is a need to expand the engagement of HSCL with families dealing with 
drug misuse (New action). 
 
The creation of a cross-pillar on Family Support Services in drug prevention is also 
proposed as a new action in the review. The review supports the implementation of 
recommendations contained in the 2004 NACD report, The Role of Family Support 
Services in Drug Prevention (Watters and Byrne 2004). The recommendations are:  
 
• increase the capacity of services to respond through an appropriate level of 
resources and training for staff in services 
• strengthen inter-agency links and networks by building knowledge of local 
community issues and attitudes thus improving communication 
• develop relevant monitoring and evaluation tools to measure effectiveness of 
services.  
 
The National Drugs Strategy Team (NDST) is given primary responsibility for 
encouraging the local and regional drugs task forces to prioritise the provision of family 
support services in their areas and action plans.  
 
                                                
2 The Home School Community Liaison scheme (HSCL) focuses on primary and post-primary schools that have been designated as disadvantaged 
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Community 
 
Prevention programmes in non-school settings 
The Steering Group for the mid-term review of the National Drugs Strategy notes that, 
while there has been progress in developing non-school-based programmes in recent 
years, there are gaps and a lack of consistency in the way the programmes are 
delivered by the different agencies. The group recommends an amendment to Action 
37 to address these gaps: 
 
• A working group should be established under the aegis of the Department of 
Education and Science to examine this area, to identify ongoing gaps and to 
develop guidelines and models of best practice for the implementation of 
substance-use programmes in non-school settings. The group should report by 
January 2006 (Action 37 amended). 
A new fund to tackle emerging needs in the LDTF areas has been announced by the 
Department of Community, Rural and Gaeltacht Affairs. This fund is currently being 
used to finance the piloting of interventions to address cocaine use in some 
communities. These interventions include training of frontline staff in both the 
community and statutory sectors dealing with cocaine users; the production of 
educational material outlining the dangers associated with cocaine use; and four pilot 
treatment interventions for specific groups such as intravenous cocaine users, 
problematic intranasal cocaine users and problematic female cocaine users. 
3.3 Selective/indicated prevention  
 
In the areas of selective and indicated prevention, the Steering Group highlights a 
number of interventions that require further development. For example, the group notes 
the importance of youth work in engaging with young people in a non-school setting, 
particularly those most at risk. In this context, the group highlights alternatives to drug 
misuse for young people and the need to prioritise high-risk areas within LDTFs 
through the Young People's Facilities and Services Fund (YPFSF) and the Sports 
Capital Programme (SCP).  The YPFSF aims to divert at-risk young people (aged10–
21) in disadvantaged areas from engaging in substance misuse through targeted 
funding of services and facilities. The SCP provides similar funding and support to 
sporting interventions in designated disadvantaged areas.  
 
The Steering Group acknowledges that approximately €85 million has been allocated, 
primarily to the 14 LDTF areas, to support over 450 services and facilities projects. The 
group states that access by the target group to these facilities, particularly to the larger 
youth and community facilities being put in place though the YPFSF, is a key issue and 
one that is being actively monitored by the Fund’s National Assessment Committee. 
The group recommends that expansion of the Fund to other areas of similar need, 
outside of the LDTFs, needs to be actively progressed; it notes that ongoing work by 
the NDST regarding the identification of future task force areas is relevant in this 
regard. Also, the group believes that targeting potentially high-risk groups, such as 
foreign national young people, should be a priority area for the Fund in the future.  
 
The Steering Group welcomes the recent circular from the Department of Education 
and Science encouraging schools to allow community access to their premises outside 
of school hours. The group also notes that this issue is being considered at present by 
the National Assessment Committee (NAC) and that the Committee will be developing 
proposals in this regard which will be brought to the IDG for consideration as soon as 
possible.  
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4. Problem Drug Use 
 
4.1 Overview 
This section provides an overview of new developments and trends in the prevalence 
and characteristics of problem drug use in Ireland for 2004 and early 2005.  
 
The EMCDDA defines problem drug use as ‘injecting drug use or long duration/regular 
use of opiates, cocaine and/or amphetamines’ (EMCDDA 2004: 50). However, this 
section, written following EMCDDA guidelines, requires clients in treatment to be 
covered. It should be stressed that not all clients in treatment fit the above EMCDDA 
definition of problem drug use. 
 
 
4.2 Prevalence and incidence estimates 
No new prevalence and incidence studies have been carried out or published in the 
current reporting period.  
 
The last national prevalence estimate for problem drug use was for opiate users. The 
research – the first national study of its type – was commissioned by the NACD and 
conducted by a team from Trinity College Dublin (Kelly et al. 2003). A three-source 
capture-recapture methodology was applied following guidelines recommended by the 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA 2002b). Three 
national data sources were used for both 2000 and 2001: clients in methadone 
substitution treatment, individuals known to be opiate users by An Garda Síochána 
(Irish police), and patients discharged from acute hospitals with an International 
Classification of Diseases code corresponding to drug dependence.  
 
While the estimated number of opiate users increased slightly between 2000 and 2001, 
the rate per 1,000 population aged 15–64 years remained remarkably stable at 5.6. For 
both years, rates were higher for men than women in all age categories. 
 
Opiate use is still predominately a Dublin phenomenon, which was reflected in the 
finding that the rate of opiate use in Dublin in 2001 was 15.9 per 1,000 population aged 
15–64 years and outside Dublin the rate was just under 1.2 per 1,000 population aged 
15–64 years. 
 
 
4.3 Profile of clients in treatment 
 
Substances used 
Drug treatment data are viewed as an indicator of drug misuse as well as a direct 
indicator of demand for treatment services. The National Drug Treatment Reporting 
System (NDTRS) is an epidemiological database on treated problem drug use in 
Ireland.  The NDTRS is co-ordinated by staff at the Drug Misuse Research Division of 
the Health Research Board on behalf of the Department of Health and Children.  For 
the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to 
ameliorate the psychological, medical or social state of individuals who seek help for 
their drug problems.’   
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Numbers treated by place of residence 
The number of treated cases in Ireland reported to the NDTRS has increased steadily, 
from 6,048 in 1998 to 9,084 in 2003 (Table 4.3.1).  This increase is explained by a 
combination of factors: a true increase in drug use, an increase in access to treatment 
services, and an increase in the number of centres reporting cases to the NDTRS.   
 
Table 4.3.1   Number (%) of cases treated for problem drug use, by treatment status, in Ireland, 
1998–2003 
Treatment status 1998 1999 2000 2001 2002 2003 
 Number (%) 
       
All cases 6048 6206 6933 7900 8596 9084 
Previously treated cases 4194 
(63.9) 
4421 
(71.2) 
4877 
(70.3) 
5664 
(71.7) 
6259 
(72.8) 
6772 
(74.5) 
New cases 1626 
(26.9) 
1673 
(27.0) 
1941 
(28.0) 
2073 
(26.2) 
2098 
(24.4) 
2198 
(24.2)  
Status unknown 228 
(3.8) 
112 
(1.8) 
115 
(1.7) 
163 
(2.1) 
239 
(2.8) 
114 
(1.3) 
Source: unpublished analysis from the NDTRS 
 
The numbers treated for problem drug use and residing in the Health Service Executive 
(HSE) Eastern Region (Dublin, Kildare, Wicklow) increased by 23% between 1998 and 
2003, while the numbers treated for problem drug use and residing in the seven health 
board areas outside the HSE Eastern Region increased by 197% during the same 
period (Table 4.3.2).  The numbers treated for problem drug use and residing in the 
HSE Eastern Region are substantially higher than numbers treated for problem drug 
use residing outside the HSE Eastern Region.  Of note, as a proportion of all treated 
problem drug users, the proportion living outside the HSE Eastern Region increased 
from 15% in 1998 to 29% in 2003; this suggests that drug misuse is becoming a 
problem outside this region.   
 
Table 4.3.2   Number (%) of cases treated for problem drug use, by HSE area of residence, 1998–
2003* 
Area of residence 1998 1999 2000 2001 2002 2003 
 Number (%) 
       
All cases 6048 6206 6933 7900 8596 9084
HSE Eastern Region 5083 
(84.0) 
5152 
(83.0) 
5323 
(76.8) 
5868 
(74.3) 
6248 
(72.7) 
6405 
(70.5) 
Seven HSE areas outside the 
HSE Eastern Region * 
886 
(14.6) 
1031 
(16.6) 
1596 
(23.0) 
2024 
(25.6) 
2328 
(27.1) 
2629 
(28.9) 
Non-resident 10 (0.2) 12 (0.2) 9 (0.1) 7 (0.1) 9 (0.1) 3 (0.0) 
Address unknown 69 (1.1) 11 (0.2) 5 (0.1) 1 (0.0) 11 (0.1) 46 (0.5) 
*The seven HSE areas are the: Midland, Mid-Western, North Eastern, North Western, Southern, South Eastern and 
Western. 
Source: unpublished analysis from the NDTRS 
 
 
Main problem drug   
 
The profile of main problem drugs reported by treated cases differed by place of 
residence (Table 4.3.3).  Overall, 94% of treated cases residing in the HSE Eastern 
Region reported an opiate as their main problem drug, while almost 20% of treated 
cases residing outside the HSE Eastern Region area reported an opiate as their main 
problem drug.  Just under 3% of treated cases residing in the HSE Eastern Region 
reported cannabis as their main problem drug, while just over 55% of treated cases 
residing outside the HSE Eastern Region reported this as their main problem drug.  In 
both areas, the numbers reporting cocaine as their main problem drug increased but 
the increase is greater outside the HSE Eastern Region.  It is important to note that 
cocaine is mainly reported as a second, third or fourth problem drug.  The reason that 
cocaine was reported as an additional problem drug in 2003 is that 84% of cases 
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reporting cocaine use are attending opiate treatment services and service providers 
reported opiates as the treated drug user’s main problem drug.   
 
Table 4.3.3   Main problem drug reported by cases treated for problem drug use, by HSE area of 
residence, 1998–2003 
Main problem 
drug 
1998 1999 2000 2001 2002 2003 
 Number (%)
       
HSE Eastern 
Region 5070 5152 5323 5868 6248 6405 
Opiates 4652 (91.8) 4840 (93.9) 5031 (94.5) 5631 (96.0) 5921 (94.8) 6020 (94.0) 
Cannabis 206 (4.1) 168 (3.3) 137 (2.6) 95 (1.6) 177 (2.8) 165 (2.6) 
Benzodiazepines 57 (1.1) 27 (0.5) 56 (1.1) 57 (1.0) 42 (0.7) 63 (1.0) 
Cocaine 56 (1.1) 32 (0.6) 47 (0.9) 43 (0.7) 73 (1.2) 134 (2.1) 
Ecstasy 46 (0.9) 50 (1.0) 32 (0.6) 30 (0.5) 18 (0.3) 11 (0.2) 
Amphetamines 24 (0.5) 18 (0.3) 2 (0.0) 4 (0.1) 1 (0.0) 2 (0.0) 
Volatile inhalants 18 (0.4) 8 (0.2) 11 (0.2) 3 (0.1) 3 (0.0) 6 (0.0) 
Other substances 11 (0.2) 9 (0.2) 7 (0.1) 5 (0.1) 13 (0.2) 4 (0.1) 
       
Seven HSE areas 
outside the HSE 
Eastern Region 886 1031 1596 2024 2328 2629 
Cannabis 419 (47.3) 553 (53.6) 933 (58.5) 1146 (56.6) 1334 (57.3) 1424 (54.2) 
Opiates 160 (18.1) 181 (17.6) 241 (15.1) 397 (19.6) 490 (21.0) 637 (24.2) 
Ecstasy 148 (16.7) 164 (15.9) 257 (16.1) 271 (13.4) 245 (10.5) 248 (9.4) 
Amphetamines 48 (5.4) 42 (4.1) 28 (1.8) 17 (0.8) 29 (1.2) 34 (1.3) 
Benzodiazepines 37 (4.2) 23 (2.2) 42 (2.6) 52 (2.6) 64 (2.7) 57 (2.2) 
Cocaine 27 (3.0) 24 (2.3) 31 (1.9) 52 (2.6) 79 (3.4) 174 (6.6) 
Volatile inhalants 17 (1.9) 24 (2.3) 30 (1.9) 37 (1.8) 43 (1.8) 23 (0.9) 
Other substances 30 (3.4) 20 (1.9) 34 (2.1) 52 (2.6) 44 (1.9) 32 (1.2) 
Source: unpublished analysis from the NDTRS 
 
Substance use among young treated drug users 
 
In Europe, adolescent substance misuse increased during the 1990s. Ireland has 
among the highest rates of substance misuse among schoolchildren in Europe. Smyth 
and O’Brien (2004) sought to describe the socio-demographic and drug-misuse profile 
of children presenting to addiction treatment services in Dublin during the 1990s. Of the 
9,874 individuals who sought addiction treatment, 1,953 (20%) were aged less than 18 
years. There was a sharp increase in the number of children seeking treatment after 
1993. The main drug of abuse was an opiate in 48% of cases. Compared to adults, the 
children were more likely to be female and less likely to inject. As the decade 
progressed, the proportion of girls increased, injecting was reported more frequently 
and there was a dramatic rise in heroin misuse. Child heroin users were more likely to 
be female and to be homeless, compared to their adult counterparts. This study 
highlights the need for a dedicated service for child drug users in Dublin. 
 
 
 
4.4 Main characteristics and patterns of use from non-treatment 
sources 
Drug use among new communities in Ireland: An exploratory study 
 
Corr (2004) carried out research to develop an understanding of problematic drug use 
among new communities in Ireland.  
 
Three members from new communities (a Russian, a Romanian and a Nigerian) were 
recruited and trained in ethnographic fieldwork techniques. The recruits then carried 
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out 280 hours of fieldwork.  The fieldwork included observing drug users in their own 
social setting and recording informal discussions with drug users and key informants; 
the data collected was recorded in a daily diary. In addition, 10 individuals from new 
communities who described themselves as problematic drug users participated in 
semi-structured in-depth interviews. Six of these interviewees were from Africa, three 
from the former USSR and one from Central/Eastern Europe. Also, the staff at 
Merchants Quay research unit organised two focus groups: one with individuals 
working with new communities in Ireland and one with drug service providers.  
 
Of the 10 problem drug users who were interviewed, seven reported heroin and three 
reported cocaine as their respective drugs of choice. Five interviewees reported 
injecting heroin. In general, there were reports of drug injecting taking place among 
individuals from Russia, Estonia and Pakistan. As a rule, heroin users from Africa 
reported smoking heroin rather than injecting it. Some members of the Somali 
community were reported to be using Khat, a chewable green leaf stimulant, while 
some members of the Russian community were reported to make a special porridge 
called Kasha, which is laced with cannabis.  None of the 10 were in treatment.   
 
With respect to accommodation, seven were staying in emergency hostels; two were 
staying with friends and one lived in rented accommodation. Eight interviewees were 
unemployed and two in full-time employment. With respect to legal status, four were 
seeking asylum, four were undocumented immigrants, one was documented as a 
labour migrant and one had refugee status. 
 
Issues of social exclusion were particularly prominent among the interviewees. Both 
interviewees and drug users encountered during the fieldwork cited escape from their 
current situation as a reason for continuing or initiating drug use. Their current 
experiences included feeling excluded, isolated and fearful of state authorities. Some 
reported using drugs to escape episodes of post-traumatic stress disorder arising from 
their experiences of war and torture prior to arriving in Ireland. Four interviewees had 
no history of problematic drug use prior to arriving in Ireland, while one had ceased 
using drugs for 10 years and had restarted in Ireland. Younger members of new 
communities were reported to use drugs as a means of mixing with and gaining 
acceptance from Irish peer groups, mainly in recreational settings such as clubs.  
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5. Drug-Related Treatment 
5.1 Overview 
This section presents new data on the treatment system and provides updated 
information on medically assisted treatment.  The definitions used are presented where 
necessary in the relevant sections.   
 
5.2 Treatment system 
On 1 January 2005, the ten health boards managing the health services in Ireland were 
replaced by a single entity, the Health Service Executive (HSE), which will manage 
Ireland’s public health sector (Health Act 2004). The Chief Executive Officer of the HSE 
is directly accountable to the Oireachtas for the performance and management of the 
HSE and the Department of Health and Children is responsible for legislation and 
policy. The former health boards were responsible for health care provision to 
populations in specific geographical areas. In the interest of continuity of care, the HSE 
has maintained these ten areas for an interim period and called them HSE areas. 
When the HSE has established itself and redeployed staff, health care will be provided 
through four HSE regions and 32 local health offices. This process commenced on 1 
September 2005. The local health offices are based on the geographical boundaries of 
the existing community care areas. Table 5.2.1 presents the past health board 
structure, the present interim structure and the proposed future regional structure of the 
public health services in Ireland.   
 
Table 5.2.1   The past health board structure, present interim structure and the proposed future 
regional structure of the public health services in Ireland 
Regional Health 
Authority 
Health boards HSE areas HSE regions  Local health 
offices/community 
care areas 
Not applicable North Eastern Health 
Board 
HSE North Eastern 
Area 
 
HSE 
Dublin/North 
East Region 
Cavan/Monaghan 
Louth  
Meath  
Dublin community 
cares areas 6–8 
 
Eastern Regional Health 
Authority (ERHA*) 
Northern Area Health 
Board 
HSE Northern Area 
Eastern Regional Health 
Authority (ERHA) 
East Coast Area Health 
Board 
HSE East Coast Area  
HSE 
Dublin/Mid-
Leinster Region 
Dublin community 
cares areas 1–5 
Wicklow  
Kildare 
Laois/Offaly 
Longford/Westmeath 
 
Eastern Regional Health 
Authority (ERHA) 
South Western Area 
Health Board 
HSE South Western 
Area 
Not applicable Midland Health Board HSE Midland Area 
Not applicable South Eastern Health 
Board 
HSE South Eastern 
Area 
 
HSE Southern 
Region 
Carlow/Kilkenny 
Wexford 
Waterford 
South Tipperary  
Four community care 
areas of Cork (North 
Lee, South Lee, North 
Cork, West Cork) 
Kerry 
 
Not applicable Southern Health Board HSE Southern Area 
Not applicable Mid-Western Health 
Board 
HSE North Western 
Area 
 
HSE Western 
Region 
Donegal 
Sligo/Leitrim 
Galway 
Mayo 
Roscommon 
Clare 
Limerick (part of) 
North Tipperary/East 
Limerick 
Not applicable North Western Health 
Board 
HSE Western Area 
Not applicable Western Health Board HSE Mid-Western 
Area 
*The ERHA is known as the HSE Eastern Region for the interim period 
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The Inter-Departmental Group (IDG) overseeing the implemention of the National 
Drugs Strategy expanded to include senior-level representation from the HSE. The 
mid-term review of the Strategy (Steering group for the mid-term review of the National 
Drugs Strategy 2005) also recommends that both the Department of Health and 
Children and the HSE be represented on the National Drugs Strategy Team (NDST). 
 
In March 2005, the HSE published its National Service Plan for 2005, outlining how the 
HSE intends to deliver its drug treatment services (Health Service Executive 2005).  
The management of all addiction services will be under the remit of the Primary, 
Community and Continuing Care service delivery unit, which will oversee a number of 
national care groups.  The national care group with specific responsibility for addiction 
services is Social Inclusion Services, but the management of methadone treatment 
services also appears under the remit of Primary Care Services and the management 
of detoxification also appears under the remit of Mental Health Services.  Therefore, it 
is not clear who is responsible for which aspects of the addiction services at present. 
The HSE National Service Plan (NSP) for 2005 emphasises that responses to the 
needs of those dependent on drugs or alcohol require a partnership approach across 
organisational boundaries (including drugs task forces) together with clear strategies to 
prevent and reduce levels of drug or alcohol misuse and harm. The plan also endorses 
a needs-based approach to the delivery of services that minimises disadvantage. 
 
A clear alignment with the National Drugs Strategy is established through the 
commitment made in the national service plan for 2005 to Action 22 of the national 
health strategy, Quality and Fairness, which states that all relevant actions in the 
National Drugs Strategy will be implemented by 2008 (Department of Health and 
Children 2001).  Moreover, the national service plan for 2005 commits Addiction 
Services, within Social Inclusion Services, to providing six-monthly reports to the 
Department of Community Rural and Gaeltacht Affairs on the implementation of the 
National Drugs Strategy, supporting the Health Research Board (specifically the 
National Drug Treatment Reporting System), and implementing the research 
recommendations of the NACD.  The NSP states that the HSE’s Addiction Services will 
monitor the two key performance indicators that relate to timeliness of access to 
treatment services.  The NSP was published prior to the mid-term review of the 
National Drugs Strategy and will be tailored in 2006 in light of the review findings.   
 
The National Drugs Strategy identified seven key performance indicators to measure 
progress under the treatment pillar (Department of Tourism Sport and Recreation 
2001). The mid-term review recommends that these be replaced by four new key 
performance indicators (Steering group for the mid-term review of the National Drugs 
Strategy 2005). The current key performance indicators monitor progress in relation to 
the provision of treatment places, prison-based treatment services, service user 
charters and rehabilitation. The number of treatment places for opiate addiction 
increased from 6,000 places by end 2001 to 7,390 places by end March 2005; this key 
performance indicator has been achieved.  According to the mid-term review, a number 
of services have drafted service-user charters and this process will be completed by 
the HSE.  Although the mid-term review recognised that more needs to be done, the 
prison services have developed an infrastructure for the delivery of methadone 
treatment and set up a number of drug-free units since 2001.  The introduction of 
counselling services and the development of post-release arrangements for those 
requiring treatment or harm reduction services will be required in the future; this key 
performance indicator has been discontinued and the rationale for the removal of this 
indicator is not stated.   
 
The key performance indicators on treatment have been revised to reflect the diversity 
of drug types and number of drugs used by those seeking treatment and requires that:  
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• 100% of problematic drug users will access appropriate treatment within one 
month after assessment. 
 
A set of guidelines has been developed and agreed (published in September 2005) to 
guide the treatment of problem drug users aged under 18 years and the KPI has been 
replaced with a new indicator: 
 
• 100% of problematic drug users aged under 18 will access treatment within one 
month after assessment 
 
The two KPIs relating to treatment will be measured through the HSE’s Addiction 
Services and the HRB’s National Drug Treatment Reporting System.   
 
The mid-term review of the National Drugs Strategy specified a number of actions for 
the HSE:  
 
• an audit of the current availability of treatment options, including an assessment 
of treatment needs and methods of tracking ongoing developments, to be 
completed by mid-2006; 
• increase the availability and range of drug-related treatment options, including 
detoxification; 
• expand the provision of needle-exchange and harm-reduction services to 
ensure wider geographic availability and availability at evenings and weekends; 
• increase the numbers of GPs and pharmacies participating in the methadone 
protocol. 
 
Treatment is provided through a network of statutory and non-statutory agencies.  
There are two broad philosophies through which treatment services are provided, 
namely: medication-free therapy and medically assisted treatment.  There is a small 
degree of overlap between the two.  Medication-free therapy uses models such as 
therapeutic communities and the Minnesota Model, though some services have 
adapted these models to suit their particular clients’ needs. Medication-assisted 
treatment includes opiate detoxification and substitution therapies, alcohol and 
benzodiazepine detoxification, and psychiatric treatment.  Various types of counselling 
are provided through both philosophies of treatment and independent of either type of 
treatment.  Alternative therapies, such as aquapuncture, are provided through some 
community projects in Dublin.    
 
The total number of drug treatment services available in Ireland and participating in the 
NDTRS increased between 1998 and 2003 (Table 5.2.2). The largest increase was in 
outpatient treatment services. In the HSE Eastern Region, counsellors employed by 
statutory services did not consistently return information on cases who received 
counselling only, therefore there is an under-representation of cases in this region 
treated for use of drugs other than opiates.  There was a small decrease in the number 
of residential treatment services.  Though only 31 (10%) general practitioners provided 
returns to the NDTRS in 2003, there were 205 general practitioners prescribing 
methadone treatment in Ireland during December 2003. The prison service does not 
participate in the NDTRS, although it does provide drug treatment services.   
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Table 5.2.2   Number and type of services providing treatment for problem drug use and number of 
cases treated (in brackets) in Ireland and reported to the NDTRS, 1998 to 2003 
Drug services 1998 1999 2000 2001 2002 
 
2003 
Outpatient 83 (4566) 86 (4497) 105 (5583) 120 (6688) 124 (7270) 135 (7576)
Residential 17 (1272) 16 (1005) 18 (796) 16 (725) 21 (798) 17 (911)
Low-threshold* 3 (182) 4 (284) 2 (280) 2 (216) 2 (149) 3 (259)
General practitioner 1 (24) 42 (413) 29 (274) 32 (271) 28 (371) 31 (323)
Treatment in prison 2 (4) 2 (7) 0 (0) 0 (0) 0 (0) 1 (11)
Not known 0 (0) 0 (0) 0 (0) 0 (0) 1 (8) 0 (0)
*Low-threshold services are services that provide low-dose methadone or drop-in facilities only.  
Source: unpublished data from the NDTRS. 
 
Action 49 of the National Drugs Strategy 2001–2008 identified the need to develop a 
protocol for treating under-18-year-olds presenting with serious drug problems 
(Department of Tourism Sport and Recreation 2001).  A working group established in 
October 2001 published its report in September 2005 (Working Group on treatment of 
under 18 year olds 2005). The working group reviewed the extent of the problem and 
noted that ‘attendances by children account for a substantial proportion of the workload 
of the addiction services in Ireland’. The group considered the legal and ethical issues 
surrounding the treatment of persons under 18 years old presenting with serious drug 
misuse problems. The group acknowledged the difficulties experienced by service 
providers, particularly in relation to consent and family involvement.  They noted that 
the current legislation allowed persons aged 16 to 17 years to consent on their own 
behalf to certain treatments. However, there appeared to be some doubt as to whether 
the courts would accept that such consent would apply to drug treatment.  In this 
context, it was felt that the concept of Gillick competence, whereby professionals could 
assess whether a young person was competent to give informed consent, could play 
an important role. The working group recommended that, where possible, the family be 
involved in treatment as this leads to better outcomes. The group stated that 
substitution treatment should not be initiated outside a specialist context. The working 
group believed that the four-tiered model developed by the Health Advisory Service in 
the UK, adapted as necessary to an Irish context, would best deliver effective services 
to young people presenting with problem drug use. This approach would ensure that 
the services provided would be based on the specific needs of the child and their 
family; provide a full range of drug-related education, prevention and treatment 
interventions; and be competent to deal with the complex ethical and legal issues 
surrounding such interventions. The four tiers were:  
Tier 1  Generic services provided by teachers, social services, gardaí (police), general 
practitioners, community and family groups for those at risk of drug use.  
Generic services would include advice and referral.   
Tier 2  Services with specialist expertise in either adolescent mental health or 
addiction, such as juvenile liaison officers, local drugs task forces, home–school 
liaison, youthreach and drug treatment centres.  They types of service delivered 
at this level would include brief intervention, counselling and harm reduction.   
Tier 3  Services with specialist expertise in both adolescent mental health or addiction 
and the capacity to deliver a combination of treatments through a multi-
disciplinary team. 
Tier 4  Services with specialist expertise in both adolescent mental health and 
addiction and the capacity to deliver a brief, but very intensive intervention 
through an inpatient or day hospital.   
 
The working group agreed that the services would be adolescent-specific, local and 
accessible, have a combination of disciplines on site, and offer assessment, treatment 
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and aftercare. In addition to the extra resources required to address the needs of these 
young people, it was suggested that greater co-ordination could maximise the impact of 
existing services.   
 
 
5.3 Drug-free treatment 
There is no new published information on drug-free treatment.   
 
 
5.4 Medically assisted treatment 
Approximately one-quarter of those who ever use heroin will develop dependence. In 
Ireland, opiate dependence is classified using the International Classification of 
Diseases and Related Health Disorders, Tenth Revision (WHO 1992). The Code F11.2 
describes an opiate-dependent client as one with ‘a strong desire to take opiates, 
difficulties in controlling their use, persistence in their use despite harmful 
consequences, a higher priority given to opiate use than to other activities and 
obligations, increased tolerance and physical withdrawals’.  Medically assisted 
treatment is also used to manage persons with alcohol or benzodiazepine dependence 
and similar definitions apply.   
 
Detoxification 
Three inpatient units and a number of outpatient treatment centres provide 
detoxification for problem opiate and benzodiazepine users in Ireland. Inpatient 
treatment centres generally provide detoxification and early rehabilitation on a short-
term basis (2 to 12 weeks). Methadone is the most commonly used drug for opiate 
detoxification; in recent years buprenorphine and lofexidine have also been used to 
detoxify opiate users in treatment centres in this country. Subutex® has been 
authorised for use in opiate dependence in Ireland since late 2002, but there is no 
combination of buprenorphine and naloxone treatment currently authorised. On 
completion of inpatient and outpatient detoxification, a number of clients go on to 
residential or non-residential after-care programmes. Of the 9,084 cases reported to 
the NDTRS in 2003, 803 (9%) attended an opiate or benzodiazepine detoxification 
service.   
 
Smyth et al. examined the medium-term follow-up outcomes of 109 patients attending 
an inpatient opiate detoxification programme between July 1995 and December 1996; 
five patients died following discharge and 109 (76%) of the remaining 144 admissions 
were interviewed (Smyth et al. 2005b).  The outcomes were ascertained through one 
interview (at between 18 and 42 months) following discharge from the inpatient opiate 
detoxification programme.  The interview determined recent opiate use and asked 
about pre-treatment and treatment adherence characteristics.  Of the 109 patients 
interviewed, 25 (23%) reported using neither opiates nor prescribed methadone 
recently.  After controlling for confounding factors, opiate abstinence was found to be 
significantly associated with completion of an inpatient treatment programme (Odds 
ratio 4.1, 95% CI 1.4–11.9), persistence with aftercare (Odds ratio 7.6, 95% CI 2.3–
25.3) and the absence of a family history of substance misuse (Odds ratio 3.3, 95% CI 
1.1–9.9).   
 
Opiate substitution 
 
Methadone maintenance involves the daily administration of methadone (an oral opioid 
agonist) as a treatment for opiate dependence. In Ireland, methadone is the opiate 
substitute of choice for maintenance therapy (Methadone Treatment Services Review 
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Group 1998). The aim of methadone maintenance therapy is to replace illicit opiate use 
with a licit oral medication in order to provide the individual with a stable lifestyle and 
reduce the harms associated with problem opiate use. Methadone is taken once per 
day because its long duration eliminates withdrawal symptoms for between 24 and 36 
hours. Given in high doses it reduces the craving for heroin and blocks the euphoric 
effects of heroin if the two drugs are taken together.  
 
Policy and protocols 
 
In 2002, the Department of Health and Children requested the Methadone Prescribing 
Implementation Committee to review the Methadone Protocol that was introduced in 
October 1998. The published review was released in June 2005 (Methadone 
Prescribing Implementation Committee 2005). 
 
According to the review, there were 6,883 people receiving methadone treatment in 
Ireland at the end of December 2003.  
 
As part of the review, submissions were invited from interested parties and 46 
submissions were received in September 2002. The submissions were analysed to 
identify themes and recommendations were made to address the themes identified.  
 
The themes identified through the submissions were: 
 
• Breadth of representation on the Methadone Prescribing Implementation 
Committee  
A number of submissions identified the need to invite onto the committee 
representatives from the community, service users, the voluntary sector, the Drug 
Treatment Centre Board, the former area health boards and the Irish Psychiatric 
Association. The committee will invite representatives of the Drug Treatment Centre 
Board, the former area health boards and the Irish Psychiatric Association to sit on the 
committee.  
 
• Revising aspects of the regulations 
Several submissions requested revisions to the prescribing of methadone. None of 
these suggestions were taken on board as it would mean re-writing the regulations.  
 
• Clients’ experiences of methadone treatment services 
Clients attending methadone treatment programmes requested that all clients should 
participate in their treatment plan, stable clients should not need to attend weekly, 
individual appointment times should be given to clients, clients continuing to use drugs 
chaotically should be treated separately from more stable clients, and the issue of 
privacy with respect to urinalysis should be addressed. The committee recommended 
that it would be more appropriate to address these issues through the service users’ 
charter in each HSE area.  
 
• Issues pertaining to general practitioners 
A number of submissions stated that there is a need to take a co-ordinated approach to 
methadone treatment outside the HSE Eastern Region and to increase the recruitment 
of level 1 and level 2 general practitioners throughout the country. The committee will 
review the role of the National General Practitioner Co-ordinator to ensure greater 
support to the areas outside the Eastern Region. A small number of general 
practitioners requested an increase in the number of clients that a practitioner is 
permitted to treat. The committee will deal with such requests on an individual basis. It 
was suggested that training on treating opiate misuse be included in undergraduate 
and postgraduate medical training. In addition, it was suggested that specialist 
Ireland – National Report 2004  45
methadone training should continue and that completion of such training should be one 
of the criteria for General Medical Service posts in deprived areas. These ideas were 
welcomed by the committee and will be recommended to the relevant authorities. It 
was also suggested that general practitioners be given the resources to comply with 
the requirements of the NDTRS. Such compliance is a condition of the general 
practitioners’ contract negotiated in 2003.  
 
• Issues pertaining to pharmacists 
Pharmacists requested joint training with other health professionals, which the 
committee considered a useful suggestion. The need to increase the recruitment of 
pharmacists was raised. The committee recommended the employment of a liaison 
pharmacist for the HSE areas outside the Eastern Region. Some pharmacists 
requested routine hepatitis B vaccination; this is available free from the HSE to all 
participating pharmacists and their staff. Pharmacists and clients raised the issue of 
security and privacy in pharmacies. The committee reported that these issues were 
outside their remit as they had resource implications, and noted that grants were 
available through the HSE for upgrading premises. Some pharmacists reported that a 
regular client might present to a pharmacy without a prescription, giving rise to a 
dilemma for the pharmacist: to follow the regulations, or to fulfil the duty of care to the 
client. The committee took a pragmatic view, stating that the pharmacist should provide 
the previously prescribed treatment, document the experience and ensure the client 
sought an up-dated prescription as soon as possible. Actions should be taken to 
prevent its occurrence if this practice is repeated on a regular basis.  
 
• Co-ordination between services and continuity of care for clients 
According to the text of the submissions, the lack both of co-ordination between 
psychiatric services and drug treatment services and of continuity of care between 
prison services and drug treatment services needed to be addressed. The committee 
agreed with these statements and welcomed the establishment of a national committee 
to develop protocols for transfer of clients between the prison services and the HSE. 
The committee stated that structures should be developed to ensure that clients on 
methadone treatment who require psychiatric treatment are not at a disadvantage.  
 
• Guidelines for the management of young drug users  
Guidelines for the management of opiate users aged under 18 years were requested; 
these were published by the Department of Health and Children’s working group in 
September 2005 (see Section 5.2).  
 
There were 19 recommendations in the review of the Methadone Treatment Protocol, 
of which 12 were completely implemented by the end of 2004, four were almost 
completely implemented and the remaining three required some further work. The 
three requiring further work related to service provision, including the range of services, 
the link between treatment services and general practitioners, and pharmacists’ 
contracts.  
 
In addition, a review of counselling services in Counties Dublin, Kildare and Wicklow 
was completed in 2004.  This has not been released to date.   
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6. Health Correlates and Consequences 
 
6.1 Overview 
This section presents new data on the incidence of drug-related mortality, and on the 
incidence and prevalence of blood-borne viruses. The definitions used are presented 
where necessary in the relevant sections.   
 
 
6.2 Drug-related deaths and mortality of drug users 
In June 2005, the Health Research Board published an overview of drug-related deaths 
in Ireland (Long et al. 2005a).  The data presented in this publication describe what is 
known about drug-related deaths and deaths among drug users in Ireland between 
1990 and 2002. The analysis presented is based on data reported to the General 
Mortality Register, and on ad hoc studies that extracted data from the coroners’ 
records, the Central Treatment List, and the HIV/AIDS surveillance system, and on an 
epidemic investigation.   
 
In Ireland, the Central Statistics Office (CSO) collates data on drug-related deaths 
extracted from the General Mortality Register (GMR). The Registrar of Births, Deaths 
and Marriages formally records all notified deaths in each jurisdiction. Depending on 
the circumstances, deaths are notified by the Coroner Service, hospitals or general 
practitioners. In addition, if the gardaí are investigating a death on behalf of the 
Coroner Service, they provide supplementary information related to the death to the 
CSO. Using data from the GMR, the CSO then categorises the cause of each death 
using the World Health Organization (WHO) diagnostic coding manual on the 
international classification of diseases (known as ICD categories) (WHO 1977).  The 
ninth revision of the ICD manual continues to be used in this country. To date, in 
Ireland, the annual number of drug-related deaths is taken to be the aggregate total 
number of deaths recorded under the ICD–9 category 304, which relates to ‘a death by 
drug dependence’, plus those recorded under ICD 9 code 965.0, which refers to 
‘poisoning by opiates and related narcotics’.  Using these definitions, the CSO extracts 
the numbers of drug-related deaths (along with demographic information) and provides 
them to the DMRD at the HRB.  At the European level, the EMCDDA has developed a 
standardised method for extracting drug-related deaths from the GMRs in all member 
states (EMCDDA 2002a).  This standardised method selects certain drug-related death 
categories and is known as ‘Selection B’.  The broad diagnostic categories and codes 
included in ‘Selection B’ are: drug psychoses (292), drug dependence (304.0, 304.2-9), 
non-dependent drug abuse (305.2-3, 305.5-7, 305.9), accidental poisoning (E850.0, 
E850.8-9, E854.1-2, E855.2, E855.9, E853.2, E851, E852, and E858.8-9), suicide and 
self-inflicted poisoning (E950.0-5), and poisoning with intent undetermined (E980.0-5).  
The substances causing death must be specified. For GMRs using ICD-9, the number 
of poisoning deaths (E-codes) must be extracted in combination with nature of injury 
codes (N-codes).  The national definition from 2005 onwards will be the EMCDDA’s 
selection B.   
 
The main findings are:  
• Between 1990 and 1994, there was a small but steady increase in the number 
of drug-related deaths, from 7 to 19, reported by the GMR in Ireland (Figure 
6.2.1). Between 1995 and 2000, there was a substantial increase, from 43 to 
119, and in 2001 there was a considerable decline (to 88) in the number of 
drug-related deaths. In 2002, the number of drug-related deaths increased 
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marginally (to 91) when compared to 2001.  The data trend follows the curve of 
the opiate epidemic in Ireland.  Detailed data are presented in Standard Tables 
5 and 6.   
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Figure 6.2.1   Number of direct drug-related deaths in Ireland, by national and by European definition, reported 
by the CSO, 1990 to 2002 (unpublished data from the vital statistics) 
 
• According to data from the GMR, almost all drug-related deaths between 1991 
and 1994 occurred in Dublin (Figure 6.2.2). Between 1995 and 2000, there was 
a substantial increase in drug-related deaths in Dublin, from 39 to 90, and a 
steady increase outside the Dublin area, from 4 to 29. In 2001, there was a 
sharp decrease in the number of drug-related deaths in Dublin (to 55) and a 
continued increase outside Dublin (to 33 in 2001 and 35 in 2002). These data 
follow trends in treated problem opiate use in Dublin and outside Dublin.   
 
 
Figure 6.2.2   Number of direct drug-related deaths in Ireland, by national and by European definition and by 
place of death, reported by the CSO, 1990 to 2002 (unpublished data from the vital statistics) 
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• From 1998 to 2001, the annual numbers of opiate-related deaths extracted by 
Byrne (2002) from the Dublin coroners’ records were consistently higher than 
those reported by the GMR. These variations may be related to differences in 
the definition of opiate-related deaths applied in each case. The GMR considers 
opiate-related deaths to be those occurring as a direct result of opiate use, 
while Byrne investigated all the coroners’ cases that tested positive for opiate 
use and so included a broader range of opiate-related deaths.  
 
• Opiate-related deaths account for the largest proportion of deaths among drug 
users in Ireland. The review of coroners’ cases found that polysubstance use 
was common among drug users who had died.  
 
• According to both the GMR and Byrne’s review of coroners’ data (Byrne 2001, 
2002) those who died as a result of drug use were older than their counterparts 
in treatment, indicating an increased risk with age. As expected, more men than 
women died. 
 
• Following a review of the Dublin coroners’ cases, Byrne reported that 13% of 
drug-related deaths were associated with imprisonment or recent release from 
prison.  
 
• Injecting drug use is associated with infection and subsequent mortality.  
 
• Deaths as an indirect result of drug use are not systematically documented and 
have been assessed only in small-scale studies in Dublin. The findings of these 
studies indicate an underestimate in opiate-related deaths but provide little 
information on other drug-related deaths. A system is required to document 
drug-related deaths and deaths among drug users.  
 
 
6.3 Drug-related infectious diseases 
In 2004 and 2005, there have been a number of publications, which update or advance 
our knowledge of blood-borne viruses among drug users in Ireland.   
 
Important changes to infectious disease legislation were introduced in Ireland on 1 
January 2004. The Infectious Disease Regulations 1981 were amended to establish a 
revised list of notifiable diseases and, for the first time, their causative pathogen 
(Statutory Instrument No. 707 of 2003 2003). As part of the revised legislation, 
laboratory directors as well as clinicians are required to report the named notifiable 
diseases.  The changes to the list of notifiable diseases are consistent with a European 
Commission Decision on communicable diseases (European Commission Decision 
2000/96/EC 2000).  Hepatitis B was already classified as a notifiable disease but the 
inclusion of laboratory directors as a source of notification will increase the number of 
notifications.  There are no data by risk factor status.  Hepatitis C occurs mainly in two 
populations in Ireland: cohorts of individuals who became infected through infected 
blood and blood products, and injecting drug users. As part of the revised legislation on 
1 January 2004, hepatitis C is now specified as a notifiable disease. The inclusion of 
hepatitis C as a notifiable disease (from 2004 onwards) will provide important data on 
new cases of hepatitis C in the general population but will not specify risk populations 
(such as injecting drug users).   
 
Voluntary linked testing for antibodies to HIV has been available in Ireland since 1985.  
By the end of 2004 there were 3,764 diagnosed HIV cases in Ireland, of which 1,203 
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(32%) were probably infected through injecting drug use (Health Protection 
Surveillance Centre 2005). In 2004, there were 365 newly diagnosed cases reported to 
the Health Protection Surveillance Centre, of which 71 (20%) were infected through 
injecting drug use (Figure 6.3.1). This represents an increase on the numbers of new 
HIV cases among injecting drug users in 2002 (50) and 2003 (49). Of the 71 new HIV 
cases, 44 were male and 27 were female and the average age was 30.1 years. Of the 
64 cases for whom place of residence was known, 60 lived in the HSE Eastern Region. 
The authors of the report highlighted the need to continue to promote the use of harm- 
reduction measures among injecting drug users.  
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Figure 6.3.1   Number of new cases of HIV among injecting drug users by year of diagnosis reported in Ireland, 
1986 to 2004 (adapted from Kelly and Clarke 2000; National Disease Surveillance Centre 2002, 2003, 2004;  
Health Protection Surveillance Centre 2005)  
 
Grogan et al. (2005) assessed the uptake of screening for blood-borne viruses and 
hepatitis B vaccine among 358 heroin users attending 21 drug treatment clinics in the 
HSE South Western Area up to December 2001.  In addition, the authors estimated the 
prevalence and incidence of blood-borne viruses in this cohort.  A one-in- four 
systematic sample of clients prescribed methadone in the 21 drug treatment clinics in 
the HSE South Western Area in December 2001 was selected from the Central 
Treatment List.  The data were collected from the clinical records and Table 6.3.1 
presents a summary of the findings: of note, 66% tested positive for hepatitis C, 17% 
for hepatitis B core antigen, 2% for hepatitis B surface antigen and 11% for HIV.  These 
results are in line with results from a study in a similar setting.  The authors point out 
that the results were ascertained from clinical records and pertain only to those 
documented in the clinical records examined, the tests were collected over an 
extended time period and those testing negative at their first test may have 
subsequently sero-converted and not have had a repeat test.  In addition, injector 
status was not ascertained and the authors acknowledge that the proportion of 
injectors testing positive for each virus would be much higher.   
 
Using a cross-sectional survey method, O’Sullivan (2004) assessed the prevalence of 
blood-borne viruses among a cohort of 90 injecting drug users attending an opiate 
substitution programme at the Drug Treatment Centre Board. The sample size was 
estimated using a wide 10% level of precision and 95% level of confidence. He 
obtained adequate blood samples from 65 of the 90 clients interviewed. The main 
findings were: 72% tested positive for hepatitis C, 17% tested positive for hepatitis B, 
no respondent tested positive for hepatitis B surface antigen and 12% tested positive 
for HIV. These results are in line with results from a study in a similar setting.   
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Table 6.3.1   Uptake of blood-borne viral screening and prevalence and incidence of such 
infections in treated  heroin users (n=358) in the HSE South Western Area up to the end of 2001 
Blood-
borne 
viruses  
Tests for Purpose 
of test 
Number 
(%) 
screened 
Number 
(%) 
tested 
positive 
at end 
of 
period 
Number 
tested 
negative 
at first 
test 
Number 
re-
tested  
Number 
(%) re-
tested 
that 
acquired 
infection 
since 
first test  
Incidence 
rate in 
person 
years 
(95% CI) 
Hepatitis 
C  
Antibodies 
to the 
hepatitis C 
viruses 
Appears 
3–6 
months 
after initial 
infection 
and 
indicates 
previous 
or current 
infection 
316 (88%) 207 
(66%) 
120 27 11 24.5 (12.2-
43.8) 
Hepatitis 
B 
Antibodies 
to 
hepatitis B 
core 
antigen 
(Anti-HBc 
IgG)  
Appears 
1–2 
months 
after initial 
infection 
and 
indicates a 
naturally 
acquired 
infection 
with the 
hepatitis B 
virus 
244 (68%) 42 (17%) 205 18 3 9.0 (1.9-
26.3) 
 Hepatitis 
B surface 
antigen 
(Anti-
HbsAg) 
Appears 1 
months 
following 
exposure 
and a 
continued 
presence 
for six 
months or 
more 
indicates a 
carrier 
status 
299 (84%) 6 (2%)     
 Anti-HBs  Indicates 
a vaccine 
induced 
immunity 
or a full 
recovery 
from 
infection 
Of the 177 
clients who 
completed 
a course of 
hepatitis 
vaccine, 
134 (76%) 
were tested 
114 were 
denoted 
as having 
a vaccine 
induced 
immunity 
    
HIV Antibodies 
to HIV 
Ever been 
infected 
with HIV 
307 (86%) 33 (11%) 278 59 4 3.4 (0.9-
8.7) 
 
In another published study, Keating et al. (2005) estimated the proportion of hepatitis C 
positive individuals with each genotype in an intravenous drug-using cohort, and then 
estimated the proportion that spontaneously cleared the hepatitis C virus. The study 
followed the progress of 496 hepatitis C antibody positive individuals attending five 
drug treatment centres in Dublin. None of this cohort had tested positive for hepatitis B 
or HIV.   
 
Of the 299 PCR positive samples that had their genotype determined, genotype 1 and 
3 were the most common (Table 6.3.2). The PCR test detects whether the virus is still 
in the blood and will show if a person has an ongoing infection.   
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Table 6.3.2   Number of PCR-positive samples by genotype of selected hepatitis C antibody 
positive individuals attending five drug treatment centres in Dublin 
Genotype Number (%)  
Total =299 
1 146 (48.8%) 
2 6 (2.0%) 
3 145 (48.5%) 
4 2 (0.7%) 
5 0 (0.0%) 
6 0 (0.0%) 
 
Of the 496 hepatitis C positive participants in the sample, 191 (38.5%) were shown to 
be HCV RNA negative when re-tested, indicating that they had spontaneously cleared 
the virus. A higher proportion of women (47.4%) than men (34.5%), p <0.01, cleared 
the virus spontaneously. A higher proportion of those with a history of jaundice (12.0%) 
than those who reported no history of jaundice (7.9%),  p <0.01, cleared the virus 
spontaneously. Age and duration of injecting drug use was not associated with 
spontaneous hepatitis C virus clearance.The rate of spontaneous viral clearance was 
higher than previously reported.  
 
Smyth et al. (2005a) examined the contribution to infection with hepatitis C of unsafe 
injecting practices and the social context of injecting in Dublin. Of the 242 participants 
who completed the questionnaire, 159 had a test for hepatitis C. The analysis was 
based on the 159 that were tested for hepatitis C. Of those tested, 61% tested positive 
for hepatitis C. After controlling for other factors, the authors found that an increrased 
number of lifetime injections increased the risk of hepatitis C. For example, those who 
had injected more than 1,000 times were almost nine times more likely to test positive 
for hepatitis C than those who injected less than 100 times. In relation to the social 
context, individuals who injected in the home of another injecting drug user were 
almost five times more likely to test positive for hepatitis C than those who injected in 
their own home or another place. Those individuals who injected in the company of 
close friends and family members were around three times more likely to test positive 
for hepatitis C than those who injected with acquaintances.   
 
Cullen et al. (2005) examined the experience of heroin users attending general practice 
with respect to risk practices for, investigation of, and treatment for hepatitis C through 
in-depth interviews. The questionnaire had a mix of closed and open questions. At the 
time of the study, 38 former or current heroin users were registered with the practice. 
Of these, 25 (66%) agreed to be interviewed. Those interviewed were more likely to be 
female and older than the other heroin users attending the practice.  At the time of the 
study, 23 of the 25 participants were receiving methadone maintenance (14 at the 
practice and nine at specialised drug treatment centres).  Twenty-two participants said 
that they had tested positive for hepatitis C, of whom 15 had consumed alcohol in the 
week prior to the study.  Nine consumed more than the recommended amount for their 
gender.  Of note, eight reported neither drinking excessively nor using heroin in the 
previous six months and were therefore suitable for investigation. Only four of the eight 
suitable clients were referred for further investigations and one had commenced 
treatment. The respondents identified ‘not sharing needles’, ‘adopting safe sexual 
practices’ and ‘not using drugs’ as ways to avoid hepatitis C transmission.  Those 
respondents who reduced their alcohol intake did so because they were concerned 
about their health, while those who increased their alcohol intake did so to substitute 
for heroin.  Some respondents had a negative perception of liver biopsy, though those 
who had undergone this investigation reported that the procedure was not as difficult to 
tolerate as expected.  Many respondents had negative perceptions of antiviral 
treatment.  The experience of treatment by medical and nursing personnel at 
secondary treatment services was mixed, with some having very positive experiences 
while others reported that the service providers were impersonal and withheld 
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information.  The authors concluded that there were a number of barriers to hepatitis C 
treatment for injecting drug users and these need to be addressed so as to encourage 
uptake of treatment.   
 
There are three main, naturally occurring, epidemiological types of botulism: food-
borne, intestinal colonisation (infant botulism) and wound botulism. The neurological 
signs and symptoms are the same for all three types and may include respiratory 
paralysis. Wound botulism is caused by growth of cells and release of toxin in vivo, is 
associated with traumatic wounds and abscesses and has been reported in drug users, 
such as those injecting heroin or sniffing cocaine. Up to the end of 1999 there were no 
confirmed cases of wound botulism in the UK (Brett et al. 2004). Between January 
2000 and the end of December 2002, there were 33 clinically diagnosed cases of 
wound botulism in the UK and Ireland. All cases had injected heroin into muscle or by 
'skin popping'. The clinical diagnosis was confirmed by laboratory tests in 20 of these 
cases. Eighteen cases were caused by type-A toxin and two by type-B toxin. 
 
 
6.4 Psychiatric co-morbidity 
Figure 6.4.1 presents the rate of first admissions among those aged 16 years or over to 
inpatient psychiatric services with a diagnosis of drug dependence, per 100,000 of the 
population in Ireland between 1990 and 2003. It is notable that the rate increased 
steadily over the reporting period and was almost four times higher in 2001 than it was 
in 1990, with a subsequent fall in 2002 and 2003.  The analysis presented in the 
National Psychiatric In-Patient Reporting System (NPIRS) does not comment on the 
possible explanations for this trend but indicates that more of those with drug 
dependence are treated through the addiction services (Daly et al. 2004).    
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Figure 6.4.1   Rate of psychiatric first admissions aged 16 years or over with a diagnosis of drug-
dependence (using the ICD-10 three character categories) per 100,000 of the population in Ireland 
and reported to the NPIRS, 1990 to 2003 
 
There were no new data published on numbers with psychiatric and addiction co-
morbidity.   
 
6.4 Other drug-related health correlates and consequences 
There are no new data published in this area in 2004 and the first half of 2005.   
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7. Responses to Health Correlates and Consequences 
 
7.1 Overview 
This section presents new data on responses to drug-related mortality, blood-borne 
viruses and psychiatric co-morbidity. The definitions used are presented where 
necessary in the relevant sections.   
 
 
7.2 Prevention of drug-related deaths 
Overview of harm-reduction approaches in Ireland 
 
The NACD commissioned Moore and colleagues at Dublin City University to review the 
international evidence for harm-reduction approaches and the availability of such 
approaches in Ireland (Moore et al. 2004). This section will concentrate on the part of 
that review that profiled harm-reduction services in Ireland. For the purpose of the 
review, a harm-reduction approach was defined as one ‘that focuses on reducing the 
harm that substance misusers do to themselves and their families.’The aim of such 
approaches was ‘to reduce the transmission of HIV, hepatitis and other infectious 
diseases and to maximise service users’ health’. The harm-reduction approaches 
asked about in the study were needle exchange (including types of injecting equipment 
distributed), methadone maintenance, replacement drugs, smoking or snorting pipes, 
and provision of information on safer injecting. Methods to prevent or manage 
overdose were not specifically examined in the study, nor was the availability or uptake 
of hepatitis B vaccine. 
 
With assistance from the regional drug co-ordinators and area operations managers, a 
purposeful sample of services and key informants (n=16) was chosen to take part in a 
thirty-minute telephone interview. The telephone interview was administered using a 
pre-tested questionnaire containing a combination of open and closed questions. Of 
the 16 service providers interviewed, nine worked in the Eastern Regional Health 
Authority (ERHA) area and one from each of the remaining seven health boards. Three 
informants from outside the ERHA reported that their work did not include harm 
reduction with drug users who used paraphernalia to administer drugs and these 
interviews were discontinued at that stage. It was unusual that three participants 
selected in a purposeful sample had no experience of working with injecting drug 
users, since such drug users live and are treated in each health board area. This 
limited the researchers’ ability to provide a national picture. 
 
The nine service providers working in the ERHA area reported working with injecting 
drug users, mainly opiate users. In addition, three service providers worked with 
cocaine users. Some service providers also reported treating cases reporting problem 
benzodiazepine use. According to service providers outside the ERHA area, the main 
problem substances were alcohol, cannabis and ecstasy.  
 
All services providers in the ERHA area reported that methadone maintenance and 
one-for-one needle-exchange facilities were available in their area. With the exception 
of filters, all other types of injecting equipment were provided to clients attending these 
services. Half of the service providers in the ERHA area reported that filters were not 
available at their service. In contrast, service providers outside the ERHA area stated 
that methadone maintenance was the mainstay of their harm reduction services and no 
injecting equipment was distributed. Pipes were not provided at any service in Ireland.  
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All service providers in the ERHA area and a tiny minority outside the area reported 
providing information on specific injecting techniques and care of an injection site. The 
service providers in the ERHA area also advised clients on safer smoking and polydrug 
use.  
 
With respect to health promotion practices, the majority of service providers in the 
ERHA area said that their services provided information and demonstrations on safer 
injecting practices in line with current evidence. The authors do not report whether such 
information was provided by services outside the ERHA area.  
 
On a national basis, the vast majority of service providers reported that the main 
purpose of harm-reduction approaches was to reduce the harm that drug users did to 
themselves. Some service providers reported that harm-reduction services reduced the 
transmission of infectious diseases. Two services providers mentioned that harm-
reduction services were a pathway to other health care services. Half of the health 
service providers in the ERHA area reported that these services promoted safer 
injecting practices.  
 
All service providers reported similar vulnerable groups, such as women, children and 
homeless clients. In addition, service providers reported that priority groups included 
polydrug users, those with mental illness, and those testing positive for HIV. It is 
interesting to note that those testing positive for hepatitis C were not regarded as a 
priority or vulnerable group. Yet, it is accepted that hepatitis C is common among 
injecting drug users, that co-infection between hepatitis C and HIV leads to more 
aggressive liver disease, and that individuals with co-infection have a poorer prognosis 
than those with a single blood-borne viral infection.  
 
All of the service providers in the ERHA area and half of those outside it reported that 
specific issues, such as blood-borne viruses, localised bacterial infections at injection 
sites and sexual health, were addressed in their programmes. It is not clear from the 
research the extent to which these issues were addressed.  
 
According to the service providers both in and outside the ERHA area, services were 
normally available without appointment and were mainly provided during office hours, 
with a small number opening in the evenings (in the ERHA) and at weekends 
(methadone services outside the ERHA). The service providers said that the main 
means of advertising was by word of mouth. Services were also advertised through 
published directories and posters in clinics.  
 
All service providers reported either formal or informal links with other health and social 
care services. Many reported working closely with persons from the criminal justice 
system. The service providers in the ERHA area reported links with self-help groups.  
 
In general, service providers in the ERHA area reported that policy did translate into 
practice, although the majority stated that there were occasions when they had to ‘bend 
the rules’ to facilitate patient care. In contrast, the majority of service providers outside 
the ERHA area reported that policy did not translate into practice, and unofficial 
practices occurred at one service, in that needles, syringes and condoms were 
distributed.  
 
The service providers in the ERHA suggested a number of developments to improve 
the current service, such as:  
• expansion of outreach work 
• greater access to low threshold services 
• increased variety of needle-exchange outlets 
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• adaptation of current services to deal with cocaine 
• provision of respite houses  
• greater inter-agency collaboration. 
 
The service providers outside the ERHA area requested: 
• an increase in resources 
• clear policies and structures with respect to needle exchange and methadone 
maintenance 
• evidence-based practice in relation to harm reduction interventions 
• strategies to reduce waiting lists for treatment 
• community-focused outreach services. 
 
National Drug-Related Deaths Index 
 
A National Drug-Related Deaths Index is to be set up in Ireland in order to comply with 
Action 67 of the National Drugs Strategy (Department of Tourism Sport and Recreation 
2001).  The Drug Misuse Research Division of the Health Research Board was 
requested to set up this index by the Department of Health and Children and the 
Department of Justice, Equality and Law Reform in February/March 2005.  The index 
will be a census of drug-related deaths and deaths among drug users in Ireland.  The 
number of drug-related deaths and deaths among drug users is one of the EMCDDA’s 
key indicators to measure the consequences of the drug situation.  The protocol for the 
data collection, validation and analysis is the EMCDDA Scientific Report: The DRD 
Standard Version 3 (EMCDDA 2002a). This was developed and validated by European 
experts.  In order to ensure a complete and accurate index it is necessary to use data 
from several sources.  The data sources are: the Coroner Service, the General 
Mortality Register, the General Registrar’s Office, the Central Treatment List and the 
Hospital In-Patient Enquiry Scheme.  Since June 2005, the Health Research Board has 
employed two researchers to work on the register.   
 
Emergency services can administer naloxone 
 
On 9 August 2005, the Minister of State at the Department of Health and Children 
introduced a new Statutory Instrument, the Medical Products (Prescription and Control 
of Supply) (Amendment) Regulations 2005 (Statutory Instrument No. 510 of 2005 
2005). This permits the supply of a number of medicinal products (including naloxone, 
for the management of respiratory depression secondary to a known or suspected 
narcotic overdose) to pre-hospital emergency care providers. This medication can be 
administered by advanced paramedics in accordance with clinical procedure guidelines 
or following a medical practitioner instruction. In addition, emergency technicians may 
administer naloxone in accordance with a medical practitioner instruction. This will 
improve the speed of response to narcotic overdoses.   
 
 
7.3 Prevention and treatment of drug-related infectious diseases 
Mid-term review of the National Drugs Strategy  
 
For the first time in Ireland specific performance indicators on harm reduction have 
been introduced.  These are: 
 
• Harm-reduction facilities available, including needle exchange where necessary, 
open during the day, and at evenings and weekends, according to need, in every 
local health office area; and 
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• Incidence of HIV in drug users stabilized, based on 2004 figures. 
 
The second of the two new harm reduction indicators is based on an increased number 
of HIV cases among drug users in 2004 (see section 6.3).   
 
Hepatitis B vaccine 
 
In Ireland hepatitis B vaccine is recommended for several high-risk groups; prisoners 
and injecting drug users are two of the high-risk groups named in the guidelines 
(National Immunisation Advisory Committee 2002). 
 
Hepatitis B vaccine is free to all injecting drug users attending drug treatment centres, 
but is not necessarily free to all injecting drug users attending general practice. The 
vaccine has become easily available at drug treatment centres but is more difficult to 
access at general practice. In general, doctors caring for injecting drug users in the 
general practice setting must order an individual dose of vaccine for each injecting drug 
user they intend to vaccinate.  Those injecting drug users without a medical card must 
pay for the vaccine. This militates against opportunistic vaccination, which is 
considered an important strategy to achieve a high level of immunisation in a 
vulnerable group.  The coverage of hepatitis B vaccination for injecting drug users is 
not monitored on a continuous basis; the coverage estimates presented in this section 
were taken from ad hoc studies at treatment centres. Grogan et al. (2005) reported that 
81% of 316 clients for whom the hepatitis B vaccine was indicated had commenced a 
course of this vaccine and 177 (56%) had completed at least three doses. O’Sullivan 
(2004) reported that 86% of those for whom the vaccine was indicated tested positive 
for anti HBs which indicates in this case a vaccine induced immunity. The uptake and 
completion rates of hepatitis B vaccine are much higher in these cohorts than those 
reported in prisoners or at general practice in Ireland between 1998 and 2001.   
 
Consensus guidelines on managing persons at risk of or infected with hepatitis C 
 
The Dublin Area Hepatitis C Initiative Group developed consensus guidelines on the 
management of hepatitis C in general practices located in the Eastern Region (Dublin 
Area Hepatitis C Initiative Group 2004). The guidelines were produced in five stages: 
identification of key stakeholders; development of evidence-based draft guidelines; 
discussion of content; reaching consensus using the Delphi method; and review of 
guidelines by a sample of general practitioner users. The guidelines are presented in a 
logical format by key aspects of care and include:   
 
• General aspects of care cover the means of transmission and actions to protect 
yourself and others; 
• Prevention or care of other blood-borne or other hepatotoxic viruses, which 
include hepatitis A and B vaccination;  
• Screening for and presentation of hepatitis C test results, which include pre-test 
counselling, post-test counselling and explaining hepatitis results;  
• Initial management of patients infected with hepatitis C, which includes means 
of transmission, alcohol and drug use, nutrition, vaccination and weight 
reduction (where necessary); 
• Subsequent management of patients with hepatitis C, referral to a hepatology 
service, conditions for treatment and information required by the hepatology 
service. 
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Consultation towards developing a regional hepatitis C strategy 
 
The findings of a consultation event held in June 2004 involving service users, service 
planners and a wide range of health and social care professionals and organised to 
assess the health and social care requirements for those with or at risk of acquiring 
hepatitis C were released in December 2004 (Hepatitis C Scientific Advisory Subgroup 
of the Blood Borne Virus Forum and the Eastern Regional Health Authority 2004).  The 
method used in the consultative process was ‘open space technology’.  ‘Open space' is 
a qualitative methodology used to enable a large and diverse group of people to 
explore complicated issues in a limited time by presenting participants with central 
themes. Organic and self-organising, the participants set a detailed agenda and 
subsequently facilitate qualitative discussion at impromptu workshops. The contents of 
the discussions are simultaneously documented. The central themes, presented in the 
invitation to this event, were: ‘What are the significant issues in formulating a region-
wide policy on hepatitis C’ and ‘What are the optimum approaches to these issues?’ 
 
Over 70 people attended the event, among them service planners, health and social 
care professionals and service users. With respect to the first of the central themes, the 
participants identified the issues they would like on the agenda on the morning of the 
event.  
 
The participants identified 16 significant issues and a workshop was organised for each 
issue. A small group discussion took place on each topic and a workshop facilitator 
recorded the issues raised during the discussion. These data were subsequently 
analysed using qualitative methods.  
 
Four common themes emerged from the 16 workshops: 
• Health promotion 
There is a need to develop a set of consistent messages on modes of 
transmission, pathways to treatment and success of treatment, with such 
messages delivered through a variety of media.  
• Role of the media 
Another need was to ensure that the mass media provides accurate information 
to the general public and high-risk groups. It was suggested that the media use 
an approach that allays fears and reduces the stigma associated with the 
infection.  
• Service provision 
It was noted that access to and availability of services to prevent or treat hepatitis 
C should not be associated with mode of transmission. There is a need for 
equivalence of care between several groups, for example, those who acquired 
their infection through blood products versus injecting drug users; those who live 
in Dublin versus outside Dublin; and those in prison versus those in the 
community. The information about, criteria for and pathways to treatment should 
be transparent and easily accessed. Expansion of nursing and psychology 
services to support those testing positive for hepatitis C is required.  
• Research, policy and planning 
In general, the participants emphasised the importance of an extended 
surveillance system to ascertain the extent of the problem but stressed that such 
a system must protect the identity of the individual. Participants also wanted 
research to develop best-practice protocols (including medical and 
complementary therapies) to manage this infection.  
 
Ireland – National Report 2004  58
In the afternoon session, the process was repeated to explore optimum approaches to 
the themes identified in the morning. Eight actions were identified and a workshop was 
organised to deal with each action. A number of common themes emerged from the 
second set of workshops: 
 
• Peer support and prevention  
The importance of using peer groups in planning and developing prevention, 
harm reduction and treatment interventions was stressed. Peer-group insight and 
experience were considered very useful in ensuring that new approaches would 
be appropriate. It was also suggested that indicators would be developed to 
monitor and evaluate prevention and harm reduction interventions.  
• Education and training 
The actions suggested were in line with the health promotion actions identified in 
the morning session.  
• Liaison, key workers, co-ordination and collaboration 
A number of suggestions were made, including appointment of key workers (such 
as liaison nurses); development of transparent communication policies and 
procedures; improvement in access to services through multi-agency 
collaboration; and introduction of a core monitoring group to ensure client-centred 
services.   
• Accessing services 
Developments to make services more accessible and user-friendly were identified 
as a priority.  
• Psychological and complementary therapies 
Respondents thought that psychological support and complementary therapies, in 
conjunction with medication, would be very beneficial to a client’s quality of life.  
 
The event represented an ongoing collaboration between two groups – the Hepatitis C 
Scientific Advisory Subgroup of the Blood Borne Virus Forum (a group of health and 
social care professionals with an interest in hepatitis C and related issues) and the 
HSE Eastern Region. At the launch of the report in December 2004, the ERHA 
presented its response to the findings and its plans for the future.  The findings of the 
open space event are being used to help inform the forthcoming HSE Eastern Region’s 
hepatitis C strategy.  It was indicated that a group convened to formulate a regional 
strategy on hepatitis C intends to audit the health services available to those with 
hepatitis C and actively to provide information on service availability and identify 
models of best practice both nationally and internationally.  This strategy will be 
published in late 2005 or early 2006.   
 
7.4 Interventions related to psychiatric co-morbidity 
Management of individuals with psychiatric and addiction co-morbidity 
 
In 2002, the NACD commissioned a team at Dublin City University to explore the 
management of individuals with a combination of mental illness and substance misuse 
in Ireland. The definition of dual diagnosis used for this study was ‘the co-existence of 
both mental health and substance misuse problems for an individual’. Two distinct 
groups of service providers treat patients with combinations of such illnesses, the 
mental health services and the addiction services. 
 
The report by MacGabhann et al. (2004) was launched on 1 November 2004. In order 
to review the management of dual diagnosis in Ireland, the researchers: 
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• Reviewed relevant national and international literature to identify the most 
appropriate methods of assessment, treatment and management of such 
illnesses.  
 
• Organised an open forum in one geographical area with a representative group 
of stakeholders (n=58/60, 97%). This included service users, mental health and 
addiction service providers, social service providers and representatives from 
the police. Participants considered the findings of the literature review in the 
context of their personal experience of dual diagnosis. The proceedings were 
documented and the transcriptions were analysed and themes were identified. 
 
• Carried out a national postal survey in order to provide a national overview of 
service provision for dual diagnosis in Ireland. This survey also ascertained 
attitudes towards and opinions about the place of dual diagnosis in Irish health 
services. A stratified sample by occupation and county of employment was 
selected. The participants were managers, clinicians and other service 
providers (n=141/191, 74%). The questionnaire consisted of 35 questions.  
 
• Completed face-to-face semi-structured interviews with 10% of the respondents 
to the national survey (n=14) to explore the key findings. The responses were 
taped and transcribed.  
 
A number of key themes were identified during the open forum: 
 
• Respondents found it difficult to conceptualise, define and assess the severity 
of dual diagnosis. 
• Policy development to date did not recognise dual diagnosis.  
• The general practitioner was the first point of contact and the main service 
provider. 
• Clients experienced stigmatisation, discrimination and marginalisation at 
addiction and mental health services. 
• Services were not always client centred, sometimes normal practices overrode 
client needs. 
• It was difficult for clients to access services.  
• Few formal structures and protocols were provided to guide staff. 
• Application of evidence-based practice varied. 
• There was inadequate communication and liaison between services. 
• Clients were lost in the gaps between the addiction and mental health services.  
• Professionals working in addiction services were educated separately to those 
working in mental health services. 
• Differences in the professional cultures of the two services led to conflicting 
beliefs and practices. 
• There were difficulties in respecting professional care and treatment provided 
by the ‘other’ service. 
• Multi-disciplinary approaches were more effective than single-discipline 
approaches.   
• A variety of service models exist, mainly serial, sometimes parallel and 
occasionally integrated.  
 
These themes were used to develop the questionnaire for the national survey.  
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The main findings of the national survey were:   
 
Over one-fifth of service providers reported that policies to address dual diagnosis were 
available in their area. The examples cited by respondents indicated that these policies 
address aspects of dual diagnosis rather than dual diagnosis itself. None of the plans 
or service reviews submitted to the researchers addressed the specific issue of dual 
diagnosis. Over two-fifths of service providers reported that formal and informal 
structures existed in their area, with more in addiction services (56%) than in mental 
health services (33%). In theory, one-fifth of respondents thought refusing treatment to 
people with dual diagnosis was justified. In practice, a large proportion of providers in 
the addiction (58%) and the mental health (43%) services reported that exclusion 
criteria applied to people with a dual diagnosis. The source of referral differed between 
the mental health services and addiction services. The mental health services accepted 
referral through general practitioners only, while the addiction services accepted 
referrals from a wide variety of sources (including self-referrals).  
 
In relation to assessment, 93% of respondents thought routine screening should be in 
place and 66% reported that they always assessed clients for dual diagnosis. Sixty-
three per cent of respondents agreed with the statement, ‘Clinical staff in my service 
are adequately trained to assess dual illnesses’, and 71% strongly agreed with the 
statement, ‘Our service identifies clients with dual diagnosis’. According to the service 
providers, dual diagnosis is recorded for 37% of cases. No respondent used a 
validated tool to assess dual diagnosis.  
 
There is some ambiguity in relation to the recognition and treatment of dual diagnosis, 
evidenced by the lack of service structures and the extent of exclusion criteria. For 
example, 92% of respondents from mental health services reported that they treat 
people with substance misuse problems, yet 43% of respondents reported exclusion 
criteria applied to people with a dual diagnosis. Seventy-one per cent of respondents 
reported that they do not follow recommended models of treatment and 39% of 
respondents agreed with the statement, ‘Clinical staff in my service are adequately 
trained to treat dual diagnosis’. 
 
Overall, the responses indicated that there was little systematic co-ordination of care 
for people with dual diagnosis evident in any health board area; only 18% of services 
offered a specific service. There were at least three models of service provision in 
operation: a parallel model (52%), an integrated model (29%) and a serial model 
(16%), although three-quarters of survey respondents agreed with the statement, ‘A 
fully integrated service is the best way to help people with dual diagnosis’.  
 
Respondents reported that 76% of services had formal communication links with other 
services, while 54% had informal communication links. Respondents were generally 
content with the level of communication between addiction and mental health services, 
though this was strongly influenced by those who had responsibilities across both 
service areas. According to the authors, a higher proportion of respondents from the 
addiction services disagreed with the statement, ‘Communication between addiction 
and mental health services is adequate to treat dual diagnosis’ than the proportion of 
their counterparts in the mental health services, (p<0.03).    
 
There was consensus throughout the study that GPs should be involved in the 
management of people with dual diagnosis. 
 
It is clear that a published national strategy is required to deal with individuals who 
have both drug addiction and psychiatric illness. In practice, there is a need to: 
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• formalise referral procedures between the mental health services and the 
addiction services;  
• reconsider exclusion criteria; 
• use valid assessment tools;  
• develop and expand the small number of evidence-based dual diagnosis 
services in existence; 
• provide appropriate treatment for psychiatric illness and problem drug use, 
regardless of the treatment provider or setting.  
 
In order to improve responses, further research is required to estimate the prevalence 
of dual diagnosis, to ascertain the needs of persons with dual diagnosis and to define 
the role of primary care professionals in the management of these combined 
conditions.  
 
 
7.5 Interventions related to other health correlates and consequences 
There are no new publications in this area in 2004 and the first half of 2005. 
 
Ireland – National Report 2004  62
8. Social Correlates and Consequences 
 
8.1 Overview 
This section highlights the association between social exclusion and problematic drug 
use by reporting on research among the homeless population, a small group of 
homeless heroin users, a small group of women with experience of prostitution and 
members from new communities in Ireland. In relation to drug-related crime, this 
section will report data on drug offences where criminal proceedings commenced and 
also on trends in such offences by offence drug type. We also report on new research 
in relation to cocaine and a major new study by An Garda Síochána on the relation 
between drugs and crime. No new information is available in relation to drug use in 
prison. 
 
8.2 Social exclusion 
Research among the homeless and a small group of homeless heroin users revealed 
that drug use is a major contributory factor to becoming and remaining homeless. In 
addition, it would seem that experiences of homelessness contribute to changes in 
drug-using patterns, with an escalation in problematic drug use and episodes of risk-
taking around sharing injecting paraphernalia being reported. Such practices can 
exacerbate the experience of being homeless and create further obstacles between 
individuals and services. Similarly, the women with experiences of prostitution highlight 
the risks involved in using drugs while engaging in sex work, and the exclusionary 
nature of some drug treatment policies against the women. Members of new 
communities report using drugs to cope with experiences of isolation and exclusion, 
including unemployment and living in emergency accommodation. This section will 
include a brief sketch of the four research reports, looking at the research aims, 
methods and key findings.  
 
Homelessness 
Research carried out on behalf of the Tallaght Homeless Advice Unit (2004) explored 
the issues, policies and practices faced by homeless heroin users from Tallaght that 
contributed to their becoming and remaining homeless. Tallaght is a large Dublin 
suburb with an estimated population of 150,000. Data-collection methods included 
interviews with 17 service users of the Tallaght Homeless Advice Unit (Female = 8; 
Male = 9).  
 
The profile of interviewees reveals a pronounced experience of social exclusion and 
social problems. Eleven were experiencing homelessness at time of interview,3 while 
15 were on a methadone-maintenance programme. The eight women interviewees had 
17 children between them; the nine men had fathered 10 children between them.  
Sixteen children were aged 4 years or under; seven were aged between 4 and 8 years; 
and four were aged between 8 and 11 years. Key findings of the research were: 
 
• All respondents had experience of intravenous drug use, with heroin and 
cocaine the main drugs being injected. 
• A majority reported that their drug use contributed to their initial homeless 
experience. Over half reported that their families were unable to cope with their 
                                                
3 Homelessness at time of interview included accommodation in B&B (3), hostel (2), relatives/friends (1), 
rough sleeping (3), transitional housing (3) and family home (1) 
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drug use, while evictions under anti-social behaviour legislation and relationship 
breakdown were cited as additional factors leading to homelessness.  
• Most agreed that their drug use helped to sustain their experience of 
homelessness and created a barrier to moving out of homelessness, e.g. all but 
one reported being evicted from hostels and B&Bs because of drug-related 
incidents. 
• Some reported that becoming homeless greatly exacerbated their drug use. For 
example, the transition to using heroin intravenously was strongly associated 
with moving into the homeless scene, particularly when frequenting emergency 
hostels and sleeping rough. 
• Repeatedly, interviewees identified the lack of accommodation for homeless 
people in Tallaght as a factor in exacerbating their drug use, as travelling into 
the city centre to access emergency accommodation increased the likelihood of 
involvement in the 'drug scene'.   
• Some interviewees reported that residing in the same B&B premises for more 
than a three-month period enabled them to stabilise their drug use and ensure 
their children attended school 
• Emergency hostels were clearly identified by all as the primary risk 
accommodation associated with chaotic use of drugs. All repeatedly stated that 
their drug use escalated in hostels, and most associated emergency hostels 
with their most chaotic periods in terms of drug use.  
• Almost a quarter reported suicide thoughts while using drugs; five reported 
heroin overdose resulting in hospitalisation. Injecting heroin was associated 
with feelings of being out of control around drugs.  
 
Lawless and Corr (2005) carried out the first drug prevalence study among the 
homeless population in Ireland on behalf of the NACD. A total of 355 individuals 
experiencing homelessness were surveyed using quota sampling, a non-probability 
technique aimed at producing a representative sample without a random selection of 
cases. Sample characteristics included: 69% (n=244) male and 31% (n=111) female, 
with a mean age of 35 years. Hostel (50%), B&B (19%) and rough sleeping (16%) were 
reported as the most common homeless accommodation types. The majority of the 
respondents were dependent on government benefits. The research revealed some 
important insights into the lives of homeless drug users under a number of headings.  
 
Prevalence of drug use 
• Seventy-four per cent reported lifetime use of an illicit drug, with cannabis the 
most frequently reported lifetime drug (69%). 
• Forty-three per cent reported cannabis as the primary illicit drug of current use, 
with 22% currently using heroin. 
• Seventy-two per cent of current drug users reported use of more than one drug, 
and 26% of rough sleepers reported the use of five drugs or more. 
• Higher rates of current heroin use (34%), current cocaine use (25%) and 
current use of crack (7%) were reported among those sleeping rough, than 
among hostel dwellers and B&B occupants. 
• Eighteen per cent reported current use of methadone; 28% of this group had 
not been prescribed methadone. 
 
Risk behaviour associated with drug use 
• Changes in drug-using patterns as a result of becoming homeless were 
reported by 77% of current users. For example, initiation into drug use (for a 
minority), changes in primary drug and routes of administration, increased 
frequency/quantity, and associated lifestyle behaviour changes were cited.  
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• Thirty-five per cent of the total study population reported having injected drugs; 
19%reported injecting heroin in the last month. 52% of current heroin users 
were daily users.  
• Fifty-four per cent of current injectors were street injectors, with males more 
likely to report injecting in public places. 
• Forty-six per cent of respondents reported that they usually injected alone, with 
males significantly more likely to report this behaviour. 
• Only 26% of current injectors reported not experiencing an injecting-related 
difficulty in the three months prior to interview, with males significantly more 
likely to report no difficulty. On the other hand, 71% of current injectors reported 
scarring and bruising of an injecting site, 32% reported abscesses or infections 
of site, while 20% reported accidental overdose in the three months prior to 
interview.  
• Fifty-three per cent of current injectors reported sharing injecting paraphernalia 
in the previous four weeks with 23% reporting lending injecting equipment and 
17% reporting borrowing.  
 
Physical and psychiatric health 
• Fifty-one per cent of problematic drug users were hepatitis C positive, 
compared to 23% of the total study population. 
• Problematic drug users reported higher rates for the majority of physical health 
complaints than was found among the total study population.  
• Problematic drug users were proportionally less likely to report having a medical 
card compared to the total study population 
• Problematic drug users were proportionally more likely to report psychiatric 
health concerns than their non-problematic drug-using counterparts.  
 
Service provision for homeless drug users 
• Almost a third of current drug users staying in emergency accommodation 
reported difficulties accessing such services due to their drug use 
• Few of the homeless services interviewed have official policies on illicit drug 
use or possession and dealing.  
• The general perception among service providers was that homeless services do 
not adequately meet the needs of homeless drug users. Service providers 
highlighted the lack of move-on options from emergency accommodation for 
homeless drug users.  
• The results would indicate that problematic drug users were more likely to 
experience problems accessing homeless services and more likely to be 
refused access to homeless services compared to the total homeless 
population. 
 
Personal drug use (n=67; 19%) was cited as the second most common reason for 
becoming homeless. Eighty-seven per cent of those experiencing homelessness first 
used drugs before becoming homeless.  
 
School drop out (early school leavers) 
Long et al. (2005b) report that 25.3% of all cases reported to the NDTRS in 2002 were 
early school leavers (left school before the age 15 years). This showed a slight 
reduction from 27.4% in 2001 and 28.2% in 2000. Regarding new treated cases, 18.2% 
reported leaving school before the age of 15, again showing a reduction from 21.1% in 
2001 and 20.1% in 2000.  
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Drug use among sex workers 
TSA Consultancy, on behalf of Ruhama a voluntary organisation working with women 
in prostitution, conducted research in Dublin over a 14-month period between 2003 and 
2004 with 19 women with experience of working in prostitution (TSA Consultancy 
2005). The aim of the research was to develop a model of intervention to support 
women involved in prostitution to access the social economy, community education or 
local employment. The research was based on the participatory research model. 
Fourteen of the women participated in more than one interview, with the majority of the 
women interviewed five times.   
  
Most of the women had engaged with the services of Ruhama for a number years and 
were keen to explore ways of taking further steps away from their experience of 
prostitution. For some of the women, this experience included additional problems of 
alcohol and drug use. For example, when engaged in active prostitution, some of the 
women reported being 'out every night' to support a drug habit and a pimp. The women 
were also aware of the dangers of not being fully alert due to the effects of alcohol and 
drugs and the inherent risks involved with prostitution. 
 
The research identified drug and alcohol use as primarily a survival mechanism for 
some of the women. For example, they would habitually get drunk or stoned or use 
prescription drugs in order to work, and then use drugs and alcohol ‘to numb the pain’ 
of prostitution. The authors report that for women working in prostitution, the need to 
maintain strict boundaries between their private and public sellves is an extremely 
important psychological tool for survival. However, for some of the women in this 
research, the use of drugs acted against this separation and 'mixed it all up'. In 
addition, when some of the women tried to access drug treatment services, their 
experience was that the existing policies that services had in place was a major barrier 
to moving on.  
 
Drug use among new communities in Ireland  
 
Merchants Quay Ireland (MQI) carried out exploratory research with the aim of 
developing an in-depth understanding of problematic drug use among new 
communities (Corr 2004). The research highlighted the association between social 
exclusion and problematic drug use among some members of new communities in 
Ireland,  
 
Three members from new communities - Russian, Romanian and Nigerian - were 
recruited and trained in ethnographic fieldwork techniques. Fieldwork included semi-
structured in-depth interviews with 10 individuals from new communities who identified 
themselves as problematic drug users. Four of the 10 reported no history of 
problematic drug use prior to arriving in Ireland, while one had ceased drug use for 10 
years and had restarted in Ireland. Six interviewees were from Africa, three from the 
former USSR and one from Central/Eastern Europe.  
 
Seven interviewees reported heroin and three reported cocaine as their respective 
drugs of choice. Five reported injecting heroin and indicated that the sharing of 
injecting equipment was prevalent. There were also reports of injecting drug use 
among individuals from Russia, Estonia and Pakistan. It was reported that injecting 
practices tended to be minimal among individuals from Africa, who tended to smoke 
heroin. Members of the Somali community were reported to be using Khat, a chewable 
green leaf stimulant, while members from the Russian community were reported to 
make a special porridge called Kasha, laced with cannabis.  
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Interviewees and other drug users met during fieldwork cited escapism from their 
current situation as a reason for continuing their drug use. Their current experiences 
included feeling excluded, isolated and fearful. Some reported using drugs to escape 
episodes of post-traumatic stress disorder that resulted from experiences of war and 
torture prior to arriving in Ireland. It was reported that younger members of new 
communities used drugs as a means of mixing with and gaining acceptance from Irish 
peer groups, mainly in recreational settings such as clubs.  
 
Seven interviewees were staying in hostels, two were staying with friends and one in 
private rented accommodation. Eight were unemployed and two in full-time 
employment. Four were seeking asylum, four were undocumented immigrants, one 
was documented as a labour migrant and one had refugee status. The majority 
expressed an interest in accessing treatment for their drug use but highlighted a 
number of barriers that prevented their engaging with services. For example:  
 
• There was scant knowledge of methadone-maintenance programmes, and 
some were persuaded by their Irish peers to treat methadone with skepticism 
as it was perceived to be as addictive as heroin.  
• Those with knowledge of methadone maintenance reported waiting lists and the 
assessment procedure as barriers to uptake. 
• Many associated treatment with abstinence and were unaware of harm-
reduction approaches (only two used a needle exchange).  
• Promotional material on treatment services is rarely available in languages 
other then English.  
• Some felt uncomfortable with the idea of 'group therapy' where the majority of 
participants were Irish; 
• Treatment options were poor, and few addressed cocaine problems.  
• Fear of being stigmatised by drug workers and fear of services reporting clients’ 
drug use to the state authorities were reported as significant barriers.  
 
8.3 Drug-related crime 
Drug offences 
Data are routinely published in the Garda annual reports for both ‘headline’ and ‘non-
headline’ offences, on the number of cases in which criminal proceedings commenced. 
The terms ‘headline’ and ‘non-headline’ in relation to drug offences were first used in 
the Garda report for 2000 and replaced the previously used terms ‘indictable’ and 
‘summary’. An offence is termed indictable or summary by the statute that creates it. In 
general, a summary offence is less serious than an indictable one. Summary offences 
are heard in the District Court by a judge without a jury. Indictable offences are tried in 
front of a jury. Using the Garda report for 2003, the most recent year for which data are 
available, we will now consider the outcome of specific drug offences where criminal 
proceedings commenced (An Garda Síochána 2004). 
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Table 8.3.1   Headline drug offences which became known to the gardaí in 2003 
Headline Offences 2003 Cultivation or 
manufacture of 
drugs 
Importation Obstruction 
under 
Drugs Act 
Possession of 
drugs for sale 
or supply 
Totals 
Offences reported or known to 
the gardaí 
 
74 35 304 2302 2715 
Offences detected 
 
74 31 288 2302 2695 
Offences in which criminal 
proceedings commenced 
 
56 10 172 1406 1644 
Results of 
proceedings 
in cases 
dealt 
with on 
indictment 
Convictions 
 
0 2 1 32 35 
Acquittals 
 
0 0 0 5 5
Nolle prosequi 
entered 
 
0 1 0 5 6 
Committed for trial 
and still awaiting 
trial 
 
0 7 1 30 38 
Results of 
proceedings 
in cases 
dealt 
with 
summarily 
Convictions 
 
8 2 32 156 198 
Dismissals 
 
3 0 21 69 93 
Charge proved 
and order made 
without conviction 
 
0 0 0 4 4 
Still pending in 
District Court 
2 9 67 481 559 
Source: Annual Report of An Garda Síochána 2004 
 
Table 8.3.1 presents the outcomes for the headline offences which became known to 
the gardaí in 2003. A total of 2,715 headline offences were reported to, or became 
known to, the gardaí in 2003. The figure in 2002 was 2,979.  
 
Of the 1,644 headline drug offences for which criminal proceedings commenced in 
2002, 46 were dealt with on indictment with a further 38 are still awaiting trial. A total of 
295 were dealt with summarily, with a further 559 still pending in the District Court. In 
2003, of those cases dealt with on indictment, 35 resulted in a conviction and 5 in an 
acquittal. Of the cases dealt with summarily, 198 resulted in a conviction and 93 were 
dismissed. The data presented in Table 8.3.1 does not provide information on the 
outcome for 706 of the 1,644 offences where criminal proceedings commenced in 
2003. 
 
The vast majority of drug offences that come before the courts are dealt with summarily 
in the District Court. Table 8.3.2 presents the non-headline offences where 
proceedings commenced as reported in the annual Garda report for 2003. 
 
Table 8.3.2   Non-headline drug offences where proceedings commenced in 2003 
Non-headline offences 2003 
Proceedings 
commenced Convictions 
Dismissed/ 
withdrawn Pending 
 
Unlawful possession, Section 3 MDA 4805 775 192 1051
 
Forging or altering a prescription 80 6 0 49
 
Other  36 1 5 7
 
Totals 4921 782 197 1107
Source: Annual Report of An Garda Síochána 2004 
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The majority of non-headline drug offences where proceedings commenced in 2003 
are for possession or ‘simple possession’ (s3, Misuse of Drugs Act 1977). Of the 7,150 
drug offences, both headline and non-headline, reported in the Garda annual report 
and in which proceedings commenced in 2003, 67% were for Section 3 offences.4  It 
can also be noted from the two above tables that, of the total number of drug offences 
in which proceedings commenced, both headline and non-headline, the vast majority 
(98.7 %) were disposed of summarily, with only 84 cases being dealt with on 
indictment. Also, of the 4,921 non-headline drug offences where criminal proceedings 
commenced in 2002, whereas there were 782 convictions, 197 were dismissed or 
withdrawn and 1,107 are still pending, the data are silent on the outcome of the 
remaining 2,835 cases in which proceedings commenced. 
 
The vast majority of drug offences reported in the annual Garda reports come under 
Section 3 MDA 1977, which prohibits possession of any controlled drug without due 
authorisation (simple possession), Section 15(1) MDA 1977 concerns the possession 
of a controlled drug for the purpose of unlawful sale or supply (possession for sale or 
supply) and Section 21 MDA, 1977 deals with obstruction. Other offences regularly 
reported on relate to the unlawful importation into the State of controlled drugs contrary 
to Section 21(2) of the MDA 1977; permitting one’s premises to be used for drug supply 
or use contrary to Section 19(1) of the MDA; the use of forged prescriptions; and the 
cultivation of cannabis plants.  
The use per se of drugs, excluding opium, is not a criminal offence in Ireland. The 
distinction between use and possession can lead to confusion in this area. Drug 
consumption or use refers to the mere use of illicit substances, and is separate from 
illicit acts such as possession, cultivation, transportation or supply. Although, in 
practice, it would be impossible to use a substance without possessing it, some legal 
systems make this distinction, prohibiting drug use as a specific offence. Figure 8.3.1 
shows trends in possession, supply and total drug offences since 1993. 
                                                
4 Data on drug offences are presented both in a statistical table and in a specific chapter on drug offences. However, 
there is a discrepancy in the total number of offences as presented in different sections. When we look at the tables 
above, the total headline and non-headline offences in which proceedings commenced is 6,565. However, the figure 
presented on page 79 of the report is 7,150. 
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Drug supply (s15 MDA) 643 709 776 908 1614 1766 1971 1706 1520 1530 1758
Drug possession (s3MDA) 3184 3069 2954 2718 5866 3865 4883 6485 7009 6038 4805
Total drug offences 4154 4498 4035 4019 7948 5942 7137 8395 8768 7976 7158
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
  
Figure 8.3.1   Trends in possession (s3MDA), supply (s15 MDA) and total recorded drug offences 
1993–2003 (from annual reports of An Garda Síochána 1993–2003)  
 
Following a slight decline in the number of drug offences prosecuted between 1994 
and 1996, there was a sharp increase in such prosecutions in 1997. This is explained 
by a 116 % increase in simple possession offences during 1996. In 1998, such 
offences decreased again sharply.5 From 1998 to 2001 the number of simple 
possession offences prosecutions again increased sharply, from a total of 3,865 such 
offences in 1998 to 7009 in 2001. Drug supply offences increased steadily from 1993 
until 1999. Between 1999 and 2001 supply offences decreased slightly. Since 2001, 
the number of prosecutions for drug supply has been on an upward trend. This is in 
contrast to simple possession offences which have decreased by 31.5% since 2001. 
 
It is unlikely that the increase in prosecutions for possession during 1997 is due to an 
increase in the incidence of such offences relative to other years. There are a number 
of possible explanations for the dramatic increase in the number of drug offence 
prosecutions during 1997. Firstly, it can be seen from Figure 8.3.2, which shows trends 
in other drug offence prosecutions, that there was also a sharp rise in the number of 
obstruction-related prosecutions (s21 MDA) in that year. Trends in the prosecution of 
drug offences other than possession and supply do not show any particular pattern. 
(O'Mahony 2004) suggests, in relation to obstruction offences, that ‘the fluctuating 
number of charges for obstruction suggests that this represents an approach to law 
enforcement that tends to go in and out of fashion amongst the Garda’.  
 
                                                
5 Before 1998, the data in the Garda reports relating to offence type presented the number of persons prosecuted in 
respect of each offence rather than the number of offences. As the same person can be charged with a number of 
offences in the same year, it can be assumed that the total offences should generally be a larger figure. However, a 
primary counting rule used in the compilation of statistics is the primary offence rule, which states that ‘where two or 
more criminal offences are disclosed in a single episode it is the primary offence which is recorded’. For an explanation 
see  Garda Síochána (2002) Annual Report p.142. 
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Figure 8.3.2   Selected MDA drug offences where proceedings commenced, 1983–2003 (possession 
s3 and supply s15 offences excluded) (from annual reports of An Garda Síochána, 1983–2003) 
 
Secondly, the GNDU was established in 1995 and this concentration of dedicated 
Garda resources to drug law enforcement is resources is likely to have had a fairly 
immediate impact on crime figures. Thirdly, the upsurge in anti-drug community activity 
in the mid-1990s following a number of drug-related deaths in inner city Dublin is likely 
to have lead to pressure on the gardaí to respond proactively (Lyder 2005). Fourthly, 
the increase may also be related to pressure brought about to enforce cannabis laws 
following the murder of journalist Veronica Guerin in July 1996 by a gang which 
featured prominently in the importation of cannabis. 
 
The total number of drug offences where criminal proceedings commenced decreased 
by just over 10% in 2003. However, a larger proportion of these (25%) were for drug 
dealing (s15 MDA) than in the previous year (19%). In 2003, 67% of the offences where 
criminal proceedings commenced were for simple possession (s3 MDA).  In 2002, 76% 
of offences were for possession. 
 
Figure 8.3.3 shows trends in drug offences where criminal proceedings commenced, 
by drug type, between 1995 and 2003. It can be seen that the majority of drug offence 
prosecutions are cannabis related. In 2003, cannabis-related prosecutions accounted 
for 57.6% of the total number of drug-related prosecutions. There has been a steady 
increase in cannabis-related prosecutions since 1996, despite a brief downturn in 1998. 
Cannabis related prosecutions decreased in 2003.  
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Cannabis 2579 1796 2671 2190 4185 4880 5143 5500 3891
Heroin 296 432 564 789 887 730 908 796 719
Cocaine 30 42 97 88 169 180 297 478 607
Amphetamines 138 152 239 273 464 391 207 300 180
Ecstasy 645 340 475 439 1023 2086 1845 1351 960
LSD 70 24 39 13 26 33 20 3 10
Other drugs 101 99 71 1839 383 95 109 89 391
Total Offence Proceeding 3859 2885 4156 5631 7137 8395 8529 8517 6758
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Figure 8.3.3   Recorded drug offences where criminal proceedings commenced, by drug type, 
1995–2003 (from annual reports of An Garda Siochána 1995–2003)  
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Figure 8.3.4    Trends in drug-related prosecutions for a selection of drugs, excluding cannabis, 
1995–2003 (from annual reports of An Garda Síochána, 1995–2003) 
 
 
Figure 8.3.4 highlights the dramatic increase in the category ‘other drug’ prosecutions 
in 1998. Offences in the ‘other drug’ category jump from 65 in 1997, to 1,839 in 1998, 
to 383 in 1999, and then back down to 95 in 2000. It is unclear from the annual report 
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why this increase occurs in 1998 but it is likely to be a recording error. We can see a 
large increase in ecstasy-related offences between 1998 and 2000, followed by a 
steady decline up to 2003. 
 
Heroin-related prosecutions have declined slightly in recent years, following a steady 
increase from 1995 to 1999. In 2003, heroin-related prosecutions accounted for 10.6% 
of the total number of prosecutions by drug type. Prosecutions related to cannabis, 
heroin, ecstasy and amphetamines all declined during 2003. 
 
There has been a steady increase in cocaine-related offences in Ireland since 1998. In 
2003, cocaine-related prosecutions accounted for just under 9% of the total 
prosecutions by drug type. Several seizures of cocaine processing equipment such as 
presses and vacuum packing equipment were also made (GNDU, personal 
communication, September 2005). 
 
Other drug-related crime 
In March 2004, the CityWide Drugs Crisis Campaign (2004) published a report entitled 
Cocaine in local communities: survey of community drug projects. This survey was 
carried out in response to the growing concern expressed by community groups across 
Dublin in relation to the emerging cocaine problem in many parts of the city. The 
authors surveyed community drug projects to establish whether cocaine users were 
being treated by local services and, if so, what services were offered to them and what 
additional services needed to be developed. 
 
Questionnaires were sent to 59 community drug projects requesting information about 
cocaine use among clients of services and within communities. Although the response 
rate was low (46%), the projects that participated in the study represented each task 
force area within Greater Dublin and that of Dun Laoghaire–Rathdown. The non-
respondents may manage drug projects where cocaine use is not a problem, and 
therefore did not complete the questionnaire, leading to a reporting bias. 
 
The report outlines the implications cocaine has for the users and their families and for 
the wider community.  
• Individuals 
o Fifty-two per cent of the project workers reported that cocaine use 
caused clients to become aggressive and agitated, resulting in 
difficulties for staff.  
o Almost two-fifths of the respondents reported that the ‘high’ from 
cocaine does not last very long; clients therefore use cocaine more 
frequently, which has cost implications.  
o Fifteen per cent of project workers reported that clients were becoming 
involved in crime in order to cover the costs of their cocaine use.  
o Twenty-two per cent of the participants reported that clients presented 
with mental health problems.  
o A number of project workers, particularly those in the south inner city 
and Ballyfermot, reported that clients injecting cocaine combined with 
heroin were developing deep vein thrombosis (DVT) and abscesses.  
• Families  
o Almost half of the participants stated that cocaine was responsible for 
domestic rows.  
o Thirty per cent claimed that parents of cocaine users were extremely 
worried and unsure of how to deal with the problem.  
o Project respondents in Dublin 8 claimed that families had no option but 
to leave the area because of cocaine-related debt or anti-social 
behaviour.  
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o Some project workers reported an increase in the number of young 
people forced to leave home because of their cocaine use.  
o Respondents reported that cocaine can also have a negative impact on 
the children of users: for example, in the Dublin 8 area a small number 
of children had been put into care because of their parents’ excessive 
cocaine use. 
• Communities 
o Fifty-eight per cent of project workers reported increases in petty crime, 
dealing and other anti-social behaviour within their community,  
o Eight per cent of project staff cited recreational cocaine use as causing 
work-related problems for a number of people living in the area.  
 
 
A major study by the Garda Research Unit was published in 2003 (Furey and Browne 
2003). The study sought to establish the link between opiate use and criminal activity in 
Ireland for the years 2000/2001. An earlier study by Keogh (1997) focused on the 
drug–crime relationship in Dublin in 1996. 
Both studies combined the use of official police statistics and interviews with drug 
users. The purpose of the Keogh study was to provide reliable information on the 
relationship between illicit drugs and the commission of crime in the Dublin 
Metropolitan Area (DMA). The study by Furey and Browne extended the analysis to the 
other Garda Síochána regions throughout the State. Another difference between the 
two studies is that Furey and Browne examined the use of opiate-based drugs only, 
while Keogh included some individuals who used only non-opiates such as ecstasy, 
cocaine and amphetamines. However, the majority (93%) of the subjects in Keogh’s 
report were opiate users.  
The two studies incorporated three principal phases. Phase One involved an estimation 
of the total number of opiate users known to the gardaí at the time of the study. In the 
Keogh study, 3,817 opiate users were identified in the DMA in 1996, while Furey and 
Browne recorded a figure of 4,706 opiate users in the DMA in 2000/2001. However, a 
valid comparison cannot be made between these figures. Firstly, Furey and Browne’s 
figure is based on data for two years, while Keogh’s figure is based on data for a single 
year. Secondly, as Furey and Browne point out, the DMA is now larger than it was at 
the time of the Keogh study, incorporating an extra Garda division. 
Phase Two involved a survey of a sample of the drug users identified in Phase One. 
The surveys sought to elicit data about the drug users themselves, their drug-taking 
environment and their criminality.  
Phase Three involved an examination of national crime figures in order to estimate the 
relationship between opiate use and crime. Keogh estimated that drug users were 
responsible for 66% of detected indictable crime, while Furey and Browne concluded 
that drug users were responsible for just 28% of detected crime. While this difference is 
quite striking, it can be partly explained by some of the survey findings from Phase 
Two. A number of these findings are given in the table below. 
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Table 8.3.3   Comparative Garda Síochána studies on drug–crime linkages, 1997 and 2003 
Variable Keogh study Furey and Browne study 
Crime as main source of income 59% 13% 
Unemployment rate among drug users 84% 55% 
Most common age of first taking drugs 15 years 15 years 
Drug first used – cannabis  51% 55% 
Drug first used – heroin  32 % 27% 
First introduced to drugs by friend 81% 86% 
Estimated daily expenditure on drugs* €51 €75 
Percentage who sourced drugs from local 
drug dealer 
 
46% 
 
76% 
Crime came before drugs 51% 33% 
Drugs came before crime 30% 56% 
Drug use and crime started together  19% 11% 
Percentage who had been in prison 81% 66% 
 * Keogh estimated that the cost of one gram of heroin in 1997 was €100 (Keogh, 1997: 40). Furey and Browne do not 
provide a figure. However, the current cost of one gram of heroin is approximately €190. 
In the Keogh study 59% cited crime as their main source of income, while the figure in 
the Furey and Browne study was 13%. It is also noteworthy that the Keogh study 
reported an unemployment rate of 84% among the sample, while Furey and Browne 
reported an unemployment rate of 55%. This latter finding supports the economic 
motivation theory by suggesting a lesser dependence on the proceeds of crime in a 
context of available employment. It also indicates an ability among opiate users to 
maintain employment despite their addiction. A factor that may have contributed to this 
is the increased availability of drug treatment in the time between the two studies. 
Indeed, Furey and Browne found that 75% of respondents claimed that their receipt of 
drug treatment had in fact decreased their criminal activity. 
A worrying finding of the Furey and Browne study relates to the apparent stabilisation 
of local drug markets over time and the ease of drug availability. The study records an 
increase from 46% to 76% in the number stating that they sourced their drugs from a 
local dealer. This has serious implications for local policing and other supply control 
initiatives. 
Another significant difference between the two studies relates to the relationship 
between respondents’ initiation into drug use and their criminal activity. While the 
Keogh study found that 51% of respondents had committed crime before beginning to 
use drugs, a finding which is broadly consistent with the international literature, Furey 
and Browne recorded a figure of 33%. 
The survey findings of the Furey and Browne study must be treated with a degree of 
caution, however, because of the poor survey response rate. The response rate in the 
Furey and Browne survey was just 27% (131 out of 486) compared to 78% (351 out of 
450) in the Keogh study. Furey and Browne compared the respondents and non-
respondents in their survey according to two available variables, gender and 
possession of a criminal record, and found little difference between the two groups. 
This provides some evidence to suggest that the sample might not be totally 
unrepresentative of the total number of drug users known to the police. Furey and 
Browne highlight the difficulties they encountered in contacting potential respondents 
and point to a 123% increase in homelessness between 1996 and 2004. 
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The difficulties encountered in accessing respondents for interview in this study show 
the obvious limitations of studies of this nature, where the police seek information 
about criminal behaviour from subjects they have arrested or known. This relates to a 
possible perception among respondents that by self-reporting criminal behaviour they 
risk exposing themselves to possible incrimination. Keogh, for example, encountered 
difficulties in acquiring specific information from respondents, particularly concerning 
their participation in violent criminal behaviour. Furey and Browne suggest that a 
possible reason for the reluctance among drug users to participate in their survey may 
have been related to a perceived deterioration in relations between the gardaí and drug 
users since 1997, which, the authors contend, may have occurred as a consequence of 
a number of policing operations targeted at drug users. 
Another methodological issue relates to the use of Garda-recorded crime statistics. In 
order to assist them in identifying known drug users and to establish the relationship 
between opiate use and crime, the two studies relied on different data sources. Keogh 
relied on manual data and an earlier Garda computer system while Furey and Browne 
used the new Garda Síochána PULSE system. The recent minority report of the Expert 
Group on Crime Statistics has highlighted major concerns in relation to the operation of 
this data system and also about earlier crime-recording practices (Expert Group on 
Crime Statistics 2004b). 
Despite these shortcomings, the Furey and Browne study provides useful and recent 
information about a hard-to-reach population. 
Of the 131 drug users surveyed by Furey and Browne (2003), 110 had looked for 
treatment and 100 had received it. Sixty-four respondents reported an association 
between the receipt of treatment and engagement in crime. Forty-nine of those 
respondents reported doing ‘a lot less’ crime (p. 34).  It is unclear whether this is 
actually the case, however. A follow-up study of the progress of those respondents who 
reported a decline in their offending behaviour as a result of drug treatment would be 
instructive. 
Furey and Browne found that opiate users are responsible for less than one-quarter of 
larceny offences (23%) and just over one-third of burglaries (37%). The lowest 
percentage (4%) of detected crime accredited to opiate users is for assault. The study 
found that 49% of respondents had been convicted of robbery, which was the highest 
crime category recorded. The authors point out that robberies represent only a very 
small percentage of headline crimes annually. Nevertheless, robbery is defined and 
experienced as a violent crime. 
Furey and Browne found that drug users are almost twice as likely to be caught 
offending as non-drug-users. They make the important point, however, that they are 
discussing ‘detected’ crime and they highlight the possibility that differences in crime 
committal ratios between drug users and non-drug-users may be due to the fact that, 
‘the attendent consequences of their drug use may have rendered them less likely than 
non-users to evade detection’ (p. 20). 
 
8.4 Drug use in prison 
No new information available. 
 
8.5 Social costs 
No new information available. 
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9. Responses to Social Correlates and Consequences 
 
 
9.1 Overview 
This section will highlight the proposal for a new pillar on rehabilitation to be added to 
the National Drugs Strategy. Also covered are the legislative obstacles facing drug 
users who have been evicted from local authority housing for anti-social behaviour, 
when they try to access rental supports to live in the private sector. The relatively small 
provision of transitional housing options and dedicated emergency accommodation 
options is also highlighted. On a more positive note, the provision of education and 
vocational training supports appears to be receiving increased attention and a recent 
review of the main education and training programme dedicated to drug users provides 
valuable learning opportunities for enhancing the relevance and quality of this service 
in the future. The section also reports on a cocaine study which considered services’ 
responses to Ireland’s developing cocaine problem. We also report on a number of 
positive developments in prison-based drug treatment. The publication of policing plans 
and progress towards the establishment of local policing structures are also reported. 
With regard to drugs in prison, new supply-control measures including the introduction 
of mandatory drug testing are significant developments, as is the publication of an 
evaluation of an arrest referral scheme in Dublin. 
 
9.2 Social reintegration 
The mid-term review of the National Drugs Strategy, completed in 2005, recommends 
that rehabilitation becomes the fifth pillar of the Strategy as it was seen as a critical 
issue and recurring theme throughout the consultation process during the review. The 
rationale for developing a fifth pillar on rehabilitation is based on the belief that drug 
users should not be kept on methadone indefinitely but assisted in 'moving on' towards 
social reintegration. The steering group notes the many different views and 
interpretations of what constitutes rehabilitation, ranging from therapeutic approaches 
on the one hand to training and social re-integration on the other. However, the group 
agrees that, in general, rehabilitation includes personal development, training, 
community integration, access to housing and employment. It is recommended that a 
working group be established under the aegis of the Department of Community, Rural 
and Gaeltacht Affairs to examine this area comprehensively and to develop an 
integrated rehabilitation provision, and report by the end of 2005 on the appropriate 
actions to be implemented.  
 
Housing 
Current legislation would seem to suggest that drug users evicted from local authority 
housing could be prohibited from securing supplementary rent allowance that would 
support them in securing accommodation in the private rental sector. Section 16 of the 
Housing (Miscellaneous Provisions) Act 1997 gives discretion to the Health Service 
Executive to refuse or withdraw Supplementary Welfare Allowance, rent or mortgage 
supplementation for private housing in the case of persons evicted, excluded or 
removed from, or refused, housing on the grounds of anti-social behaviour.  
 
The exclusionary nature of this legislation has recently been acknowledged by the 
Homeless Persons Unit (HPU), which has the responsibility for allocating homeless 
status to individuals and which is the main referral agency to accommodation services 
in Dublin. The HPU states: 
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If the person is evicted for anti-social reasons, according to the Housing 
(Miscellaneous Provisions) Act, 1997, rent allowance ‘may be restricted’. In 
practice the HPU says that people are excluded from rent allowance and 
are placed into emergency accommodation instead. (Bergin et al. 2005: 13) 
 
In addition, recent changes to the provision of rent supplements mean that new 
applicants must now pay their own rent for six months before becoming eligible for rent 
supplement. This can have adverse implications for people being released from 
residential drug treatment or prison, or  those evicted from local authority housing and 
dependent on social welfare payments. Interestingly, only one organisation that works 
directly with drug users, Merchants Quay Ireland, has been invited to participate in the 
Rent Supplement Coalition that has been set up to campaign for changes in the current 
situation.  
 
Transitional housing 
A small number of specific transitional housing interventions target drug users, mostly 
provided by the voluntary sector, with some financial assistance from the statutory 
sector. Merchants Quay Ireland provides a transitional housing intervention dedicated 
to former drug users who experience homelessness following completion of residential 
drug treatment. According to the Merchants Quay Annual Review 2004 (2005), 
accommodation is provided for a period of up to 24 weeks and during 2004 there were 
12 residents in the house. The Arrupe Society, also a voluntary organisation working 
with homeless drug users, provides transitional accommodation through the Avoca 
project. Residents include individuals who  have completed residential treatment. The 
intervention encourages residents to maintain a drug-free lifestyle (Fr Peter McVerry, 
personal communication, 2004). The Sisters of Mercy in Cork provide transitional 
housing to men and women who have completed residential drug treatment, through 
the Fellowship House and Renewal Programme respectively (Sr Cait O'Leary, personal 
communication, 2005). In the statutory sector, the Health Service Executive Northern 
Area Rehabilitation/Integration Service (RIS), with Focus Ireland and Keltoi, is 
providing assisted housing units in George's Hill for people coming out of Keltoi and 
working towards reintegration. Currently, seven housing units are being prepared. The 
programme includes the following components: individual work, group work, home 
management/lifeskills training, and community-based training, education and 
employment opportunities (C Morgan, personal communication, 2005).   
 
Emergency accommodation 
Similarly, a small number of emergency accommodation options specifically target 
individuals engaged in problematic drug use. DePaul Trust Ireland provides a low-
threshold, harm-reduction hostel for young rough sleepers, many of whom are 
intravenous drug users. Facilities include 16 beds in seven twin and two single rooms. 
The Caretakers Hostel operated by Focus Ireland targets out-of-home young people 
aged 16–21 years who are misusing drugs. Accommodation includes nine beds, five 
for males and four for females. According to a recent annual report, 40 young people 
used the service during the period May to December 2003, (Focus Ireland 2003). 
Haven House provides 24 beds in 10 rooms for single homeless women with children, 
including women with alcohol or drug problems. The Health Service Executive Northern 
Area operates the 'Out Of Hours Service' in Lefroy House,  providing an emergency 
social work service to young people aged 12–18 years who present as out-of-home 
outside office hours.  
 
Education and training 
Vocational training and employment support interventions are provided by FÁS, the 
National Training and Employment Authority, to individual drug users through 
dedicated LDTF projects and through mainstream community employment (CE) 
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schemes. A recent review of the special FÁS CE scheme for drug users (Bruce 2004) 
reports that, as of 30 January 2004, there were 812 participants. However, this number 
represents a shortfall as FÁS has 'ring-fenced' approximately 1,000 CE places to 
provide training to drug users across the LDTF areas.  
 
The review highlights a number of key issues that require explanation. For example, 
twice as many females (67.7%) as males (32.3%) were participating on the scheme. 
However, recent data from the NDTRS for 2002 (Long et al. 2005b) shows that males 
represented 71% of cases living and treated in Ireland for problematic drug use. This 
suggests that male problematic drug users are not well disposed to accessing 
vocational training and employment support interventions.  
 
In addition, the review notes the difference between the providers of the FÁS scheme 
and the participants in their understanding of the primary goals of the CE scheme. On 
the one hand, FÁS aims to provide vocational training aimed at enhancing the labour 
market prospects of clients, while on the other hand Bruce (2004: 59–60) observes 
that: 
 
The most common theme for participant respondents was that, for them, CE 
was rehabilitative rather than job oriented. Many saw employment as a worthy 
but essentially remote aspiration. Most were focused on staying stable – with 
others aiming to become drug free as soon as possible. This would appear to 
stem from the immediacy of medical and personal needs rather than any 
rejection of employment outcomes per se.  
 
The review provides insights into the strengths and weaknesses of the special FÁS CE 
scheme according to supervisors, project workers, FÁS personnel and participants. For 
example: 
 
• Some supervisors experienced role confusion where, on the one hand, many 
operated in strong personal support and advocacy roles for participants. Others 
saw their roles sometimes tending towards addiction recovery support, while 
others viewed their role as partly therapeutic or as one of advocacy. Many 
supervisors, dealing on a daily basis with the many complex personal issues of 
participants, found difficulty in articulating a vocational employment perspective 
in any realistic sense. Most project workers expressed the view that meaningful 
progression to the labour market was not an option for the majority of 
participants or that, if it were, it could take substantially longer than three years. 
• Many acknowledged a lack of training and resources.  
• Background issues regarding poverty and social deprivation were widely 
reported as complicating progress towards a labour market orientation. In this 
regard, a strong emphasis was placed on the role of education as the key lever 
of change for the individual (and the community). The achievement of 
certification was frequently mentioned as providing both the best impetus to 
work and a strong reinforcement of therapeutic aspects.Strong opinions were 
expressed about the HSE’s lack of consistency or strategic involvement in the 
area.  
• A general concern expressed was the lack of standardisation and practice. 
Projects varied greatly not only in terms of outcomes (which were felt to be 
inadequately monitored anyway) but also in terms of process and operation. 
Particular concerns were expressed by most respondents around assessment 
criteria, identification of needs and the structure of activities to meet these 
needs. There was a concern that FÁS was called on to meet a range of social, 
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personal and economic needs for which it had neither the expertise nor 
resources. 
• The high value placed by all respondents on education and the recognition of 
certification attained shows that longer-term perspectives on community and 
vocational reintegration are not absent. The range of problems expressed was 
notable. It included issues around money and allowances, homelessness, a 
very poor standard of general health and inadequate diet. Many respondents 
expressed concern about their ability to stay clean and avoid relapse. One of 
the most consistently valued elements of CE participation was the growth in 
self-esteem and self-confidence.  
 
The HSE Northern Area Rehabilitation/Integration Service (RIS) has been involved in 
developing a number of innovative initiatives to support current and former drug users 
in accessing vocational training and employment options (C Morgan, personal 
communication, 2005). For example:  
 
• Bridge to the Workplace is a one-year pilot 'work experience' initiative aimed at 
stimulating change and progression for those with a history of problematic drug 
use. This intervention seeks to expand the progression potential of 40 people 
with addiction through the establishment of a workplace, work experience 
stimulation programme for up to 26 weeks, as part of a planned progression 
route. It is a multi-agency collaborative effort involving the HSE, FÁS, 
Blanchardstown Local Employment Service (LES), Finglas/Cabra LES, 
Northside LES, Ballymun Job Centre, and Dublin Inner City Partnership. The 
main target groups are clients of addiction services and LES networks.  
 
• KeySkill is a rehabilitation/reintegration and counselling service initiative. It ran 
for a total of nine sessions, each session lasting two hours. Six clients were 
assessed as suitable for the pilot; five commenced; and four completed the 
programme, achieving the 'Certificate of Achievement' and 'Letter of 
Competence'. Attendance was excellent and punctuality rated as very good. 
Four clients continue to link in with RIS for the duration of pilot.  
 
The Blanchardstown EQUAL Inter-agency Initiative was developed to establish a co-
ordinated approach to providing quality supports and services to former and current 
drug users in the Blanchardstown area of Dublin. The key objective was to bring 
together statutory and voluntary agencies working with current and former drug users 
in order to establish clear inter-agency protocols and good working relationships. The 
primary aim is to enhance opportunities for the target group to progress towards 
employment opportunities. Developments to date include a protocol on lead agency 
working, which provides a definition of the term and establishes the responsibilities of 
the lead agency. According to the protocol, a lead agency assumes the most significant 
role in providing and co-ordinating services to a client, including the provision of a key 
worker. Responsibilities include carrying out a needs assessment, holding and 
managing the overall care plan and tracking and following up on a client to prevent 'a 
fall through the cracks'. In addition, a protocol on confidentiality has been developed 
and adopted by all eight participating agencies, covering areas such as the limits of 
confidentiality, sharing client information, working with under-18s and accommodating 
clients’ access to files containing information on them. From February to April 2004 the 
protocols were piloted among the agencies. Preliminary evaluation results show that 
co-operation between agencies is improving, particularly on the challenging issues of 
three-way meetings and lead agency referrals. A three-way meeting is one between 
the lead agency, the agency the client has agreed to be referred to, and the client. The 
Blanchardstown EQUAL Initiative evaluation noted that three-way meetings were 
consistently reported as being positive both for introducing clients to new agencies and 
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for resolving issues arising for clients between agencies (Blanchardstown EQUAL 
Initiative 2004). The lead agency approach is seen by most agencies as having 
clarified the roles of other services and allowed the interventions to be client-focused. 
Following the pilot phase, all eight agencies agreed to mainstream the use of the 
protocols in their work programmes. However, lead agencies recognise that these new 
approaches will take time to develop, to embed and to implement. As part of the 
evaluation of the pilot phase, a facilitated focus group session was held with eight 
clients in early September 2004. All the clients had been through the inter-agency 
initiative and found it to be a better way of working. According to the evaluator, they 
questioned why it was not used everywhere when it had so many advantages for 
service users. 
 
Responding to cocaine use 
The lack of services available to cocaine users was of particular concern to those who 
participated in the cocaine study conducted by the CityWide Drugs Crisis Campaign 
(2004). According to the report, almost one in five of the community drugs projects that 
participated in the study said that they had no services for cocaine users; however, the 
majority of projects did provide some services. These included: acupuncture, yoga, 
reiki, relaxation methods, Indian massage, and home detoxification through 
acupuncture and acupressure.  Almost 60% of the projects provided counselling, while 
45% provided harm-reduction services specifically for cocaine users. Fourteen per cent 
provided practical support, such as laundry, bathing facilities and nursing care.  Half of 
the project workers claimed that they were not aware of any other service treating 
cocaine use in their area. Project workers stated that they would be interested in 
providing: 
• alternative therapies specifically for cocaine users 
• cocaine-specific education programmes 
• respite for cocaine users 
• detoxification programmes. 
However, in order for such services to be developed, project workers felt that they 
would need additional training and an increase in staffing and funding, and evidence of 
political will to tackle the issue.  The findings of this study support the findings reported 
by the NACD (2003) in its overview of cocaine use in Ireland.    
 
Drug treatment in prison 
Following a number of studies which showed high levels of drug use and drug-related 
infectious diseases among the Irish prisoner population (Allwright et al. 2000; Dillon 
2001; Hannon et al. 2000; Long et al. 2001; Long et al. 2003; Long et al. 2004a), during 
2000 and 2001 the Irish Prison Service, along with other agencies, developed both 
drug treatment service plans and healthcare plans for Irish prisoners (Group to Review 
the Structure and Organisation of Prison Health Care 2001; Irish Prison Service 2000; 
Irish Prison Service 2003). By the end of 2002, the Prison Service was at an advanced 
stage of drafting an Irish Prison Drug Service Policy that would be in line with Ireland’s 
National Drugs Strategy and with the World Health Organization’s Health in Prisons 
Project: Prisons, Drugs and Society (WHO (Europe) Health in Prisons Project and the 
Pompidou Group of the Council of Europe 2001). This policy is awaiting approval from 
the Minister for Justice, Equality and Law Reform.  
 
A number of positive developments have occurred, such as the introduction of 
evidence-based methadone treatment services that can be accessed by the majority of 
opiate-dependent prisoners. Attempts have also been made to vaccinate a significant 
minority of prisoners against hepatitis B, something very few prisons, nor, indeed, 
community health services, have managed. The employment of registered nurses 
facilitated the separation of disciplinary and healthcare roles. There has also been an 
increase in the availability of drug-free units (Long et al. 2004a). 
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In 2004, a consultant psychiatrist in addiction was appointed by the HSE Northern Area 
to provide a service to prisoners in Mountjoy Prison in Dublin. The number of prisoners 
in receipt of methadone maintenance has also increased – from 184 in December 2000 
to 290 at the end of July 2004 (Department of Community Rural and Gaeltacht Affairs 
2004). 
 
9.3 Prevention of drug-related crime 
Policing 
In 2004 Divisional Drug Policing Plans were posted on the Garda website at 
www.garda.ie. A co-ordinating framework has been established under an Assistant 
Garda Commissioner. It assigns responsibility for co-ordinating the Garda Drugs 
Strategy at a regional, divisional and district level. 
 
A programme of education for Garda Divisional Search Teams has been developed 
and is currently being implemented to advise best practice in relation to the discovery 
and safe investigation of clandestine drug laboratories where there is a danger of 
volatile substances being encountered which might constitute a danger to the public or 
members of An Garda Síochána carrying out a search. 
 
A Garda initiative called ‘Operation Anvil’, aimed at targeting organised crime and other 
serious criminal activity (including drugs), was initiated in 2005. The GNDU reports that 
the operation, which focuses on the Dublin Metropolitan Region, ‘has yielded significant 
results to date, including many drug seizures and the seizure of in excess of 100 
firearms’. (GNDU, personal communication, September 2005). 
 
The Garda Síochána Act 2005 provides for the development of Joint Policing 
Committees at local-authority level and for the establishment of local policing fora in 
designated areas under the umbrella of such committees. These bodies are to act as 
fora where matters relating to local issues of policing and crime, including drug-related 
issues, can be discussed and where strategies and recommendations for dealing with 
issues locally can be formulated (see section 1.2).  The guidelines for this legislation 
are currently being formulated. There are currently three Community Policing Fora, in 
the North Inner City, Finglas/Cabra and the South Inner City, with another one agreed 
for the Blanchardstown drugs task force area of west Dublin (Connolly 2004b; 
Oireachtas Joint Committee on Justice, Equality, Defence and Women's Rights 2005).  
 
Customs 
A Customs cutter (RCC Suirbhéir) was commissioned in 2004. The boat will patrol the 
coastline with the purpose of intercepting vessels suspected of drug smuggling. 
 
Drugs in prisons 
Along with traditional supply prevention methods, new visiting arrangements which 
involve prior nomination and identification of visitors have been introduced in Mountjoy 
Prison to prevent drug smuggling. The Irish Prison Service has also installed nets over 
a number of prison yards to prevent drugs being propelled over prison walls. 
 
The Minister for Justice, Equality and Law Reform, Mr Michael McDowell TD, 
announced the publication of new draft prison rules in June 2005. The rules deal with 
all aspects of prison life, including accommodation, visiting rights, discipline, health and 
education. The existing prison rules date back to 1947. The new rules make provision 
for the introduction of compulsory or mandatory drug testing (MDT) of prisoners, a 
commitment in the Agreed Programme for Government between Fianna Fáil and the 
Progressive Democrats (Fianna Fáil and the Progressive Democrats 2002). 
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Section 28 (5) (a) of the new Prison Rules provides: ‘In the interest of good order, 
safety, health and security and in accordance with directions set down by the minister, 
a prisoner … shall, for the purpose of detecting the presence or use of an intoxicating 
liquor or any controlled drug … provide all or any of the following samples, namely – 
urine, saliva, oral buccal transudate, hair.’ The announcement comes at a time of 
increased debate as to the merits of MDT. The Irish Penal Reform Trust (IPRT) has 
consistently opposed the introduction of MDT. Speaking to Drugnet Ireland, Rick Lines, 
executive director of the IPRT, said:  
 
… such testing increases heroin use among prisoners, increases 
injecting and the risk of HIV and hepatitis C transmission through 
shared syringes, reduces the uptake of voluntary drug treatment by 
prisoners, and wastes money that could be better spent on more 
effective drug programmes. (Connolly 2005a) 
 
Arrest referral 
Action 13 of the National Drugs Strategy 2001–2008 obliges An Garda Síochána ‘To 
monitor the efficacy of the existing arrest referral schemes and expand them, as 
appropriate’. Action 19 promotes such early intervention approaches to problem drug 
use: ‘Incidences of early use of alcohol or drugs by young people coming to Garda 
attention to be followed up by the Community Police and/or the health and social 
services, in order that problem drug misuse may be diagnosed/halted early on through 
appropriate early intervention’ . The main aim of arrest referral schemes is to provide 
information to arrestees about appropriate services and to facilitate referral to treatment 
at the primary points of entry into the criminal justice system, usually the police station. 
Arrest referral is an early intervention aimed at people who have been arrested and 
whose offence may be linked to drug use. Such policies are premised on the idea that 
treatment will lead to a reduction or cessation of illicit drug use and will thus reduce or 
negate further drug-related offending by the drug user.  
 
Pilot arrest referral procedures have been put in place in Cork, Dún Laoghaire and 
Ballymun. In addition, a further pilot arrest referral scheme is in operation in the North 
Inner City Drugs Task Force area. This has recently been evaluated and a summary 
report published (Connolly 2005b). 
    
Juvenile arrest referral schemes are consistent with the principles outlined in the 
Children Act 2001, which emphasise prevention and the diversion of young offenders 
from prosecution (see Ireland National Report 2004). The summary report published by 
the North Inner City Drugs Task Force (2005) and funded by the Department of Justice, 
Equality and Law Reform on a pilot arrest referral scheme in Dublin’s north inner city 
was launched in April 2005 by Noel Ahern TD, Minister of State with responsibility for 
the National Drugs Strategy. 
 
The report considers best practice approaches in the UK, where significant progress 
has been achieved in introducing arrest referral schemes. The report also considers an 
arrest referral scheme in operation at Gransha Hospital in Derry, the Derry Arrest 
Referral Team (DART) Alcohol/Drugs Service, and outlines three different arrest 
referral intervention models. The information-giving model provides information such as 
leaflets on treatment, but there is no advice, counselling or follow-up; the incentive or 
coercive model involves cautioning an arrestee to seek advice from a drugs worker or 
postponing a cautioning decision pending attendance by the arrestee at a drug service; 
and the proactive model involves specialist arrest referral workers based in the police 
stations or on call. 
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The north inner city pilot scheme involves co-operation between the outreach services 
of the HSE Northern Area, An Garda Síochána North Central Division and the local 
drugs task force. Participation in the scheme is completely voluntary for arrestees and 
does not interfere with the normal operation of the criminal justice system. The initial 
take-up of the scheme has been low. The report provides data for juveniles arrested in 
the North Central Division stations of Store Street, Mountjoy, Bridewell and Fitzgibbon 
Street between May and September 2003. Of the 214 arrestees, 167 were male. Only 
14 (6.5%) of these arrests were made under the Misuse of Drugs Act MDA 1977. 
  
The take-up rate for the scheme is reported as ‘quite low’, with only a small number of 
individuals referred to the health services. The report acknowledges that many young 
arrestees will not see their drug use as problematic but rather as ‘dabbling’ or 
‘recreational’ and will therefore not seek help. Also, the low number of MDA-related 
arrests leads the authors to question whether the scheme should be broadened to all 
juvenile arrestees, ‘regardless of their offence within appropriate qualifications’. 
The low take-up rate of the scheme is consistent with data provided by the NDTRS. 
Table 9.3.1 shows the number and percentage of cases reported to the NDTRS by 
court, probation or police.  As can be seen, the proportion of cases referred from these 
criminal justice agencies is low and has remained relatively unchanged between 1998 
and 2002. 
 
Table 9.3.1   The number (%) of cases reported to the National Drug Treatment Reporting System 
who were referred by police, probation or court, 1998–2002  
 1998 1999 2000 2001 2002 
Police, probation, court   518 (8.8)   427 (7.1)   439 (6.5)   480 (6.4)   598 (7.4) 
Total cases1   5862   5993   6754   7532   8116 
1 Cases in which the referral source was recorded. 
Source: Unpublished data from the National Drug Treatment Reporting System, Health Research Board 
 
 
The low take-up rate in the Dublin scheme is consistent with findings from other such 
schemes in their early stages. Referrals in the Derry scheme increased from 85 in 2001 
to 249 in 2003. Similarly, as the pilot becomes increasingly established in the north 
inner city, the gardaí report that the number of referrals is also growing. The primary 
recommendation of the report is that the pilot phase of the scheme should be 
extended, with additional resources in terms of staff, programme development and 
monitoring.  
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10.  Drug Markets 
 
10.1 Overview 
Following feedback on Ireland’s 2004 national report, in this section we consider 
available police data on drug offence prosecutions by Garda region in order to identify 
trends in drug distribution at middle market level throughout the country. We also report 
on the European School Survey Project on Alcohol and other Drugs (ESPAD) in 
relation to drug availability and sources. Data on drug seizures and trends are also 
presented and analysed. Available data on drug prices and purity, although limited, are 
also reported. 
 
10.2 Availability and supply 
No studies have been conducted on Irish drug markets. With regard to the international 
drug market, the original sources of supply vary according to the type of drug. 
 
When drugs are seized, Irish law enforcement personnel, including the gardaí and 
Customs, seek to determine the destination of the drugs by considering a number of 
factors associated with the particular seizure: the size of the seizure, the geographical 
location of the seizure, whether for example weather conditions inadvertently caused a 
diversion into Irish waters of a particular shipment, or the circumstances of the 
individuals apprehended along with the drugs (CDLE, personal communication, June 
2004). The figures presented below in relation to drug destinations should therefore be 
regarded as ‘guesstimates’. 
 
With regard to the importation and internal distribution of drugs, the  ‘middle market’, a 
possible indicator of distribution patterns is drug-related prosecutions by drug-type and 
by Garda division. While this data, which is presented in the Garda annual reports, 
primarily reflects law enforcement activities and the relative ease of detection of 
different drugs, it may also provide an indicator of national drug distribution trends and 
whether, for example, we can see a concentration of prosecutions along trafficking 
routes. Also, with regard to heroin, which has always been a predominantly Dublin-
based phenomenon, a comparative analysis of heroin-related prosecutions by Garda 
division can indicate whether the heroin market is spreading outwards from Dublin. 
This law enforcement data can also be considered along with other data sources such 
as the NDTRS to identify common patterns. 
 
Cannabis resin 
The major producing country of cannabis resin, the principal form of the drug used in 
Ireland, is Morocco (EMCDDA 2004). The main supply route for cannabis resin is from 
Morocco via Spain, the Netherlands or the UK to Ireland. The bulk of cannabis resin 
seized by Customs in 2003 was concealed in freight consignments from North Africa. 
Large quantities of cannabis resin has also been seized along the south coast of 
Ireland being smuggled by yachts, small craft or converted fishing vessels (CDLE,  
personal comunication, July 2005) 
A strong decrease in the trafficking trend for cannabis resin was detected in 2001 by 
Customs at Dublin Port. The reason for this decrease has not been identified. Of the 
cannabis resin seized in 2002, 10% was transported by air and 90% by sea (Garda 
National Drugs Unit 2003). Reporting on possible reasons for a decrease in cannabis 
trafficking into Ireland for that year, the GNDU states: ‘The major decrease in trafficking 
in cannabis in Ireland can probably be attributed to the fact that four major shipments 
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were intercepted during 2001, which were destined for the UK market thereby causing 
traffickers to stop trying to use Ireland as a transit country’ (Garda National Drugs Unit 
2003: 8). Customs report that, although the number and quantity of cannabis seizures 
has been showing signs of decline in recent years, indications are that this trend is 
reversing (CDLE, personal communication, December 2003). 
Cannabis herb 
The cannabis herb seized in Ireland originates primarily in South Africa and Thailand. It 
arrives in Ireland via different countries, including France, Germany, the UK, the 
Netherlands and Belgium. In 2001 there was a large increase in the amount of 
cannabis herb seized in Ireland. This was reported as being due to Ireland being 
targeted as a transit country for supplying cannabis herb to the UK market (CDLE, 
personal communication, December 2003) 
  
Customs seized over 19 tonnes of cannabis herb in the years 2001/2 and the vast bulk 
of this was detected in a small number of very large seizures in maritime freight (18 
tonnes), the bulk of the balance being detected in passenger baggage at the airports: 
‘The majority of these [seizures] have been seized from freight consignments 
originating in Spain, South Africa and Thailand. One significant consignment which was 
seized during 2002 involved the smuggling of nearly 6 tonnes of herbal cannabis, 
nearly €25 million worth, concealed within concrete garden furniture which had 
originally been shipped from Thailand’ (CDLE, personal communication, December 
2003). It is believed that this consignment was destined for the UK market. 
 
The largest proportions of cannabis related prosecutions take place in the Dublin 
Metropolitan and Southern regions, Figure 10.2.1. The large concentration of such 
prosecutions in the Southern Region may be partially explained by the importance of 
the south coast as an importation point for cannabis resin coming from North Africa. It 
is also noteworthy that, following a generally consistent increase in cannabis-related 
prosecutions in all regions between 1995 and 2002, in 2003, there was a decrease in 
such prosecutions in all Garda regions. This is likely to reflect a change in Garda 
enforcement strategy rather than and decline in cannabis availability or use. 
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Figure 10.2.1   Trends in cannabis-related prosecutions by Garda region, 1995–2003 (from annual 
reports of An Garda Síochána 1995-2003) 
Key to Garda regions: Eastern Region: Carlow/Kildare; Laois/Offaly; Longford/Westmeath; Louth/Meat Dublin 
Metropolitan Region: Eastern; North Central; Northern; South Central; Southern; Western Northern Region: 
Cavan/Monaghan; Donegal; Sligo/LeitrimSouth Eastern region: Tipperary; Waterford/Kilkenny; Wexford/Wicklow 
Southern Region: Cork City; Cork; Cork West; Kerry; Limerick Western Region: Clare; Galway West; Mayo; 
Roscommon/ Galway East 
 
Synthetic drugs 
Synthetic drugs such as ecstasy and amphetamines are produced in numerous 
locations throughout the EU but there is a concentration of such production in the 
Netherlands and, to a lesser extent, in Belgium, the UK, Spain and Germany (Europol 
2001). Central and Eastern Europe have also emerged as producers of synthetic 
drugs, with illicit laboratories discovered in Poland, Bulgaria, Hungary and the Baltic 
states. The UK, the Netherlands and Germany report the highest number of illicit 
amphetamine laboratories, while the Netherlands and Belgium produce 80% of the 
MDMA (ecstasy) consumed worldwide. The main place of origin for ecstasy in Ireland 
is the Netherlands and, to a lesser extent, Belgium (Moran et al. 2001). 
 
The UK is the main transit country for the ecstasy arriving in Ireland. The GNDU 
reported that in 2001 all of the amphetamine seized in Ireland was transported by mail, 
and that 50% of the ecstasy was transported by air and 50% by mail (Garda National 
Drugs Unit 2003). Amphetamine trafficking trends were regarded as stable in 2001, 
while ecstasy showed a strong decrease. In 2002, the GNDU reported that 5% of the 
amphetamine seized in Ireland was transported by air and 95% by sea. Trafficking 
trends were regarded as stable. This suggests the possibility of a significant change 
from year to year in the transportation methods used for amphetamines. 
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 Figure 10.2.2   Trends in ecstasy-related prosecutions by Garda region, 1995–2003 (from 
annual reports of An Garda Síochána 1995-2003) 
 
Despite the concentration of population in the Dublin Metropolitan Region, ecstasy-
related prosecutions appear to be dispersed quite widely throughout the state. If 
prosecutions can be regarded as an indicator of availability, then the ecstasy drug 
market can be regarded as quite diffuse. Ecstasy-related prosecutions peaked in 2000 
in the Eastern, Southern and Northern regions and in 2001 in the Dublin Metropolitan, 
South Eastern and Western regions. In 2003, ecstasy-related prosecutions declined in 
all Garda regions. It is unclear whether this reflects a change in Garda enforcement 
practice or a decline in the availability and use of ecstasy. 
 
According to the GNDU, ‘During the reporting period there were indications that Ireland 
is likely to become a producer of synthetic drugs. This suspicion is based on a number 
of unusual and significant seizures’ (GNDU, personal communication, September 
2005). These seizures were of Benzylmethylketone (BMK) and Piperonylmethylketone 
(PMK) in Dublin, precursors used in the manufacture of ecstasy and amphetamine and 
also of amphetamine processing equipment in Tipperary. The GNDU also reports a 
‘noticeable increase in the availability of regulated pharmaceutical products at street 
level within the city centre of Dublin’ (GNDU, personal communication, September 
2005). 
 
Heroin 
Most of the heroin arrives into Ireland by sea and a small percentage by mail. 
Trafficking trends appear stable. According to the GNDU, ‘most trafficking of heroin into 
Ireland is organised by Irish nationals, based in Ireland or the UK. The drugs are 
imported mainly hidden in vehicle parts or personal baggage’ (Department of Health 
and Children 2002). There has been a steady decline since 1999 in the number of new 
cases of problematic opiate use in Dublin, as reported to the NDTRS (Kelly et al. 
2005). This is an indirect indicator of new recruitment into opiate use. 
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Figure 10.2.3   Trends in heroin-related prosecutions in the Dublin Metropolitan Region, 1995–2003 
(from annual reports of An Garda Síochána 1995–2003) 
 
Figure 10.2.3 shows the trends in heroin-related prosecutions in the DMR as a 
percentage of all such prosecutions. It can be seen that the vast majority of heroin-
related prosecutions occur in Dublin. 
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 Figure 10.2.4   Trends in heroin-related prosecutions by Garda region outside the Dublin 
Metropolitan Region, 1995–2003  (from annual reports of An Garda Síochána 1995–2003) 
 
However, as can be seen from Figure 10.2.4, which shows heroin-related prosecutions 
outside the Dublin Metropolitan Region since 1995, there has been a steady increase 
in heroin-related prosecutions in the Eastern Region, from 0 prosecutions in 1995 to 75 
in 2003. While the trends in the other regions are more sporadic, it is clear that, 
although heroin remains predominantly a Dublin-based phenomenon, it is no longer 
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exclusively based in the capital. It would require further research to determine whether 
this represents a shift or displacement in the heroin market outside the capital city. 
However, it is apparent that, while heroin-related prosecutions have decreased in the 
Dublin Metropolitan Region since 2001, they have increased in the areas immediately 
surrounding Dublin. Furthermore, these findings are consistent with findings from the 
National Drug Treatment Reporting System with regard to trends in treated problem 
drug use in the Eastern Region  (Kelly et al. 2005; Long et al. 2005b) 
 
Cocaine / crack 
The available indicators suggest a significant increase in cocaine trafficking in Ireland 
in recent years. The cocaine which arrives in Ireland comes primarily via the UK and 
the Netherlands (Garda National Drugs Unit 2003). 
 
The GNDU estimated that all of the cocaine seized in Ireland in 2001 was destined for 
the Irish market. It is estimated that 50% of cocaine seized arrived by air and 50% by 
mail. A slight decrease in trafficking trends in cocaine was identified in 2001. However, 
reporting on an increase in cocaine trafficking for 2002, the GNDU states that it ‘is 
probably attributable to the fact that use has become more mainstream and the drug is 
more widely sold at street level’ (Garda National Drugs Unit 2003: 8).  Customs also 
report that the number and quantity of cocaine seizures increased significantly after 
2001, stating that ‘cocaine is being smuggled into Europe by means of impregnation of 
clothing and in concealments in polystyrene packaging, shoes, picture frames and 
cosmetics and also as a consequence of its being swallowed and concealed internally’ 
(CDLE, personal communication, May 2004). 
A recent survey conducted by the CityWide Drugs Crisis Campaign, which was carried 
out in response to an increased concern among community groups about an emerging 
cocaine problem, found evidence of increased trafficking of cocaine at retail level 
(CityWide Drugs Crisis Campaign 2004). Figure 10.2.5 shows trends in cocaine-related 
prosecutions in the Dublin Metropolitan Region as a proportion of the total number of 
such prosecutions.  From 1995 until 1999, only a small number of cocaine-related 
prosecutions took place outside the Dublin Metropolitan Region. However, although 
cocaine prosecutions in the Dublin Metropolitan Region have continued to rise each 
year since 1999, the proportion of the total number of cocaine-related prosecutions 
which are not Dublin-based has also continued to grow. 
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Figure 10.2.5   Trends in cocaine-related prosecutions in Dublin Metropolitan Region, 1995–2003 
(from annual reports of An Garda Síochána 1995–2003) 
 
As can be seen from Figure 10.2.6, there has been a sharp increase in cocaine-related 
prosecutions in the Southern Region since 1999, rising from 10 prosecutions in 1999 to 
136 in 2002. Although there was a slight decrease in such prosecutions in the Southern 
Region in 2003, there was a 167% increase in cocaine-related prosecutions in the 
Eastern Region. Increases were also recorded in the Northern, South Eastern and 
Western regions. 
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Figure 10.2.6   Trends in cocaine-related prosecutions outside the Dublin Metropolitan Region, 
1995–2003 (from annual reports of An Garda Síochána 1995–2003) 
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In the Garda annual reports, drug-related charges are broken down into various 
categories. Of particular interest with regard to drug trafficking in Ireland is the category 
‘drug supply’ (s15 Misuse of Drugs Act 1977/84). As can be seen from Figure 10.2.7 
most supply offences occur in the Dublin Metropolitan Region. Figure 10.2.8 shows 
trends in supply offences in the other Garda regions throughout the state. Offences by 
drug type are not presented in the annual reports. 
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Figure 10.2.7   Trends in supply offences in Dublin Metropolitan Region, 1995–2003 (from annual 
reports of An Garda Síochána 1995–2003) 
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Figure 10.2.8   Trends in supply offences outside Dublin Metropolitan Region, 1995–2003  (from 
annual reports of An Garda Síochána 1995–2003) 
 
When we compare Figures 10.2.7 and 10.2.8, we can see that from 1995 to 1997 drug 
supply offences increased in all Garda regions, except for the Southern and South 
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Eastern regions during 1996 when such offences declined slightly. In 1998, supply 
offences increased in all regions, with the largest increase in the Southern Region. 
From 1998 to 2002, supply offences decreased each year in the Dublin Metropolitan 
Region, down from a total of 1,214 offences in 1997 to 553 in 2002. However, the total 
number of offences increased up to its highest recorded point of 1,971 offences in 
1999. This came about primarily as a result of a 158% increase in such offences in the 
Eastern Region and a 136% increase in the Western Region. Increases were also 
recorded in the Northern, South Eastern and Southern regions in 1999. In 2002, supply 
offences increased in all Garda regions except for the Dublin Metropolitan and 
Northern regions. It is unclear whether this reflects a real decrease in such offences in 
the Dublin and Northern regions, alterations in drug market patterns or a change in 
enforcement activities and resource deployment. In 2003, supply offences decreased in 
all Garda regions except for the Dublin Metropolitan and Eastern regions. 
The ESPAD surveys (Hibell et al. 2000; Hibell et al. 1997; Hibell et al. 2004) also 
consider the question of drug availability. Table 10.2.1 provides figures from the most 
recent ESPAD survey (2003) on the perceived availability of substances (Hibell et al. 
2004). The survey was conducted in 35 countries. The figures relate to those who 
answered ‘very easy’ or ‘fairly easy’ to the question, ‘How difficult do you think it would 
be for you to get each of the following?’ Among the 35 ESPAD countries, Ireland ranks 
first for perceived availability among respondents of inhalants, crack, cocaine and 
ecstasy. This appears remarkably high. For example, with regard to crack, Ireland is 
ranked joint first with the UK. However, the crack market in Ireland is not developed to 
anywhere near the same extent as in the UK. Also, with regard to ecstasy, 34% of Irish 
students perceive it as ‘very easy’ or ‘fairly easy’ to obtain. In the Netherlands and 
Belgium, the principal producing countries of the drug, the figures are 16% and 20% 
respectively. These findings suggest an exaggerated perception of drug availability in 
Ireland. 
 
Table 10.2.1   Perceived availability of substances: Percentages among Irish students answering 
‘Very easy’ or ‘Fairly easy’ in ESPAD Survey, average percentage among all ESPAD countries, and 
Ireland’s ranking against other ESPAD countries, 2003  
 Inhalants Anabolic 
steroids 
Marijuana Amphetamine LSD Crack Cocaine Ecstasy Heroin Magic 
Mushrooms 
Ireland  77 12 60 17 16 18 22 34 17 25 
ESPAD 
Average 
41 11 35 13 12 10 12 17 11 13 
Ireland’s 
Ranking in 
terms of 
Perceived 
Availability 
of 
Substances 
1 14 2 10 7 1 1 1 2 3 
Source: Hibbell B et al. (2004)  
In the 2003 ESPAD study, 73% of Irish students knew of some place they could easily 
buy cannabis; the European average was 55%. Thirty per cent of Irish students 
reported that cannabis was easily available in school, which was just under twice the 
EU average. Table 10.2.2 compares the findings from Ireland with the average for the 
other 35 ESPAD countries. 
 
Ireland – National Report 2004  93
Table 10.2.2   Places where marijuana or hashish can be easily bought: percentages among Irish  
students in ESPAD Survey, and average percentage among all ESPAD countries, 2003 
 Don’t know any place Street, park School Disco, bar House of a dealer Other 
Ireland 27 36 30 31 27 9 
ESPAD  
Average 
45 23 16 27 21 13 
Source: Hibell et al. (2004) 
Drug dealers and individual drug sources 
There is some empirical evidence in Ireland on the proportion of drug users who also 
sell drugs (Furey and Browne 2003; Keogh 1997; O'Mahony 1997). Furey and Browne 
(2003) conducted a survey of 131 drug users. Respondents for whom crime was a 
source of income in the last month were asked to indicate the types of crime 
committed. Of the 47 who answered, the following types of crime were the ones most 
engaged in on a frequent basis: shoplifting (n=29), burglary (n=18), robbery (n=17), 
selling drugs (n=15) and stealing from cars (n=14). 
The ESPAD survey (Hibell et al. 2004) found that, of the 40% of students who had 
used illicit drugs, 19% had received the drug for the first time from a friend or sibling, 
and 15% had shared it in a group. 
10.3 Seizures 
A key performance indicator (KPI) in the National Drugs Strategy is to increase the 
volume of opiates and all other drugs seized by 25% by the end of 2004 and by 50% by 
the end of 2008, using the volume of seizures in the year 2000 as a base. However, as 
the quantities of drugs seized can vary significantly from year to year, with a few very 
large seizures in one year distorting the overall picture, the number of separate 
seizures is generally regarded as a more useful indicator. The mid-term review of the 
Strategy recommended a new KPI to monitor the number as distinct from the quantity 
of seizures. The new KPI under the Supply Reduction pillar of the Strategy stipulates 
that by 2008 ‘the number of seizures’ must have increased by 20% based on 2004 
figures’ (Steering group for the mid-term review of the National Drugs Strategy 2005). 
 
There is also evidence to suggest that Ireland is occasionally used as a transit country 
for drug supplies to the UK market and elsewhere in Europe (Garda National Drugs 
Unit 2003). For example, the Customs Service seized over 19 tonnes of herbal 
cannabis in the period 2001/2002. From the intelligence available to it, Customs has 
concluded that the bulk of this product was for the UK market and elsewhere (CDLE, 
personal communication, July 2005). Therefore, the number of drug seizures should 
not be regarded as necessarily reflecting drug use at a national level. Either way, one 
can assume that relatively stable prices and drug supply would indicate that the 
amount seized is a small fraction of the whole. 
 
The majority of seizures, whether made by Customs or gardaí, are recorded in the 
annual reports of the Garda Síochána. The seizure statistics published in the annual 
reports of the Revenue Commissioners include only those seizures made by Customs 
officers. However, seizures also result from joint Garda–Customs operations and 
investigations. Although the seizure figures in the Garda annual reports include most 
Customs seizures, we will present the figures provided by Customs in recent years 
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separately, so as to enhance the overall picture of enforcement activities at different 
stages of the drugs market. Seizures made by Customs will usually occur at points of 
access into the country such as sea- and airports, land frontiers, postal centres and 
approved Customs premises. Table 10.3.1 shows the number of drug seizures as 
reported in the annual reports of the Garda Síochána,6 and Table 10.3.2 shows those 
presented in the annual reports of the Revenue Commissioners. 
  
Table 10.3.1   Number of seizures of specific drugs recorded in annual reports of Garda 
Síochána, 1995–2003 
 1995 1996 1997 1998 1999 2000 2001 2002 2003 
Cannabis resin 3031 3233 3753 4264 4322 4401 5960 2746 3366
Cannabis herb 148 179 294 213 188 219 253 242 309
Cannabis plants 26 36 55 36 28 21 20 36 30
Heroin 209 664 599 884 767 598 802 714 660
Cocaine 42 93 157 151 213 206 300 429 566
Ecstasy-type substances* 571 405 347 466 1064 1864 1485 1027 1083
Amphetamines 89 217 475 680 467 169 162 243 211
LSD 62 42 48 19 29 31 6 0 5
Other 0 375 454 317 240 197 181 166 147
 
Total 4178 5244 6182 7030 7318 7706 9169 5603 6377
 
∗ Ecstasy-type substances include MDA, MDMA and MDEA. 
Source: Annual reports of An Garda Siochána 1995–2003 
 
 
Table 10.3.2:  Number of seizures of specific drugs recorded in annual reports of the 
Revenue Commissioners, 2000–2003 
 
 
 
 
 
 
 
 
 
 
 
Source: Annual reports of the Revenue Commissioners 2000–2003  
 
When we compare Table 10.3.1 and  Table10.3.2 for the years 2000 to 2003, we can 
see that, in the case of heroin, cocaine, ecstasy and amphetamines, seizures made by 
Customs represent only a small proportion of the total number of seizures recorded in 
the Garda annual reports. However, Customs appear to have made a large number of 
seizures of herbal cannabis between 2000 and 2003. Also, many of these seizures do 
not appear to have been included in the Garda annual reports. 
 
The total number of cannabis seizures reported in the Garda Annual Report for 2003 
was 3,705. Cannabis seizures are classified under three headings: herbal cannabis, 
cannabis resin and cannabis plants. The vast majority of cannabis seizures made in 
Ireland are of cannabis resin. However, most of the seizures of herbal cannabis made 
by Customs between 2000 and 2002 do not appear to have been reported as such in 
the Garda annual reports. Customs reported 764 seizures of herbal cannabis in 2000; 
the Garda report presents a figure of 219 for that year. In 2001, Customs reported 957 
seizures of herbal cannabis, while only 253 are recorded in the Garda report. In 2002, 
Customs reported 493 herbal cannabis seizures; only 242 appear in the Garda report 
                                                
6 The number of seizures for each drug was not reported in the Garda Reports prior to 1995. Only the quantity and the 
total number of seizures was reported. 
Drug seized 2000 2001 2002 2003 
Heroin 6 7 2 4 
Cocaine 12 3 22 27 
Ecstasy 12 13 7 8 
Amphetamines 7 7 2 4 
Cannabis resin 160 211 115 244 
Herbal cannabis 764 957 491 494 
Seizure totals 961 1198 641 781 
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for that year. In 2003, Customs reported 494 herbal cannabis seizures while 309 
seizures appear in the Garda report. 
 
This can partly be explained by the fact that many of these seizures by Customs, 
particularly of small amounts, might not result in a prosecution or conviction. This might 
occur in cases where there is an absence of sufficient supporting evidence, for 
example, where the drugs came through the mail. However, all seizures will still be 
accounted for and reported as such by Customs (CDLE, personal communication, 
June 2004). 
 
The total number of drug seizures recorded in the annual reports of the Garda 
Síochána decreased by 17.2% between 2000 and 2003, down from 7706 to 6377 
seizures. Seizures made by Customs decreased by approximately 18.7% during this 
period, down from 961 seizures in 2000 to 781 in 2003.   
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Figure 10.3.1   Trends in the number of drug seizures for selected drugs 1995–2003 (from annual 
reports of An Garda Síochána 1995–2003) 
 
Figure 10.3.1 shows the trends in the number of seizures of specific drugs between 
1995 and 2003, the most recent year for which statistics are available. The total 
number of drug seizures more than doubled between 1995 and 2001, increasing from 
4,178 in 1995 to 9,169 2001. In 2002 there was a significant decrease of 39% in the 
total number of drug seizures. As can be seen, however, this decrease appears to 
have been caused by a 51% decrease in cannabis resin seizures and a 31% drop in 
ecstasy seizures. In 2003 the total number of seizures increased from 5,603 in 2002 to 
6,377 seizures in 2003. Figure 10.3.2 excludes cannabis seizure trends and shows 
trends in the other main drugs seized. 
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Figure 10.3.2   Trends in the number of heroin, cocaine, ecstasy, amphetamines and LSD seizures 
1995–2003 (from annual reports of An Garda Síochána 1995–2003) 
 
As can be seen from Figure 10.3.2, heroin seizures appear to have peaked at 884 in 
1998, followed by a decline to 598 seizures in 2000. In 2001, the number of heroin 
seizures rose to 802. Heroin seizures have decreased by just under 18% since 2001, 
down from 802 in 2001 to 660 in 2003. 
 
In Ireland, cocaine seizures increased steadily to a total of 213 in 1999, dropped 
slightly in 2000, and increased sharply to a total of 566 seizures in 2003. Customs 
report that the biggest single trend observed in the last two years was the increase in 
the number of cocaine seizures and also in the volume of cocaine seized. Twenty-two 
seizures totalling 19,473 kg of cocaine, with a reported value of €2,000,000, were 
made in 2002 (Revenue Commissioners 2003).  
 
Ecstasy is the second most commonly seized drug in Ireland. Following a sharp 
increase in the number of ecstasy seizures, from 347 in 1997 to 1,864 in 2000, there 
was a decrease to 1,027 seizures in 2002 and then a slight increase to a total of 1,083 
seizures in 2003. 
 
Amphetamines seizures increased from 89 in 1995 to 680 in 1998, followed by a 
continuous decline to a total of 162 in 2001. In 2003 there was 211 amphetamine 
seizures. 
 
Cannabis remains the principal drug seized in Ireland, accounting for 58% of total drug 
seizures in 2003. There has been a steady increase in cannabis seizures since 1995, 
with a significant increase from 4,641 seizures in 2000 to 6,233 in 2001. However, in 
2002 there was a 51% decrease, with the number of cannabis seizures down to 3,024. 
In 2003, cannabis seizures increased to a total of 3,705 seizures. 
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Seizure quantities  
Owing to the fluctuations in quantities of drugs seized from year to year, the number of 
seizures is regarded as a more useful indicator of drug availability and supply than 
quantities. For example, quantities may fluctuate widely from one year to the next, as in 
one year, there may be a few very large seizures. However, identifying the quantities of 
drugs seized can be a useful indicator of enforcement activities. Also, as mentioned 
above, increasing the volume of drugs seized is a commitment within the National 
Drugs Strategy 2001–2008 (Department of Tourism Sport and Recreation 2001).  
Quantities of drugs seized are reported in the annual reports of the Garda Síochána 
and in the annual reports of the Revenue Commissioners, which record the drug 
seizures in which the Customs Service is involved.  
 
In 2003 both the volume of cannabis resin seized and the number of seizures 
increased. The total quantity of cocaine seized in 2003 was 107.5 kg. This represents a 
500% increase on the amount seized in 1995. The volume of heroin seized has 
remained relatively consistent over the past few years, while the volume of cocaine 
seized has increased significantly. This suggests that, contrary to speculation in the 
media and elsewhere, the increase in the availability and use of cocaine might not be 
displacing heroin, with heroin volumes remaining consistent. 
 
 
10.4 Price/purity 
Price 
Street drug prices as used by An Garda Síochána are set out in a Garda Headquarters 
Directive. Street prices for each drug are calculated on the basis of a special survey 
conducted among: 
• Garda personnel involved in combating drug possession and supply at street 
level 
• the Forensic Science Laboratory 
• the Garda National Drugs Unit 
• anecdotal evidence. 
 
The most recent survey (2004) saw a reduction in the street price of cocaine from 
approximately €100 per gram to €70 (GNDU, personal communication, September 
2005). 
Purity 
 
According to the Forensic Science Laboratory, drug purity levels have remained fairly 
constant, with heroin ranging from 30% to 40% and cocaine ranging from 9% to 25% 
(FSL, personal communication, September 2005). 
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Part B – Selected Issues 
Summary 
 
 
11.  Gender differences 
 
 
11.1 Interpretation of gender data on: 
 
a. Consumption in the general population and young people 
 
Gender differences in drug use in the general population and in young people in Ireland 
can be ascertained from a number of national surveys and, where such surveys have 
been repeated using the same methodology, trends in drugs use by gender can also 
be examined. 
 
Gender differences in the general population 
 
The first national drug prevalence survey in the general population was carried out by 
the NACD between October 2002 and April 2003 (National Advisory Committee on 
Drugs and Drug and Alcohol Information and Research Unit 2005). The survey 
followed best practice guidelines recommended by the EMCDDA (2002b). The 
questionnaire, based on the ‘European Model Questionnaire’, was administered 
through face-to-face interviews with respondents aged between 15 and 64 years 
normally resident in households in Ireland. The final achieved sample was 4,918, 
representing a response rate of 70%. The sample was weighted by gender, age and 
health board area to maximise its representativeness of the general population. The 
main results, in terms of gender differences, from this survey are discussed below. 
 
Gender differences in lifetime, last year and last month prevalence (%) for selected 
drugs among adults (15–64 years) in Ireland for the years 2002 and 2003 are shown in 
Table 11.1.1. In terms of lifetime prevalence, almost twice as many men (24%) as 
women (13%) reported ever using an illegal drug. The level of use reported for cocaine, 
LSD, magic mushrooms and poppers was more than twice as high among men. 
However the lack of confidence intervals around these estimates makes it difficult to 
determine if these differences are statistically significant. Women reported higher 
lifetime prevalence rates for sedatives, tranquillisers and anti-depressants than men 
(15% compared to 9%) and for other opiates (4% compared to 2%). In both cases 
these drugs could have been obtained either with or without a prescription. Information 
on sedative, tranquilliser and anti-depressant use and other opiate use without a 
prescription has not yet been published separately. 
 
In terms of last-year prevalence, men reported a rate of illegal drug use over twice as 
high as women. The greatest gender differences were seen in the rates for magic 
mushrooms (six times greater) and for amphetamines and cocaine use (over three 
times greater). In contrast, almost twice as many women as men (7% compared to 4%) 
reported the use of sedatives, tranquillisers and anti-depressants (with or without a 
prescription) in the last year. Overall, twice as many men (4%) as women (2%) 
reported the use of an illegal drug in the previous month. There was a similar gender 
difference in the levels of cannabis use during this period, with twice as many men 
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(3.4%) as women (1.7%) reporting use in the previous month. Again, the lack of 
confidence intervals around these estimates makes it difficult to determine if these 
differences are statistically significant. 
 
Table 11.1.1   Gender differences in lifetime, last year and last month prevalence (%) for 
selected drugs among adult males and females (15–64 years) in 2002/2003 
Drug Lifetime 
prevalence 
Last-year prevalence Last-month prevalence 
 Males 
% 
Females
% 
Males
% 
Females
% 
Males 
% 
Females 
% 
Any illegal drugs1 24.0 13.1 7.8 3.4 4.1 1.7 
Cannabis 22.4 12.3 7.2 2.9 3.4 1.7 
Heroin 0.7 0.3 0.1 0.1 0.1 0.1 
Methadone2 0.4 0.3 0.2 0.2 0.1 0.2 
Other opiates2,3 2.0 4.0 0.4 0.5 0.2 0.1 
Cocaine powder 4.1 1.6 1.7 0.5 0.7 - 
Crack 0.5 0.1 0.1 0.1 - - 
Amphetamines 4.0 1.9 0.7 0.2 0.2 0.1 
Ecstasy 4.9 2.6 1.5 0.6 0.6 * 
LSD 4.4 1.4 0.2 - * - 
Magic Mushrooms 5.7 2.0 0.6 0.1 0.1 - 
Solvents 2.2 1.1 * 0.1 * - 
Poppers 3.9 1.3 0.4 0.4 0.1 * 
Sedatives, Tranquillisers, 
Anti-depressants2 
 
9.3 
 
15.0 
 
4.2 
 
7.3 
 
3.0 
 
4.9 
1.  Any illegal drugs include amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents. 
2.  With or without a prescription. 
3.  Other opiates include opium, Temgensic®, buprenorphine, Diconal, napps, MSTs®, pethadine, DF118® 
(dihydrocodiene), and morphine. 
-  no respondents in this category 
*  less than half of 0.1% (<0.05) 
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 2005 
 
In April 2003 the results of the second national Survey of Lifestyle, Attitudes and 
Nutrition (SLÁN) were published (Kelleher et al. 2003). The SLÁN survey was first 
undertaken in 1998 (Friel et al. 1999) and repeated again in the summer of 2002. In 
both surveys a small number of questions on drug use were asked, allowing drug use 
patterns to be examined. As in 1998, the sampling frame was the electoral register, the 
target population thus being adults aged 18 years and over. A proportionate random 
sampling design was used to select the survey sample. The questionnaires were 
posted to respondents and were self-administered. A total of 5,992 questionnaires 
were returned from a valid sample of 11,212 sent out, giving a response rate of 53.4%. 
This compares with a response rate of 62.2% in the 1998 survey. The report notes that 
the 2002 survey had fewer young males (18–34-year-olds) than the earlier survey and 
than occur in the general population as a whole.  
 
The published SLÁN results provide only a limited analysis of the drug-use questions. 
Prevalence figures for males and females are reported separately. While the first SLÁN 
report did not report any drug prevalence data, the second SLÁN report provides data 
from both the 1998 and 2002 surveys, thus allowing gender comparisons over time. 
These comparisons are discussed below. 
 
Lifetime, last-year and last-month prevalence of cannabis use for adult males and 
females (18+ years) in 1998 and 2002 are shown in Table 11.1.2. Prevalence rates are 
higher for males than females and this gender difference has remained over time. For 
both genders, there has been an increase in the proportion of people claiming to have 
ever used cannabis or to have used the drug in the last year or in the last month. The 
largest increase occurred in ‘lifetime’ use and may reflect a growing willingness to 
experiment with cannabis. It should be stressed however that no confidence intervals 
were provided around these estimates so that the differences between the two surveys 
could be due to sampling variation. 
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Table 11.1.2   Trends in lifetime, last-year and last-month prevalence of cannabis use for 
adult males and females (18+ years) between 1998 and 2002 
Cannabis use Adult males
1998 
% 
Adult males 
2002 
% 
Adult females
1998 
% 
Adult females
2002 
% 
During lifetime 21.9 26.2 13.8 19.1 
During last year 11.0 12.1 6.2 6.7 
During last month 6.7 7.8 2.8 3.0 
Source: Kelleher et al. 2003 
 
Apart from the cannabis figures the SLÁN report also provides last-year prevalence 
rates by gender for amphetamines, cocaine, ecstasy, heroin, LSD, magic mushrooms, 
solvents, and tranquillisers or sedatives (without a doctor’s prescription), see Table 
11.1.3. For most drugs, men had higher use in the last year than women and this 
gender difference remained over time. Again, the lack of confidence intervals makes it 
difficult to determine if these differences are statistically significant. The fact that the 
gender differences in the use of tranquillisers or sedatives (without a doctor’s 
prescription) are not as marked as the gender differences observed in NACD’s drug 
prevalence survey (described above) strongly suggests the need to provide separate 
data on the use of these drugs with and without a prescription. 
 
Table 11.1.3   Trends in last-year prevalence of amphetamines, cocaine, ecstasy, heroin, 
LSD, magic mushrooms, and solvent use for adult males and females (18+ years) 
between 1998 and 2002 
Used in last year Adult males 
1998 
% 
Adult males  
2002 
% 
Adult females 
1998 
% 
Adult females 
2002 
% 
Amphetamines 3.6 2.4 1.3 0.6 
Cocaine 1.8 3.0 0.6 1.9 
Ecstasy 2.9 3.9 1.5 2.4 
Heroin 0.5 0.4 0.3 0.5 
LSD 1.9 1.6 0.8 0.8 
Magic Mushrooms 2.2 2.3 0.6 0.6 
Solvents 0.5 0.7 0.3 0.6 
Tranquillisers or 
sedatives1 
 
1.3 
 
1.4 
 
1.3 
 
1.0 
1.  Without a doctor’s prescription 
Source: Kelleher et al. 2003 
 
Gender differences in young people 
 
Also in April 2003, the results of the second national Health Behaviour in School-aged 
Children (HBSC) survey carried out in Ireland were published (Kelleher et al. 2003). 
The HBSC survey is a cross-national research study conducted in collaboration with 
the World Health Organization (WHO) Regional Office for Europe. Its aim is to gain 
new insight into, and increase our understanding of, young people’s health and well-
being, health behaviour and their social context. A total of six HBSC surveys have been 
conducted across Europe since the early 1980s. The first HBSC survey conducted in 
Ireland was carried out in 1998 (Friel et al. 1999) and repeated again in 2002. In both 
surveys a small number of questions on drug use were asked, allowing drug use 
patterns to be examined. The sampling procedures followed those used in 1998. 
Individual schools within health boards were first randomly selected and classes within 
schools were subsequently randomly selected for participation. The objective was to 
achieve a nationally representative sample of school-going children. The survey was 
carried out between April and June 2002 and covered children aged 10–17 years 
present in school on the day of the survey. A total of 176 schools out of a valid sample 
of 347 participated in the survey, giving a school response rate of 50.7%. However, 
only 5,712 questionnaires from 93 schools received by the end of the summer term 
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were included in the second HBSC report to maintain seasonal comparability with the 
first HBSC report. 
 
The published HBSC results provide only a limited analysis of the drug-use questions. 
Prevalence figures for males and females are reported separately for lifetime and last-
year use of cannabis and lifetime use of glue or solvents. While the first HBSC report 
did not report any drug prevalence data, the second HBSC report provides data from 
both the 1998 and 2002 surveys, thus allowing comparisons over time. These 
comparisons are discussed below. 
 
For school-going boys there was a small drop in both lifetime and last-year prevalence 
of cannabis use between 1998 and 2002, Table 11.1.4. School-going girls on the other 
hand experienced an increase in cannabis use. Again, the lack of confidence intervals 
around these estimates makes it difficult to determine if these differences are 
statistically significant. In both surveys, boys had higher rates of cannabis use than 
girls, though this difference was not as marked in the 2003 survey. 
 
Table 11.1.4   Trends in lifetime and last-year prevalence of cannabis use for school-
going boys and girls (10–17 years) between 1998 and 2002 
Cannabis use Boys 
1998 
% 
Boys 
 2002 
% 
Girls 
1998 
% 
Girls 
2002 
% 
During lifetime 16.2 14.2 8.6 11.7 
During last year 14.0 13.4 6.7 9.5 
Source: Kelleher et al. 2003 
 
Lifetime prevalence of glue or solvent (inhalants) use increased slightly between the 
two surveys for both genders, Table 11.1.5. Again, boys had higher rates of inhalant 
use than girls in both surveys. 
 
Table 11.1.5   Trends in lifetime prevalence of glue or solvent use for school-going boys 
and girls (10–17 years) between 1998 and 2002 
Glue or solvent use Boys 
1998 
% 
Boys 
2002 
% 
Girls 
1998 
% 
Girls 
2002 
% 
During lifetime 6.0 7.7 3.7 4.9 
Source: Kelleher et al. 2003 
 
As discussed in Section 2.3 the third European School Survey Project on Alcohol and 
Other Drugs (ESPAD) was published in December 2004 (Hibell et al. 2004). The third 
ESPAD survey was conducted in 35 European countries during 2003 and collected 
information on young people’s alcohol and illicit drug use. The target population was 
school-going children born in 1987. Thus, those surveyed were aged either 15 or 16 
years at the time of the survey. As in the earlier ESPAD surveys, the 2003 survey was 
conducted with a standardised methodology and a common questionnaire to provide 
comparable European data over time. Gender differences in drug use in the 2003 Irish 
ESPAD survey compared with a previous Irish ESPAD survey conducted in 1999 
(Hibell et al. 2000) are discussed below. 
 
For school-going boys there was a small increase in lifetime prevalence of cannabis 
use between 1999 and 2003 (Table 11.1.6). School-going girls, on the other hand, 
experienced a much larger increase in lifetime use of cannabis, up 10% from 29% in 
1999 to 39% in 2003. While last-year prevalence remained the same for boys between 
the two survey periods, it again increased by 10% for girls (22% in 1999, 32% in 2003). 
While last-month prevalence (current use) dropped for boys between 1999 and 2003, it 
increased for girls from 11% to 17%. This increasing trend in cannabis use by school-
going girls is similar to that found by the HBSC surveys, though direct comparisons are 
made difficult because of the different age groups. While the prevalence of cannabis 
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use was higher for boys than girls in the 1999 survey, this gender difference was 
reversed in the 2003 survey. Again, the lack of confidence intervals around these 
estimates makes it difficult to determine if these differences are statistically significant. 
 
Table 11.1.6   Trends in lifetime, last-year and last-month prevalence of cannabis use for 
school-going boys and girls (15–16 years) between 1999 and 2003 
Cannabis use Boys 
1999 
% 
Boys 
2003 
% 
Girls 
1999 
% 
Girls 
2003 
% 
During lifetime 35 38 29 39 
During last year 31 31 22 32 
During last month 18 16 11 17 
Source: Hibell et al. 2004; Hibell et al. 2000 
 
While lifetime, last year and last month prevalence of inhalant use dropped for boys 
between 1999 and 2003, it remained stable or increased slightly for girls (Table 11.1.7). 
While boys had slightly higher rates of inhalant use than girls in the 1999 survey, this 
gender difference was reversed in the 2003 survey, a pattern similar to that observed 
for cannabis use. 
 
Table 11.1.7   Trends in lifetime, last-year and last-month prevalence of inhalant use for 
school-going boys and girls (15–16 years) between 1999 and 2003 
Inhalant use Boys 
1999 
% 
Boys 
2003 
% 
Girls 
1999 
% 
Girls 
2003 
% 
During lifetime 22 14 21 21 
During last year 12 7 10 11 
During last month 5 2 3 4 
Source: (Hibell et al. 2004 and Hibell et al. 2000) 
 
b. Mortality and drug-related deaths 
In June 2005, the Health Research Board published an overview of drug-related deaths 
in Ireland (Long et al. 2005a).  The data presented in this publication describe what is 
known about drug-related deaths and deaths among drug users in Ireland between 
1990 and 2002. According to the authors, the Central Statistics Office (CSO) in Ireland 
collates data on drug-related deaths extracted from the General Mortality Register 
(GMR).  The Registrar of Births, Deaths and Marriages formally records all notified 
deaths in each jurisdiction.  Depending on the circumstances, deaths are notified by 
the Coroner Service, hospitals or general practitioners.  In addition, if the gardaí are 
investigating a death on behalf of the Coroner Service, they provide supplementary 
information related to the death to the CSO.  Using data from the GMR, the CSO then 
categorises the cause of each death using the World Health Organization (WHO) 
diagnostic coding manual on the international classification of diseases (known as ICD 
categories).  The ninth revision of the ICD manual continues to be used in this country.  
At the European level, the EMCDDA (2002a) has developed a standardised method for 
extracting drug-related deaths from the GMRs in all member states.  This standardised 
method selects certain drug-related death categories and is known as ‘Selection B’.  
The broad diagnostic categories and codes included in ‘Selection B’ are presented in 
EMCDDA guidelines.  The substances causing death must be specified. For GMRs 
using ICD-9, the number of poisoning deaths (E-codes) must be extracted in 
combination with nature of injury codes (N-codes).  Using this definition, the CSO 
extracts the numbers of drug-related deaths (along with demographic information) and 
provides them to the DMRD at the HRB.   
 
Figure 11.1.1 presents the number of direct drug-related deaths, by gender, reported 
from 1990 to 2002 using the European definition known as Selection B.  The vast 
majority of drug-related deaths occur among men, which is not surprising since the vast 
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majority of drug users are men.  Of note, there was a steady increase in the number of 
drug-related deaths among women between 1994 and 2000 and a levelling off in 2001 
and 2002.  The number of drug-related deaths in males increased steadily between 
1990 and 1993, and more dramatically between 1994 and 1999; and between 2000 
and 2001 there was a sharp decrease in the number of men who died.   
 
 
Figure 11.1.1   Gender of direct drug-related deaths in Ireland, by national and by 
European definition, reported by the CSO, 1990–2002 (unpublished data from the vital 
statistics) 
 
c. Treatment demand data 
 
Drug treatment data are viewed as an indicator of drug misuse as well as a direct 
indicator of demand for treatment services. The National Drug Treatment Reporting 
System (NDTRS) is an epidemiological database on treated problem drug use in 
Ireland.  The NDTRS is co-ordinated by staff at the Drug Misuse Research Division of 
the Health Research Board on behalf of the Department of Health and Children.  For 
the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to 
ameliorate the psychological, medical or social state of individuals who seek help for 
their drug problems.’  Data is collected on both new and previously treated cases. For 
the purposes of this analysis, the gender profile of new (incident) cases reported to the 
NDTRS for the period 1998 to 2003 is described below.   
 
The number of new cases treated for problem drug use increased, from 1,626 in 1998 
to 2,198 in 2003 (Figure 11.1.2).  As expected, more men than women were treated for 
drug use. The number of both male and female cases treated increased over the 
period under review; the increase was greater among men than women.  Between 
1998 and 2003, on average 25% of new cases treated were women, the proportion 
ranging between 23% and 27%.  In the most recent three-year period, there has been 
a small downward trend in the proportion of new female cases treated, from 26% in 
2001 to 23% in 2003.   
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Figure 11.1.2   Number of new cases treated for problem drug use, by gender, 1998–2003 
 
The majority of new cases, both male and female,are treated at outpatient facilities 
(Figure 11.1.3).  A higher proportion of females (79%) than males (72%) are treated at 
outpatient facilities (Figure 11.1.4).  A lower proportion of females (17%) than males 
are treated in residential facilities; this may be due to the fact that more women (6%) 
than men (1%) are caring for children on their own.  Between 1998 and 2003, there 
was a large increase in the number of general practitioners providing methadone 
treatment services in Ireland but, despite this, the number of general practitioners 
participating in the NDTRS was still very low. During the reporting period, the prison 
service did not participate in the NDTRS, although it did provide drug treatment 
services. 
Figure 11.1.3   Number of new cases attending each service provider, by gender, 
1998–2003 
 
New cases treated for drug use by gender, 1998-2003
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Type of service provider attended by new cases by gender, 1998-2003
0% 20% 40% 60% 80% 100%
Male
Female
Not known 0.0% 0.1%
Prison 0.0% 0.0%
General practice 1.0% 1.3%
Low threshold 2.4% 2.2%
Residential 24.4% 17.2%
Outpatient 72.2% 79.3%
Male Female
 
 
Figure 11.1.4   Proportion of new cases attending each service provider, by gender, 
1998–2003 
 
Figures 11.1.5 and 11.1.6 present the numbers and proportions, by source of referral to 
drug treatment services, for new cases by gender.  A higher proportion of females (8%) 
than males (3%) were referred through the social services.  As expected, a lower 
proportion of females (6%) than males (18%) were referred through the criminal justice 
system.   
 
 
New cases source of referral for drug treatment by gender, 1998-2003
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Figure 11.1.5   Number of new cases referred to drug treatment services, by source and 
gender, 1998–2003 
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New cases source of referral for drug treatment by gender, 1998 to 2003
0% 20% 40% 60% 80% 100%
Male
Female
Not known 2.3% 2.3%
Other 8.4% 11.8%
Social services 3.0% 7.5%
Hospital or other medical source 6.1% 7.8%
Other drug treatment centre 6.0% 6.6%
General practitioner 10.5% 11.3%
Court, probation or police 17.5% 6.3%
Family and friends 21.2% 19.8%
Self 24.9% 26.5%
Male Female
 
Figure 11.1.6   Proportion of new cases referred to drug treatment services, by source 
and gender, 1998–2003 
 
With the exception of the youngest age group, the distribution of age at which use of  
the main problem drug commenced was broadly similar for new cases by gender 
between 1998 and 2003 (Figure 11.1.7).  A slightly higher proportion of men (21%) 
than women (18%) started using their main problem drug before they were 15 years 
old.  Over 50% of both men and women started to use their main problem drug 
between 15 and 19 years of age.   
 
The delay in seeking treatment for both newly treated men and women is demonstrated 
when Figure 11.1.7 and  Figure11.1.8 are compared.  For example, only 2% of males 
and 3% females treated sought treatment before reaching 15 years of age, whereas 
21% of men and 18% of women started using their main problem drug before they 
were 15 years old.  The same delay was noted in the 15–19-year-old age group.  Of 
note, a higher proportion of women (73%) than men (66%) sought their first treatment 
in the under-25-year age groups.   
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New cases age first used main problem drug by gender, 1998-2003 
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
5,000
Male 1,808 4,467 1,170 415 174 67 35 10 1 3 1
 Female 506 1,473 384 138 58 32 11 7 5 0 3
Less 
than 
15
15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
 
Figure 11.1.7   Age at which new cases commenced using their main problem drug, by 
gender, 1998-–2003 
 
  
Figure 11.1.8   Age at which new cases were treated for problem drug use, by gender, 
1998–2003 
 
Half of both men and women commenced using any drug by the age of 15 years and 
half of the injectors commenced injecting drug use before they were 19 years old  
(Table 11.1.8).  Half of both men and women had left school before they were 16 years 
old.  Of note, the median age of first treatment was one year lower for women than for 
men.  It is important to note that pregnant women (and their partner if in a stable 
relationship) are treated on presentation to the services and do not have to go through 
the normal assessment procedure or on a waiting list; this may influence the median 
age.    
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Table 11.1.8   Median age at which new cases treated for problem drug use commenced 
using drugs, left school, injected and sought treatment, 1998–2003 
 Median age (5 and 95 percentile) 
 Male Female 
Age first used any drug 15 (11-21) 15 (12-24) 
Age left school 16 (13-18) 16 (13-18) 
If injected, age first injected 19 (15-31) 19 (15-29) 
Age of first treatment 22 (16-37) 21 (15-37) 
 
Figure 11.1.9 and Figure 11.1.10 present the primary problem drug used by new 
treated cases, by gender, for the period 1998 to 2003. The numbers and proportions of 
males treated for stimulants, cocaine and cannabis use were very high compared to 
those of their female counterparts. The proportion of males treated for opiate use was 
also higher than that of females but the difference was not as high as for stimulants, 
cocaine or cannabis use.  There was a slightly higher proportion of males than females 
treated for use of volatile inhalants. A higher proportion of females than males was 
treated for use of hypnotics and sedatives.   
 
 
Figure 11.1.9   Number of new cases by main problem drug and gender, 1998–2003 
 
New cases treated for drug use main problem drug by gender, 1998-2003
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Figure 11.1.10   Proportion of new cases by main problem drug and gender, 1998–2003 
 
A higher number and proportion of males (72%) than females (67%) treated for the first 
time reported using more than one drug between 1998 and 2003 (Figure 11.1.11 and 
Figure 11.1.12).  This is an indicator that male drug users may be more difficult to treat 
than female drug users, though factors such as psychiatric co-morbidity may 
complicate the situation.   
 
Figure 11.1.11   Number of new cases who used more than one problem drug, by gender, 
1998–2003 
 
New cases treated problem drug use main problem drug by gender, 1998-2003
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Figure 11.1.12   Proportion of new cases who used more than one problem drug, by 
gender, 1998–2003 
 
Cannabis, stimulants and alcohol were the most common additional drugs used by new 
cases (Figure 11.1.13).  A higher proportion of males than females used stimulants as 
an additional problem drug, while a higher proportion of females than males used 
hypnotics or opiates.   
0% 20% 40% 60% 80% 100%
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Female
Others 0.7 1.1
Volatile inhalants 1.8 2.6
Hallucinogens 5.6 4.1
Opiates 12.2 16.5
Hypnotics 16.9 25.6
Cocaine 17.4 17.2
Alcohol 33.3 29.6
Cannabis 38.3 36.5
Stimulants 51 9 40 5
Male Female
 
Figure 11.1.13   Proportion reporting additional problem drugs, by drug type and gender, 
1998–2003  
 
New cases treated for drug use reported polydrug use status, by gender, 1998-2003
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Between 1998 and 2003, higher numbers of men than women reported injecting drug 
use at their first treatment (Figure 11.1.14), but a higher proportion of women (34%) 
than men (28%) reported injecting drug use (Figure 11.1.15).  This is explained by the 
higher proportion of opiate users among women (58%) than men (43%).  When 
injecting drug use was examined in opiate users only, 60% of males and 57% of 
females injected.   
 
 
Figure 11.1.14   Number of new cases reported injecting drug use, by gender, 1998–2003 
 
Figure 11.1.15   Proportion of new cases reported injecting drug use, by gender, 1998–
2003 
 
A lower proportion of women (59%) than men (69%) lived with their parents or family, a 
higher proportion of women (19%) than men (13%) lived with their partner, with or 
without children, and, as expected, a higher proportion of women (6%) than men (1%) 
lived alone with children (Figure 11.1.16).    The type of accommodation did not vary 
between men and women (Figure 11.1.17).   
New cases' treated for drug use injector status by gender, 1998-2003
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Figure 11.1.16  Proportion of new cases living with each category of house companions, 
by gender, 1998–2003 
 
Figure 11.1.17   Proportion of new cases living in each type of accommodation, by 
gender, 1998–2003 
 
A lower proportion of women (18%) than men (30%) were in regular employment and a 
higher proportion of women (11%) than men (15%) were students (Figure 11.1.18).   
 
House companions of new cases treated for drug use by gender, 1998-2003
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Partner alone 8.2% 10.7%
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Alone 6.6% 6.4%
Male Female
New cases treated for drug use reported type of accommodation, by gender, 1998-2003
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Figure 11.1.18   Proportion of new cases by employment status and gender, 1998–2003 
 
The place of residence in Ireland differed by gender (Figure 11.1.19).  A higher 
proportion of female than male drug users lived in Dublin.  The opposite was observed 
outside Dublin.      
New cases place of residence by gender, 1998-2003
0% 20% 40% 60% 80% 100%
Male
Female
Not known 0.8 0.6
Reside outside Ireland 0.1 0.1
Reside in Dublin 41.5 54.1
Reside in elsewhere in Ireland 57.6 45.1
Male Female
 
 
Figure 11.1.19   Proportion of new cases by place of residence and gender, 1998–2003 
 
New cases treated for drug use employment status by gender
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Not known 2.3% 2.1%
Other 4.6% 6.9%
Unemployed 51.4% 53.5%
Retired or disability 0.9% 4.4%
Student 10.5% 14.9%
Regular employment 30.3% 18.3%
Male Female
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d. Infectious diseases 
The number and proportion of new HIV cases among injecting drug users, by gender, 
from 2000 to 2004 is presented in Table 11.1.9.  The majority of cases are male. Over 
the five-year period, an average of 36% of HIV cases in injecting drug users were 
female.  Between 1998 and 2003, on average 25% of new cases treated for problem 
drug use were women (Figure 11.1.2), indicating a possible excess risk of HIV among 
women.  The surveillance system for hepatitis does not collect risk factor data.   
 
Table 11.1.9   Number (%) of new HIV cases in injecting drug users in Ireland, by gender, 
2000–2004 
 2000 2001 2002 2003 2004
 Number (%) 
Male 53 (64) 16 (59) 25 (69) 30 (64) 44 (62) 
Female 30 (36) 11 (41) 11 (31) 17 (36) 27 (38) 
Total 83 27 36 47 71 
Source: National Disease Surveillance Centre 2001–2004; Health Protection Surveillance Centre 2005 
 
The prevalence of HIV or hepatitis B among injecting drug users was not associated 
with gender in any published prevalence studies. Only two studies, a community-based 
study and a study of prison entrants, reported a higher prevalence of hepatitis C in 
women injecting drug users compared to male injecting drug users (Table 11.1.10)  
 
Table 11.1.10   Review of studies identifying risk factors for hepatitis C among drug users 
in Ireland 
Year published 
and authors 
Study design Study population, 
sample size and 
statistical method 
Gender associated with testing 
positive for hepatitis C 
1995 
Smyth et al. 
Old and new attendees registered 
at Trinity Court Drug Treatment 
Centre, Dublin, August 1992 to 
August 1993 
 
272 injectors living in 
Dublin 
Bivariate analysis 
Yes, 94% of female injectors tested 
positive for hepatitis C compared to 
80% of male injectors. 
. 
 
2001 
Long et al. 
Cross-sectional survey Prison entrants 
Total: 596 
Of whom 173 were 
injectors 
Multivariate analysis 
Yes, women injectors were over 
three times more likely to test 
positive for hepatitis C than men, 
89% versus 69% respectively.  
 
 
e. Crimes and arrests 
The primary source of information on crime and law enforcement activities in Ireland on 
a yearly basis is the annual report of the Garda Síochána The report includes a chapter 
on drug offences, giving the number of drug offences in which proceedings were taken 
and the number, age and gender of persons charged as well as the nature of the 
offence. The Garda annual report is primarily a reflection of the activities and 
effectiveness of law enforcement organisations, rather than of the prevalence of drugs 
or the incidence of drug-related crime. The figures are influenced by a number of 
factors: the willingness of the public to report crime to the gardaí, recording practices, 
law enforcement activities and effectiveness in detecting drugs and drug-related 
offences. Effectiveness can, in turn, be influenced by law enforcement strategy, 
resource availability and deployment and the susceptibility of offenders to being 
caught. The limitations of official statistics, such as those in the annual report of the 
Garda Síochána, in terms of describing the overall crime picture, have been highlighted 
by a number of writers in the area (Connolly 2006). 
 
In 2003, the most recent year for which figures are available, 6,044 persons were 
prosecuted for drug offences. Of these, 5,548 were male and 496 were female. Figure 
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11.1.20 shows trends in persons prosecuted for drug offences from 1995 to 2003. 
Prosecutions of both males and females increased sharply between 1996 and 1997. 
Following a slight decrease in 1998, prosecutions of males increased from 5,409 in 
1998 to 7,352 in 2001, and then declined to 5,548 in 2003. In contrast, the number of 
females prosecuted declined sharply in 1998 and has remained stable since then. 
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Figure 11.1.20   Persons prosecuted for drug offences, by gender, 1995–2003 (from 
annual reports of An Garda Síochána 1995–2003) 
 
Figures 11.1.21 to 11.1.23 show prosecutions by gender and age.  The sharp rise in 
prosecutions between 1996 and 1997 occurred among those aged between 17 and 21. 
This rise is more likely to reflect a change in enforcement practices than any change in 
drug use. The murder of  journalist Veronica Guerin and the emergence of anti-drugs 
street activity in 1996 most likely contributed to the intensification of law enforcement 
activities during this period.7 The number of prosecutions of males aged over 21 
increased between 1999 and 2001 and then decreased, while prosecutions of males 
between the ages of 17 and 20 increased steadily from 1995 to 2000 and then 
declined. The number of females aged 17 and over prosecuted has remained low and 
constant since 1998. The most striking trend is in respect of the prosecution of male 
children (under-17s). While the number of females prosecuted in this age group has 
remained low and steady since 1995, the number of young males in this age group 
prosecuted for drug offences has increased from 127 in 1997 to 426 in 2003. 
 
 
 
                                                
7 See Section 8.3 for a discussion of these developments. 
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Figure 11.1.21   Number of over-21-year-olds prosecuted for drug offences, by gender, 
1995–2003 (from annual reports of An Garda Síochána 1995–2003)  
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Figure 11.1.22   Number of 17–20-year-olds prosecuted for drug offences, by gender, 
1995–2003 (from annual reports of An Garda Síochána 1995–2003)  
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Figure 11.1.23   Number of under-17-year-olds prosecuted for drug offences, by gender, 
1995–2003 (from annual reports of An Garda Síochána 1995–2003)  
 
Drug-related crime 
International research suggests that women’s drug use and offending are different from 
men’s. A review of international literature by Willis and Rushforth (2003) found that, for 
women drug users, the severity of their drug use is more closely related to their 
criminality than it is for men, particularly for prostitution and property crime activities. 
  
Dillon (2001) found, from a small sample of drug-using prison inmates, that most of the 
female respondents surveyed were what she termed ‘reluctant criminals’, and that they 
engaged in crimes which they perceived involved the lowest levels of risk of arrest. 
Such crimes included prostitution, whereby ‘a move from shoplifting and other forms of 
larceny to prostitution was seen to offer women a way to earn money while minimising 
the risk of arrest’ (p. 41). Dillon’s study also found that women were more likely to have 
become involved in crime after commencing drug use, while men were more likely to 
have been involved in crime prior to drug use. 
 
The general absence of Irish gender-specific research in this area makes it difficult to 
identify the local picture or to make comparisons with international research. It is clear 
from Irish research, however, that a source of income availed of by drug users in 
Ireland, particularly females, to sustain their drug habit, is prostitution. A survey of 351 
drug users by Keogh (1997) found that, of the female respondents (number= 81), 15%   
stated that they had received some income from prostitution. None of the male users 
surveyed (number=270) admitted to prostitution or pimping. However, the author 
suggests that these figures may reflect ‘some under-reporting by the men, amongst 
whom selling sex may be stigmatised’ (p. 42). 
A recent participatory research project conducted with 19 women working in 
prostitution (TSA Consultancy 2005) found that they reported habitual use of alcohol or 
drugs to cope with the work and its aftermath (see Section 11.4 for a fuller account).  
 
11.2 Gender-specific responses on children and young people 
Prevention programmes in Ireland are not targeted at gender-specific audiences.  
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11.3 Responses to problem drug use and gender; gender-specific harm 
reduction responses 
In this section the gender-specific responses of two service providers based in Dublin 
are outlined – the Health Promotion Unit of Merchants Quay, and the Women’s Health 
Project, which promotes the health and well-being of female sex workers. 
 
Geoghegan et al. (1999) explored the differences in drug-using characteristics, by 
gender, in clients attending Merchants Quay Health Promotion Unit.  The unit includes 
a needle exchange as well as a number of other health services.  Between May 1997 
and April 1998, there were 934 new attendees at the needle exchange.  Of these new 
clients, 24% were female and 76% were male.  The new female clients were younger 
than the male clients, on average 22 versus 24 years respectively.  Female clients 
were nine times more likely to report having a sexual partner who injected drugs than 
male clients.  Female clients were 69% more likely to be living with an injecting drug 
user than male clients.  In addition, the women who participated in this study were 
almost four times more likely to report sharing injecting equipment with their sexual 
partner than the men.  Women were also 79% more likely to report sharing injecting 
paraphernalia than men.  Of note, the interval between initiating injecting drug use and 
attending the health promotion unit was shorter for women than for men.  A higher 
proportion of male clients (22%) had received one or more doses of the hepatitis B 
vaccine than their female counterparts (11%). Furthermore, a higher proportion of 
clients (30%) who had ever been in prison had received one or more doses of the 
vaccine than had the proportion that had never been in prison (8%). Since men are 
more likely to be imprisoned than women, it is likely that most of the clients attending 
the Merchants Quay Unit had received their hepatitis B vaccination in prison.  New 
female injectors were significantly more likely to suffer from physical and mental health 
problems than their male counterparts. This was surprising, as new female injectors 
had shorter injecting careers than new male injectors. 
 
Based on these finding, Merchants Quay Ireland designed a study to examine the 
health status of female drug users attending the Unit (Lawless 2004).  The study 
employed a mix of quantitative and qualitative methods and was funded by the Health 
Research Board. The research was conducted over an eight-week period and 
commenced in November 2001.   
 
The researchers conducted a focus group to ascertain female drug users’ interest in 
the research project and to assist in the design of appropriate data-collection tools. 
They administered a health information form to establish the participants’ socio-
demographic details, drug-using history including drug-taking practices, sexual-risk 
behaviours, current health problems, and prior use of health services. Following 
completion of the health information interview, participants took part in semi-structured 
interviews. The data collected during the semi-structured interviews provided insight 
into each woman’s perception of her health status and her past experience of primary 
care services. Each client had a detailed medical assessment, which included a 
medical, surgical and gynaecological history. Details of current medication were 
documented. A physical examination and laboratory tests were completed. Seventeen 
clients completed the health information form and participated in the semi-structured 
interviews. Fifteen clients had a medical assessment, though two declined any 
laboratory tests. Eleven women returned for follow-up interventions.   
 
The main findings of the study were: 
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Of the 17 women interviewed, the majority were under 30 years of age (14/17), 
homeless (9/17) and had child-care responsibilities (11/17). Almost half of the women 
(8/17) reported that their partner was an injecting drug user.  
 
Heroin was the primary drug of choice for all 17 participants. Over three-quarters were 
polydrug users. All 17 had injected illicit drugs and nine were currently injecting. Of 
those currently injecting, six had experienced one or more problem at an injection site. 
Thirteen were currently taking prescribed methadone. Excluding methadone, eight 
participants were taking other prescribed medications, mainly antidepressants and 
sleeping tablets.  
 
Over two-fifths (7) of the participants reported that their health status was either bad or 
very bad. In the three months prior to the study, 16 women reported psychological 
problems; of these, 11 reported anxiety and 14 reported depression. With respect to 
sexual risk factors, three women reported ever having a sexually transmitted infection.  
 
Of the 16 clients who had a medical assessment, six reported that they had asthma, 
while three had epilepsy. Twelve had experienced a gynaecological problem. Nine 
women were either obese or overweight. Thirteen clients had been admitted to hospital 
one or more times and, of these, three were admitted as a result of a suicide attempt. 
In the three months prior to the study, over three-quarters (13/17) had contact with a 
medical service provider. The most frequent sources of medical consultation were 
general practitioner, drug worker and accident and emergency services.  
 
Of the 17 women who participated in the interview, 11 had received at least one dose 
of the hepatitis B vaccine. Thirteen clients requested one or more laboratory tests. Of 
these, all 13 tested positive for antibodies to hepatitis C and two tested positive for 
antibodies to hepatitis B.  
 
Overall, the study findings indicate that women who inject opiates have complex health 
and social problems and do use health services, though the services used in each 
instance may not be the most appropriate. Polydrug use, depression, anxiety and 
hepatitis C were common health problems among these women, confirming the need 
to provide mental health, addiction and infectious disease interventions at drug 
treatment centre level. The young age profile, level of child care responsibilities and 
lack of stable housing highlight the importance of, and need for, social services (such 
as counsellors, family therapists, community welfare officers and social workers) at all 
similar drug treatment centres.  
 
The Women’s Health Project in the HSE East Coast Area promotes the health and 
well-being of women involved in prostitution.  In 1988, an Eastern Health Board (EHB) 
outreach programme commenced with three outreach workers who were working in 
public health nursing at the time (O’Neill and O’Connor 1999). The main aim of the 
outreach team was HIV prevention, with drug users being the main target group, 
especially those not in contact with other services. A harm-reduction approach was 
used, promoting safer injecting techniques and safer sex. In 1991, it was decided to 
commence a specific project for women working in prostitution, the Women’s Health 
Project (WHP). This was motivated by concerns being raised in other countries about 
the number of women infected with HIV mainly contracted through sexual intercourse. 
While a small number of drug-using women were working in prostitution at that time, as 
shown by peer research carried out in 1996, by 1997 the numbers were starting to 
increase.  In 1999, there were approximately 400 female intravenous drug users 
involved in prostitution in Dublin (estimated Garda figure). The Women’s Health Project 
has had contact with 260 of these. Clients attending the project have access to medical 
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and addiction services, which employ a harm-reduction approach.  This project 
provides a drop-in service twice a week, on Wednesday afternoon and Thursday night. 
 
11.4 Gender-specific treatment data and approaches – differences in 
treatment organisation 
a. Availability of gender-specific treatment  
 
Ashleigh House 
 
Ashleigh House, part of the Coolmine Therapeutic Community, provides a women's 
residential programme. It offers a drug-free environment for women wishing to address 
substance abuse problems in their lives. One of the key principles of this Coolmine 
programme is the concept of self-help, which encourages residents to play an active 
role and be responsible for their own rehabilitation and recovery. The programme has 
three phases: 
 
1. Group therapy and one-to-one counselling allow the individual woman to 
identify and address any physical and psychological factors associated with her 
addiction and explore her self-awareness and self-identity.  
2. Residents begin to work towards re-establishment in the wider community. All 
residents are assisted in seeking and securing full-time employment while 
residing at Ashleigh House. The main focus is on reintegration and 
resettlement. Individual work continues, through ongoing one-to-one 
counselling and specialised groups.  
3. In the final, aftercare phase, when the two previous phases have been 
successfully completed, residents are assisted in moving out of Ashleigh House 
and into their own accommodation. Clients are encouraged to attend a weekly 
support group at Coolmine.  
 
In addition, child-support workers run parenting skills course on a weekly basis for the 
women. Other available activities include art, music, drama, weekend passes for 
swimming, bowling, cinema, yoga, Ki massage, saunas. Ashleigh House has a close 
liaison with local colleges and schools to assist residents with literacy and/or numeracy 
problems. Women are encouraged to attend evening classes or clubs of their choice.  
 
 
Pregnancy and drug use and the establishment of the drug-liaison midwife service in 
Ireland  
 
In Ireland the need for a specialised intervention service to assist pregnant women with 
problem drug use has been apparent since the early 1980s (Ryan et al. 1981).   
 
Four studies presented data on the socio-demographic profile of respondents in the 
eighties and early nineties (Ryan et al. 1981; Kelly et al. 1983; O’Connor 1988; 
Thornton et al. 1990).  In general, the respondents were young, single and had low 
levels of educational attainment.  Thornton et al. (1990) reported that all 38 cases in 
their study came from deprived areas in Dublin.   
 
Ryan et al. (1981) and Kelly et al. (1983) reported that a high proportion of respondents 
had a history of psychiatric illness.  O’Connor et al. (1988) and Thornton et al. (1990) 
reported high levels of infectious diseases (such as HIV and hepatitis B) among the 
drug users.  Ryan et al. (1981) and Kelly et al. (1983) reported that 80% of the 
respondents used opiates.  Infants born to mothers with problem opiate use have a 
high incidence of low birth weight (Coughlan et al. 1999).  These infants may also 
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develop signs and symptoms of opiate withdrawal and subsequently, require admission 
to a neonatal unit (Thornton et al. 1990; Coughlan et al. 1999).   
 
Bosio et al. (1997) published the estimated prevalence of illicit drug use among 
antenatal and postnatal attendees at the Rotunda Hospital in Dublin at 2.8% and 5.6% 
respectively.  These data give some idea of the size of the problem at that time.   
 
The first response to the increasing numbers of pregnant opiate addicts was in 1984, 
when the Drug Treatment Centre Board established a special programme for pregnant 
women reporting problem opiate use. The programme provided low-dosage 
methadone maintenance (20mg of Physeptone Linctus) administered daily, a weekly 
group therapy session and fortnightly attendance at antenatal clinics in the treatment 
centre. Over the period 1984 to 1986, 45 pregnant heroin addicts availed of this 
programme.  A formal statutory response to the increasing numbers of pregnant 
women with problem drug use (primarily problem opiate use) and the high levels of 
morbidity among this group was initiated in 1999 when a specialised drug liaison 
midwife service was established in the Eastern Regional Health Authority area (Scully 
et al. 2001). This service is provided through a drug-liaison midwife at each of the three 
Dublin maternity hospitals.  These midwives also have links to the community-based 
addiction centres in the respective health board areas. 
 
Pregnant women and their partners (if active drug users) presenting for assessment of 
their problem drug use are treated immediately. Staff refer pregnant clients attending 
drug treatment centres to the midwives and the midwives conduct the initial 
assessment at the drug treatment centres.  The midwife then monitors the client 
through pregnancy and the six-week postnatal period.  S/he offers support and 
information on pregnancy and drug use.  This includes attending the maternity hospital 
with the women during their antenatal and postnatal visits to liaise with obstetricians in 
order to ensure a consistent care plan and explain medical issues to the women and 
explain drug-related issues to the medical staff.   
 
Scully et al. (2004) reviewed the referrals to the drug liaison midwife based at the 
Coombe Hospital from April 1999 to April 2000 through a retrospective review of 
clinical records.  There were 111 referrals to the service. Only 21 women had planned 
their pregnancy.  Eighty-three women were in treatment for substance abuse when 
referred to the drug liaison midwife.  In total, 53 women were assessed as opiate 
unstable and 21 were benzodiazepine unstable.  Fifty-six women attended for five or 
more visits.  Thirteen per cent of women had a caesarean section, which was lower 
than the proportion of caesarean sections (16%) for all maternity cases at the hospital 
in 1999.  Almost 11% of infants were delivered prematurely, which was higher than the 
proportion of premature deliveries (6%) for all maternity cases at the hospital in 1999.  
Just under 43% of infants were admitted to the Special Care Baby Unit, and 29% had a 
diagnosis of neonatal abstinence syndrome.  Of the 85 women taking prescribed 
methadone, 47% of their infants experienced withdrawals from methadone.  Higher 
methadone dose was associated with an increased risk of withdrawals.  There was one 
neonatal death and no maternal deaths.  All infants were discharged to the custody of 
their mothers.  Only 11 women returned for a developmental check, and of these, six 
had developmental problems.    
 
 
11.4 Gender-specific social reintegration approaches 
Gender-specific social reintegration approaches are not a predominant feature of 
responses to drug misuse in Ireland. However, there are a small number of 
interventions specifically targeting women. The SAOL Women's Project located in the 
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North Inner City of Dublin and the STAR Women's Project located in the Dublin suburb 
of Ballymun target women who are seeking to stabilise their drug use. Both projects 
provide a wide mix of family supports, vocational training and employment supports, 
educational supports, and advice with budgetary and social welfare matters. In 
addition, both projects provide relapse prevention supports, counselling and social 
outings. An overview of both projects is provided below.  
 
Two other initiatives are described in this section. The Renewal Women's Residence 
Programme, based on the Minnesota abstinence model, offers a residential supportive 
environment for women in the early stages of recovery from addictions and particularly 
for those emerging from residential treatment. The Next Step Initiative aims to develop 
a model of intervention to support women involved in prostitution to access the social 
economy, community education or local employment. 
 
SAOL Women's Project 
The SAOL project gets its title from the anglicised acronym of the Gaelic words; 
Seasamhact, Abaltacht, Obair and Leann, meaning Stability, Ability, Work and 
Learning. Established in 1995, following research by Dunne (1994) that highlighted the 
many difficulties women reported in accessing mainstream drug treatment services that 
did not take account of the different and specific needs of women drug users such as 
childcare and women's health issues, the SAOL project aims to assist women to 
achieve and maintain stability in their lives and work towards meaningful social 
reintegration.  
 
Bowden (1997) conducted an interim evaluation of the project. The evaluator reported 
that participants were unanimous that the project was a very positive experience in 
their lives. They reported an improvement in self-esteem and felt their ideas and 
opinions were valued within the project. An improvement in literacy skills and overall 
educational development was reported as the most important change to their lives.   
 
Recently released data from the project (J Byrne, personal communication, 2005) show 
that, from a total of 69 women who had been through the programme up to 2004:  
• 13 (27%) left school between the ages of 10 and 13 
• 27 (56%) left school between the ages of 14 and 15 
• 8 (17%) left school between the ages of 16 and 18 
• 37 (77%) never sat the Junior or Group Certificate 
• 9 (19%) reached Junior Certificate Level standard 
• 2 (4%) achieved Leaving Certificate Level 
 
Of the 69 women who had been through the programme up to 2004, 48 completed the 
two-year programme; 14 were deemed unsuitable and their contract was terminated; 4 
left the project voluntarily and 3 participants died. The outcomes for the 48 who 
completed the programme were as follows: 
 
• 14 increased their education levels by one (e.g. Junior to Leaving Certificate) 
• 8 increased their education levels by two (e.g. pre-Junior to Leaving standard) 
• 14 increased their education levels by three (e.g. pre-junior to Third Level) 
• 12 remained static at their pre-existing education level 
• 24 increased their literacy levels by one grade 
• 10 increased their literacy levels by two grades 
• 3 increased their literacy levels by three grades 
• 11 remained static at their pre-existing literacy levels  
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A notable achievement by the SAOL project has been the development of meaningful 
links with external institutions and organisations. For example, over the two-year period 
1997 to 1999 the project participated in the New Opportunities for Women (NOW) 
Community Employment initiative and developed a project called 'Bringing Female 
Drug Users in from the Margins. This initiative enabled participants to take part, for the 
first time, in third-level education. Over this period, 12 participants successfully 
completed a Women's Studies Certificate Programme at University College Dublin 
(UCD). In 2002 SAOL participated in a one-year Daphne programme, a European 
initiative concerned with addressing domestic violence. The SAOL participation 
examined the links between domestic violence and addiction, by seeking to explain 
addiction as a survival technique in situations of domestic violence. Subsequently 
SAOL developed working relations with a number of women's organisations around 
Ireland, working to address domestic violence and provide services such as women's 
refuges to female victims. This partnership approach has broadened the profile of 
SAOL and extended the network of supports available to female participants. As a 
direct consequence, Women's Aid, a national support organisation for women, now 
provides a specific support service for women from inner-city Dublin who are 
experiencing domestic violence. 
 
STAR Women's Project 
The STAR Women's' Project has developed,since its establishment in 1998 to become 
an established community employment (CE) intervention for women from the Ballymun 
area who are working to stabilise their drug use. The project is sponsored by FÁS, the 
State Training and Employment Authority, and also receives part funding from the HSE 
Northern Area Addictions Service. It provides two years’ intensive training and support 
to female participants. The project is based on an adult education model, with the 
emphasis on learning through the group and situating the learning process in the social 
and cultural life experience of the participants. 
 
The training programme runs for one/two years and employs 16 participants who 
attend five mornings a week. All participants are taken on for a probationary period of 
3–6 months, although this may be increased if an individual is experiencing difficulty 
meeting the structural demands of the project. Some participants drop out owing to a 
variety of causes such as relapse into active drug misuse, non-attendance, or irregular 
attendance. In some cases, domestic violence and lack of childcare facilities can result 
in irregular attendance. In addition, the project provides an addiction support group, a 
parenting programme and regular arts and crafts classes. 
 
Updated data provided by the project show that participants were successful in gaining 
a high level of accreditation through their training. For example, they received the 
following number of training awards: 30 certificates in 2001, 17 certificates in 2002, 24 
certificates in 2003, 28 certificates in 2004. Additional recent data provided by the 
project on progress of participants when they left the project reveals that for the year 
2004, four went on to full employment; eight went on to further community employment; 
three went on to further vocational training (e.g. FÁS, PACE); two are deceased; and 
four potential participants did not commence the course. 
 
Renewal Women's Residence Programme 
The Renewal Women's Residence Programme was set up by Tabor Lodge, located in 
the southern area of the country, in response to a need for a residential supportive 
environment for women in the early stages of recovery from addictions and particularly 
for those emerging from residential treatment. Renewal has accommodation for 10  
women. Length of stay is approximately three months. Residents are encouraged to 
find part-time or voluntary employment. Family participation is welcomed and 
encouraged. Residents are expected to attend weekly aftercare sessions. The 
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programme emphasises personal responsibility, peer support, participation in a twelve-
step programme and life-style changes. The programme is based on the Minnesota 
abstinence model. Group sessions and one-to-one counselling form the therapeutic 
base of the programme. The FÁS Social Employment Scheme provides an excellent 
training and work experience programme for those who wish to participate.  
 
Next Step Initiative 
The Next Step Initiative (NSI) was developed by the voluntary organisation Ruhama 
through a participatory action research project. The aim of the NSI was to develop a 
model of intervention to support women involved in prostitution to access the social 
economy, community education or local employment. The core objectives of the 
initiative were: 
 
• to undertake participatory research with a cohort of women who have 
experienced prostitution in order to identify the range of barriers, internal and 
external that affect them, and  
• to use this learning to develop a model of intervention that could facilitate 
marginalised women to take the next step in their personal development. 
 
The research engaged with a total of 19 women through the course of 350 hours of 
fieldwork. Fourteen of the women participated in more than one interview, with only two 
women engaging for a single one-hour interview. The majority of the women were 
interviewed five times, for an hour each time, with some women engaging in nine 
interview sessions. The spacing of interviews allowed the women to revise and reflect 
on what they had previously discussed. The interviews were not recorded but 
researchers made notes which were written up when the interview terminated. The 
women interviewees were then asked to review the notes and approve and make 
changes and/or additions. 
 
Most of the women were keen to explore ways of taking the next step from their 
experience of prostitution and additional problems of alcohol and drug use. Some of 
the women reported that when engaged in active prostitution, they were 'out every 
night' to support a drug habit and a pimp. The role of drug and alcohol use mostly 
acted as a survival mechanism as the women would habitually get drunk or stoned or 
use prescription drugs in order to work and then use drugs and alcohol to numb the 
pain of prostitution. However, the women did report awareness of the dangers of not 
being fully alert owing to the effects of alcohol and drugs and the inherent risks 
involved in prostitution. 
 
The research identified the need for the women to maintain strict boundaries between 
their private and public selves as an important psychological tool for survival. However, 
for some of the women the use of drugs acted against this separation and 'mixed it all 
up'. In addition, when some of the women tried to access drug treatment services, their 
experience was that existing policies underpinning services was a major barrier to 
moving on.  
 
The Next Step Initiative has now been developed as a model of support and 
intervention, targeting women working in prostitution who are keen to access the social 
economy. The model has been tested for credibility and legitimacy among a number of 
marginalised women, service providers and specialist services, and the feedback 
suggests widespread endorsement. The report recommends that policy makers, 
service providers and specialist services should accept and endorse this model of 
support as the optimum means of supporting women involved in prostitution to take the 
next step in their personal development journey.  
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11.6 Gender-specific aspects in the criminal justice system 
a. Responses to petty crime 
 
Petty crime is not defined as such in Ireland. In the annual reports of An Garda 
Síochána crimes are categorised into ‘headline’ and ‘non-headline’ offences. Most drug 
offence prosecutions are for the simple possession of cannabis (s3 Misuse of Drugs 
Act. 1977) (Connolly 2006). These are categorised under ‘non headline’ offences and, 
as such, can be regarded as less serious. Most drug offences are tried summarily, 
before a judge and without a jury. A number of schemes exist to divert people away 
from further involvement in the criminal justice system. Such schemes include arrest 
referral schemes and the Garda Juvenile Diversion Programme, which has been in 
existence since 1963 (Ireland National Report 2004). These generally relate to young 
people who have been apprehended for minor offences and are not targeted in a 
gender-specific way: the numbers of males or females involved in the schemes reflect 
offending proportions as seen in Figures 11.1.19–11.1.22. 
 
The Garda Juvenile Diversion Programme has now been placed on a statutory basis 
with the passage of the Children Act 2001. The programme provides that if certain 
criteria are met an offender under 18 years of age may be cautioned as an alternative 
to prosecution. In 2003, drug possession offences accounted for 5.3%  of the total 
number of offences for which juveniles were referred for caution. Drink-related offences 
made up 20.7% of the total. Referrals by gender for drug offences are not presented in 
the Garda reports.  
 
b. Gender-specific prison responses 
Table 11.1.11 provides data, by age and gender,on the number of persons committed 
to prison under sentence (i.e not on remand) for drug offences in 2002, the most recent 
year for which figures are available. Of the 274 persons committed to Irish prisons for 
drug offences during 2003, 263 were male and 11 were female. It is not clear from the 
available official data how many people were committed to prison for offences related 
to their drug use. However, a number of prison studies have shown strong links 
between drug use, crime and imprisonment.8 A survey of 777 prisoners (59 of them 
women) found that 51% of the male and 69% of the female prisoners reported being 
under the influence of drugs when they committed the offence for which they were 
serving a sentence (Hannon et al. 2000). 
 
Table 11.1.11   Males and females committed for drug offences under sentence, by age 
group, 2002 
Age group (years) 15–17 17–21 21–25 25–30 30–40 40–50 50+ Total 
Males (drug offences) 5 9 52 66 87 42 2 263 
Females (drug offences) 1 1 5 2 1 1 0 11 
Total committals (all offences) 281 537 1183 1024 1208 987 94 5314 
Source: Irish Prison Service (2004) 
 
Table 11.1.12 shows that 8 of the 11 women imprisoned for drug offences in 2003 
received sentences of one year or more. In recent years an increasing proportion of 
Ireland’s female prison population has comprised non-nationals convicted for being 
involved in the importation of drugs or acting as ‘drug couriers’. According to Quinlan 
(2003: 57) ‘they have represented up to between 20 to 25% of Ireland’s imprisoned 
women and many of them come from South Africa’. The phenomenon of non-national 
female drug couriers has changed the profile of Irish female prisoners, not only in terms 
                                                
8 For a review of these studies see Connolly (2006) 
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of the total numbers imprisoned, but also in terms of the length of their sentences. 
Quinlan (2003) argues that the introduction of mandatory drug sentences under the 
1999 Criminal Justice Act, whereby those found in possession of more than €12,700 
worth of drugs must receive a sentence of more than 10 years’ imprisonment, has led 
to a lengthening of the average sentence served by female prisoners. Heretofore, she 
argues, ‘only 3% of the 751 women committed to Mountjoy Prison between September 
2000 and September 2001 received prison sentences of one year or over’ (p. 59).  
 
Table 11.1.12   Males and females committed to prison for drug offences, by sentence 
length, 2003 
Sentence length <3 mths 3-6 mths 6mths-1yr 1-2yrs 2-3yrs 3-5yrs 5-10yrs >10yrs Life Ttl 
Males 52 32 66 16 25 51 20 1 0 263 
Females 0 2 1 3 2 1 2 0 0 11 
Source: Irish Prison Service (2004) 
 
The Womens’ Prison, The Dóchas Centre, can be described as representing an 
innovative approach to imprisonment in Ireland. Dóchas is a purpose-built, modern 
prison, with accommodation for 80 women in seven separate ‘houses’ within  the 
complex. Two houses are designated as drug free. 
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12 European drug policies: extended beyond illicit drugs? 
 
12.1 Official endorsement by the National Drugs Strategy 
Ireland’s ‘Building on Experience: National Drugs Strategy 2001–2008’ was developed 
to deal with the harm caused to individuals and society by the misuse of drugs 
(Department of Tourism Sport and Recreation 2001).  The references and approaches 
proposed indicate that the actions deal mainly with illicit drugs, in particular, opiate 
misuse. 
 
As part of the prevention approach, links at national, regional and local level between 
the National Drugs Strategy and the National Alcohol Policy were called for, ‘to ensure 
complementarity between the different measures being taken’. Treatment services for 
drug and alcohol use were not officially linked, though, in practice, many of the drug 
services treat clients for alcohol dependence.  As alcohol is a legal substance, it is 
generally regarded as inappropriate to deal with its availability using the mechanisms 
for controlling the supply of illicit drugs. 
 
During the consultation process for the mid-term review of the National Drugs Strategy 
in 2004, participants expressed concerns about alcohol use in Ireland, in particular, 
binge drinking (Steering group for the mid-term review of the National Drugs Strategy 
2005).  At that time, participants questioned the rationale for two separate strategies 
and many felt both substances should be dealt with in a single strategy.  The steering 
group for the mid-term review believed that the question of combining both strategies 
was beyond its remit.  The group recommended that a working group (involving key 
stakeholders of both the alcohol and drugs areas) be established to explore the 
potential for better co-ordination between the two areas and how synergies could be 
improved.  The working group will also examine and make recommendations on 
whether a combined strategy is an appropriate way forward.  This working group will 
report by the end of 2006. 
 
The mid-term review of the National Drugs Strategy published in 2005 recognised the 
need for an approach to treating problem drug use that could deal with a range of drug 
dependencies and polydug use (Steering group for the mid-term review of the National 
Drugs Strategy 2005).  The main emphasis is on developing treatment strategies to 
manage cocaine and opiate use, but alcohol was mentioned as an important secondary 
drug. 
 
Tobacco, doping substances in sport, or gambling are not covered in Ireland’s current 
National Drugs Strategy or its subsequent review. 
 
12.2 Genesis and rationale 
Alcohol misuse is increasingly being recognised as a major health and social problem.  
The publication entitled ‘Treatment demand for problem alcohol use in the South 
Eastern and Southern Health Board areas 2000–2002', which documented treatment 
demand for problem alcohol use in community settings and special residential services, 
reported that twice as many are treated for problem alcohol use than drug misuse and 
one-fifth of those with problem alcohol use also misuse drugs (Long et al. 2004b).  As 
mentioned above, people working in the drugs prevention and treatment areas would 
support an approach that would link alcohol and drugs. 
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12.3 Responsibility and competences 
The Department of Community, Rural and Gaeltacht Affairs in Ireland has responsibility 
for co-ordinating and overseeing the implementation of the National Drugs Strategy 
and a number of government departments have responsibility for implementing the 
actions of the strategy and reporting to the Department of Community, Rural and 
Gaeltacht Affairs on their progress (Steering group for the mid-term review of the 
National Drugs Strategy 2005). 
 
The Department of Health and Children is responsible for implementing the National 
Alcohol Policy, and a number of other departments are responsible for implementing 
specific actions (Department of Health 1996). 
 
The National Drugs Strategy assigned responsibility for ensuring ‘complementarity’ 
between alcohol and drugs measures to the following interagency co-ordinating 
mechanisms (Department of Tourism Sport and Recreation 2001). The Inter-
Departmental Group (for Drugs), in conjunction with the Department of Health and 
Children and the National Drugs Strategy Team, was to develop formal links at local, 
regional and national levels with the National Alcohol Policy by the end of 2001. In 
addition, the National Drugs Strategy Team was tasked with meeting regularly with the 
co-ordinator of the National Alcohol Policy, and a member of the Team was to sit on 
the body charged with the co-ordination of the National Alcohol Policy. 
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13.  Developments in drug use within recreational settings 
Recreational settings are defined by the EMCDDA for the purposes of this section as 
clubs, discotheques, bars, parties, restaurants, outdoor events (e.g. festivals) and 
temporary venues, including the ‘run up’ and the ‘fall out’ surroundings. 
 
13.1 New findings about trends in drug use, patterns of consumption 
and availability within recreational settings 
To date there have been no Irish studies which have specifically examined drug use 
within recreational settings. 
 
There is however ad hoc evidence to indicate that drugs are used within recreational 
settings and that, even in the absence of quantitative information on the nature and 
extent of this drug use, responses have been developed to tackle the use of drugs 
within such settings. 
 
According to Murphy et al. (1998) ecstasy use in the club scene in Ireland emerged at 
broadly the same time as elsewhere in Europe, from the mid- to late-1980s, gaining 
widespread popularity in the early 1990s. One of the first public references to a 
developing Irish dance culture and the attendant use of ecstasy was a report in the 
media of a Garda (Irish police) drugs operation in a County Donegal night club in 1992 
(O'Mahony 1996). The operation, colloquially known as the ‘Rave in the Cave’, 
provided the Irish pubic with a rare, for its time, glimpse into the ‘rave’ scene. 
 
A qualitative study in the late 1990s, involving 20 in-depth interviews with ecstasy users 
aged 17 to 27 years, found that a majority initiated their ecstasy use either in clubs or in 
other recreational setting, such as parties or pubs (Murphy et al. 1998). Taking ecstasy 
while alone was unusual, but sometimes ecstasy would be taken or continue to be 
used after clubs in small-group settings. Polydrug use was common. Ecstasy was 
usually consumed in conjunction with alcohol and other drugs, including amphetamines 
and/or cannabis. 
 
A decade later, a similar qualitative study, involving 10 in-depth interviews with 
‘recreational’ cocaine users aged 25 to 29 years, found that a majority had initiated 
their cocaine use in the company of friends in a social setting (Mayock 2001). However, 
these social settings were more likely to be private than public and most respondents 
preferred to continue using cocaine in private, rather than public, social settings. While 
some respondents did use cocaine in dance or club settings, the inconvenience of 
preparing it made it less conducive to using in a public place. Practically all 
respondents in the study reported the concurrent use of alcohol and other drugs while 
using cocaine. 
 
Results from the third European School Survey Project on Alcohol and Other Drugs 
(ESPAD) show that in 2003 that nearly a third (31%) of school-going children (15–16 
years) in Ireland stated that marijuana or hashish could easily be bought in discos, 
bars, etc. (Hibell et al. 2004). However, when compared with the second ESPAD 
survey, carried out in 1999, this represented a drop from 48% (Hibell et al. 2000). In 
both surveys, more girls than boys indicated that they could easily buy marijuana or 
hashish in discos, bars, etc. It is not clear from these surveys if the drugs are actually 
used within these settings. 
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13.2 An overview of developments in responses, national policies and 
legal aspects 
Developments in responses 
 
The third phase of the National Drugs Awareness Campaign, launched in October 
2004, focuses on cocaine (Health Promotion Unit 2004). The campaign is aimed at 18– 
35-year-olds and is designed to disprove some of the common urban myths 
surrounding cocaine use. The core message of this phase is that: ‘There is no fairytale 
ending with cocaine’ and it used nursery rhyme characters, such as ‘Jack and Jill’ and 
‘Georgie Porgie’, to illustrate the stark facts about the psychological, physical, sexual 
and financial problems that can arise from using cocaine as a recreational drug. The 
campaign features three individual advertisements placed in the restrooms of 
entertainment venues, such as pubs and clubs, throughout Ireland and is supported by 
beer mats, free postcards and print advertisements in selected national newspapers 
and magazines. 
 
In July 2005 the campaign focused on the dangers of mixing cocaine with other drugs, 
especially alcohol (Health Promotion Unit 2005b). The campaign again includes placing 
posters in the restrooms of 70 of the largest entertainment venues, such as pubs and 
clubs, throughout Ireland and is supported by beer mats and print advertisements in 
selected national newspapers and magazines. Again, the posters use nursery rhyme 
characters, such as ‘Mary’ and ‘Little Jack Horner’. For example, one poster shows 
Mary in a collapsed position (Health Promotion Unit 2005c), with the accompanying 
message:  
 
Mary had a little blow,  
As pure and white as snow. 
 
And everywhere that Mary went,  
She snorted another row.  
 
Between each line she did some shots, 
Which really wasn't cool.  
 
The toxic mix of booze and coke left her 
with a permanently damaged heart. 
 
There's no fairytale ending with cocaine. 
 
 
In addition to the National Drugs Awareness Campaign, a number of local initiatives 
have focused on recreational settings. Two are described below. 
 
The 'Club Cork' Alcohol & Drugs Awareness Training Programme 
This programme was launched in Cork City in March 2004, targeting publicans, 
security staff and bar staff in the city. The aim is to increase awareness of the negative 
effects of alcohol and drug misuse and help participants identify possible solutions to 
deal with such issues. The training programme has been piloted in a number of Cork 
City bars/clubs. More than 50 staff comprising publicans, bar staff and security staff 
took part in the two half-day training sessions where training was provided by 
emergency medical technicians, security personnel, Accident & Emergency consultants 
and gardaí. Feedback from the pilot programme has been very positive, with 
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participants and trainers enjoying the interactive and practical nature of the course. 
Participants report being better informed about the misuse of drugs and alcohol and 
find it beneficial in terms of their working environment. Many expressed an interest in 
further training (Southern Health Board, personal communication, June 2004). 
 
The 'Gaf' Health Advice Cafe 
The provision of drug and alcohol free entertainment in a health promotional setting 
has been developed as a key alternative to drug use for young people in Galway City,  
situated in the West of Ireland. The 'Gaf' provides drug and alcohol free entertainment 
in a safe environment and on Friday nights local bands play to a packed house until 
10.30pm. Latest data from the project shows that an average of 1,000 young people 
attend the project per month, with 68% in the 15–17-year age group. Slightly more 
females (53%) than males (47%) attend the project. As part of an evaluation to review 
and develop the service, a survey was recently carried out among participants 
assessing their experiences and perceptions of the service. A total of 115 survey 
questionnaires composed of both open and closed-ended questions were completed. 
The results show that 55% of those surveyed attend the 'Gaf' once a week, and 77% of 
respondents perceived the 'Gaf' to be either excellent or good. One of the thematic 
responses coming from respondents was their reliance on 'peers' for information and 
support on drug-related and health-related issues. In addition, the responses indicate 
that the young people surveyed see the 'Gaf' as an acceptable alternative venue to 
meet friends for socialising purposes (Western Health Board, personal communication, 
July 2002). 
 
 
Policy and legal developments 
 
The Licensing (Combating Drug Abuse) Act 1997 provides, inter alia, for the 
disqualification for ever from obtaining an intoxicating liquor, public dancing or public 
music and singing licence on conviction for a drugs offence. It also provides for the 
revocation for ever of such licences on conviction for a drugs offence. It further 
provides for the revocation of such licences for allowing premises to be used for the 
sale of controlled drugs. In such a case the licence holder will be disqualified for five 
years from holding such a licence. Section 11 allows the court, when granting a 
licence, to include conditions to ensure all reasonable arrangements are made to 
ensure that persons entering the premises are not in possession of any controlled drug 
and that the premises are not used for the sale or supply of any controlled drug. The 
Act also contains a number of provisions to prevent the organisation of unlicensed 
parties, such as so-called ‘rave’ parties for example. Other sections of the Act provide 
powers to the gardaí to enter a place where an unlicensed party is taking place and to 
seize sound equipment and to the courts to forfeit such equipment. 
 
Action 27 of the National Drugs Strategy obliges the Garda Siochána, the Health 
Boards and vintner representative bodies to ‘prepare guidelines… for publicans and 
night-club owners regarding drug dealing on, or in the vicinity of, their premises. These 
guidelines should set out clearly the actions which the owner of the premises should 
take in response to drug dealing…’ (Department of Tourism Sport and Recreation 
2001: 114). In June 2005 an information booklet, entitled Guidelines regarding drug 
dealing on or in the vicinity of licensed premises, was launched with the aim of 
addressing Action 27 (An Garda Síochána and others 2005). The guidelines were 
drawn up by An Garda Síochána, with the co-operation of the Licensed Vintners 
Association, the Irish Nightclub Industry Association, the Vintners Federation of Ireland, 
the Department of Health and Children, and the Irish Hotels Federation. The guidelines 
cover such matters as the law in relation to drug issues, the legal conditions and 
appropriate procedures for the conducting of searches of persons entering premises, 
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signs of drug misuse by customers, what to do if drugs are found, first aid, and the 
monitoring of queues. 
 
Operation Nightcap was initiated in 1999 to curb drug activity in licensed premises. It 
involves the strategic deployment of undercover gardaí in licensed premises to 
apprehend drug dealing and drug use. In 1999, it is reported that drug charges were 
taken against 87 persons following such operations. Notices were also served on an 
unspecified number of licensed premises under the provisions of the Licensing 
(Combating Drug Abuse) Act 1997 (An Garda Síochána 2000). In 2002, Operation 
Nightcap resulted in 17 premises being targeted following which nine notices were 
served under the terms of the Act (An Garda Síochána 2003). 
 
Action 12 of the National Drugs Strategy obliges the gardaí to ensure that operations 
similar to Operation Nightcap are implemented in urban centres throughout Ireland 
where drug dealing is ongoing.  The progress report on the National Drugs Strategy 
states in relation to Action 12 that, ‘A draft document on the future conduct of such 
operations has been submitted to the Commissioner. This document recommends 
regional training which is anticipated to commence during 2004’ (Department of 
Community Rural and Gaeltacht Affairs 2004: 42).  
 
 
Ireland – National Report 2004  133
Part C 
 
14.  Bibliography 
14.1 List of references 
 
Allwright S, Bradley F, Long J, Barry J, Thornton L and Parry JV (2000) Prevalence of 
antibodies to hepatitis B, hepatitis C and HIV and risk factors in Irish prisoners: 
results of a national cross-sectional survey. British Medical Journal, 321: 78–82. 
An Garda Síochána (2000) Annual Report of An Garda Síochána 1999. Dublin: Stationery 
Office. 
An Garda Síochána (2003) Annual Report of An Garda Síochána 2002. Dublin: Stationery 
Office. 
An Garda Síochána (2004) Annual Report of An Garda Síochána 2003. Dublin: Stationery 
Office. 
An Garda Síochána and others (2005) National Drugs Strategy 2001–2008 (Action Point 27): 
guidelines regarding drug dealing on or in the vicinity of licensed premises. Dublin: An 
Garda Síochána. 
Bergin E, Lalor T, Lawless K and Pym M (2005) Settlement first: assessment of the 
effectiveness of the Housing Act 1988 and Integrated Strategy 2000 in meeting the 
housing needs of people who are homeless. Dublin: Simon Communities of Ireland.  
Blanchardstown EQUAL Initiative (2004) Making inter-agency protocols work: the 
development of common protocols by agencies working with current or former drug 
users: a model of good practice. Dublin: Blanchardstown EQUAL Initiative. 
Bosio P, Keenan E, Gleeson R, Dorman A, Clarke T, Darling M et al. (1997) The prevalence 
of chemical substance and alcohol abuse in an obstetric population in Dublin. Irish 
Medical Journal, 90(4): 149–150. 
Bowden M (1997) An interim evaluation of the SAOL Project. Dublin: SAOL. 
Brett MM, Hallas G and Mpamugo O (2004) Wound botulism in the UK and Ireland. Journal 
of Medical Microbiology, 53(6): 555–561. 
Bruce A (2004) Drugs task force project activity for FAS community employment participants: 
a review. Dublin: Universal Learning Systems.  
Byrne R (2001) Opiate-related deaths investigated by the Dublin City and County Coroners 
in 1998, 1999 and 2000. Addiction Research Centre Briefing No. 1. Dublin: University 
of Dublin. 
Byrne R (2002) Opiate-related deaths investigated by the Dublin City and County Coroners, 
1998–2001. Addiction Research Centre Briefing No. 2. Dublin: University of Dublin. 
Centre for Health Promotion Studies NUI Galway (2000) General health care study of the 
Irish prison population. Dublin: Stationery Office. 
CityWide Drugs Crisis Campaign (2004) Cocaine in local communities: survey of community 
drug projects. Dublin: CityWide Drugs Crisis Campaign. 
CityWide Family Support Network (2004) Supporting grandparents. supporting children: 
report on the consultation with a number of carers involved in family support groups in 
the Greater Dublin area. Dublin: CityWide Family Support Network. 
Connolly J (2004a) Criminological and sociological aspects of cannabis use. In Morgan M 
(ed.) Consequences of cannabis use: an examination of relevant research. Dublin: 
National Advisory Committee on Drugs. 97–120. 
Connolly J (2004b) Developing integrated policing: the Blanchardstown community policing 
forum. Dublin: Blanchardstown Local Drugs Task Force. 
Ireland – National Report 2004  134
Connolly J (2005a) Prison rules provide for mandatory drug testing. Drugnet Ireland, (15): 15. 
Connolly J (2005b) Arrest referral in the north inner city. Drugnet Ireland, (14): 13–14. 
Corr C (2004) Drug use among new communities in Ireland: an exploratory study. Dublin: 
National Advisory Committee on Drugs. 
Cullen W, Kelly Y, Stanley J, Langton D and Bury G (2005) Experience of hepatitis C among 
current or former heroin users attending general practice. Irish Medical Journal, 98(3): 
73–74. 
Daly A, Walsh D, Moran R and Kartalova O'Doherty Y (2004) Activities of the Irish 
Psychiatric Services 2003. Dublin: Health Research Board. 
Department of Community Rural and Gaeltacht Affairs (2004) National Drugs Strategy 2001–
2008: progress report. Dublin: Department of Community, Rural and Gaeltacht 
Affairs. 
Department of Education and Science (2004) Statistical report 2002/2003. Dublin: Stationery 
Office. 
Department of Health (1996) National Alcohol Policy. Dublin: Stationery Office. 
Department of Health and Children (2001) Quality and fairness: a health system for you – 
health strategy. Dublin: Stationery Office. 
Department of Tourism Sport and Recreation (2001) Building on experience: National Drugs 
Strategy 2001–2008. Dublin: Stationery Office. 
Dillon L (2001) Drug use among prisoners: an exploratory study, Dublin: Health Research 
Board. 
Dublin Area Hepatitis C Initiative Group (2004) Hepatitis C among drug users: consensus 
guidelines on management in general practice. Irish Journal of Medical Science, 
173(3): 145–150. 
Dunne C (1994) Female drug users and service provision: a study of female drug users' 
characteristics and their implications for service response. Unpublished thesis. University of 
Dublin. 
EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2002a) The DRD-
Standard, version 3.0: EMCDDA standard protocol for the EU Member States to 
collect data and report figures for the key indicator drug-related deaths by the 
standard Reitox tables. EMCDDA project CT.02.P1.05. Lisbon: European Monitoring 
Centre for Drugs and Drug Addiction. 
EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2002b) Handbook for 
surveys on drug use among the general population. EMCDDA project CT.99.EP.08 B. 
Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 
EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2004) Annual Report 
2004: the state of the drugs problem in the European Union and Norway. 
Luxembourg: Office for Official Publications of the European Communities.  
European Commission (2005a). Eurobarometer 63: public opinion in the European Union. 
Retrieved 27 October 2005 from 
http://europa.eu.int/comm/public_opinion/archives/eb/eb63/eb63_en.pdf 
European Commission (2005b). Eurobarometer 62: public opinion in the European Union. 
Retrieved 27 October 2005 from 
http://europa.eu.int/comm/public_opinion/archives/eb/eb62/eb_62_en.pdf 
European Commission Decision 2000/96/EC (2000). Commission Decision of 22 December 
1999 on the communicable diseases to be progressively covered by the Community 
network under Decision No 2119/98/EC of the European Parliament and of the 
Council. Retrieved 27 October 2005 from http://europa.eu.int/eur-
lex/pri/en/oj/dat/2000/l_028/l_02820000203en00500053.pdf 
Ireland – National Report 2004  135
Europol (2001) European Union situation report on drug production and drug trafficking 
2000-2001. Drugs Information Bulletin. The Hague: Europol. 
Expert Group on Crime Statistics (2004a) Report of the Expert Group on Crime Statistics. 
Dublin: Department of Justice, Equality and Law Reform. 
Expert Group on Crime Statistics (2004b) Minority report of the Expert Group on Crime 
Statistics. Dublin: Department of Justice, Equality and Law Reform. 
Fianna Fáil and the Progressive Democrats (2002) An agreed programme for government 
between Fianna Fáil and the Progressive Democrats. Dublin: Fianna Fáil and the 
Progressive Democrats. 
Fianna Fáil and the Progressive Democrats (2005) Progress report on the implementation of 
an agreed programme for government between Fianna Fáil and the Progressive 
Democrats: July 2005. Dublin: Fianna Fáil and the Progressive Democrats. 
Focus Ireland (2003) Annual report 2003. Dublin: Focus Ireland. 
Friel S, Nic Gabhainn S and Kelleher C (1999) The national health & lifestyle surveys: survey 
of lifestyle, attitudes and nutrition (SLÁN) & the Irish health behaviour in school-aged 
children survey (HBSC). Galway: National University of Ireland. 
Furey M and Browne C (2003) Opiate use and related criminal activity in Ireland 2000 & 
2001. Research Report No. 4/03. Templemore: Garda Research Unit. 
Garda National Drugs Unit (2003) Annual reports questionnaire: part III. IIlicit supply of 
drugs: extent, patterns and trends in illicit drug cultivation, manufacture and 
trafficking. Ireland 2002. Unpublished questionnaire to the United Nations Office on 
Drugs and Crime. 
Grogan L, Tiernan M, Geogeghan N, Smyth B and Keenan E (2005) Bloodborne virus 
infections among drug users in Ireland: a retrospective cross-sectional survey of 
creening, prevalence, incidence and hepatitis B immunisation uptake. Irish Journal of 
Medical Science, 174(2): 14–20. 
Group to Review the Structure and Organisation of Prison Health Care (2001) Report of the 
group to review the structure and organisation of prison health care services. Dublin: 
Stationery Office. 
Hannon F, Kelleher C, Friel S, Barry M, Harrington J, McKeown D et al. (2000) General 
healthcare study of the Irish prison population. Dublin: Stationery Office. 
Health Promotion Unit (2001) Framework for developing a college alcohol policy. Dublin: 
Department of Health and Children. 
Health Promotion Unit (2004). National Drugs Awareness Campaign targets cocaine use. 
Department of Health and Children. Retrieved 26 October 2005 from 
http://www.drugsinfo.ie/pressrel041004.htm 
Health Promotion Unit (2005a) The health of Irish students. Dublin: Department of Health 
and Children. 
Health Promotion Unit (2005b) Growing cocaine use targeted by National Drugs Awareness 
Campaign. Department of Health and Children. Retrieved 26 October 2005 from 
http://www.drugsinfo.ie/pressrel040705.htm 
Health Promotion Unit (2005c). There's no fairy tale ending with cocaine: Mary. Department 
of Health and Children. Retrieved 26 October 2005 from 
http://www.drugsinfo.ie/fairytale/mary.htm 
Health Protection Surveillance Centre (2005) Newly diagnosed HIV infections in Ireland: 
quarters 3 & 4 2004, and 2004 annual summary. Dublin: Health Service Executive. 
Health Service Executive (2005) National Service Plan 2005. Dublin: Health Service 
Executive. 
Hepatitis C Scientific Advisory Subgroup of the Blood Borne Virus Forum and the Eastern 
Regional Health Authority (2004). Hepatitis C in the Eastern Regional Health 
Ireland – National Report 2004  136
Authority: results of a multi-agency consultation event. Unpublished document by the 
Hepatitis C Scientific Advisory Subgroup of the Blood Borne Virus Forum and the 
Eastern Regional Health Authority. 
Hibell B, Andersson B, Bjarnason T, Kokkevi A, Morgan M and Narusk A (1997) The 1995 
ESPAD report: alcohol and other drug use among students in 26 European countries. 
Stockholm: The Swedish Council for Information on Alcohol and Other Drugs, CAN 
and Council of Europe, Co-operation Group to Combat Drug Abuse and Illicit 
Trafficking in Drugs (Pompidou Group). 
Hibell B, Andersson B, Ahlström S, Balakireva O, Bjarnasson T, Kokkevi A et al. (2000) The 
1999 ESPAD report: alcohol and other drug use among students in 30 European 
countries. Stockholm: The Swedish Council for Information on Alcohol and Other 
Drugs, CAN and the Council of Europe, Co-operation Group to Combat Drug Abuse 
and Illicit Trafficking in Drugs (Pompidou Group). 
Hibell B, Andersson B, Bjarnasson T, Ahlström S, Balakireva O, Kokkevi A et al. (2004) The 
ESPAD report 2003: alcohol and other drug use among students in 35 European 
countries. Stockholm: The Swedish Council for Information on Alcohol and Other 
Drugs, CAN and the Council of Europe, Co-operation Group to Combat Drug Abuse 
and Illicit Trafficking in Drugs (Pompidou Group). 
Hope A, Dring C and Dring J (2005) College lifestyle and attitudinal national (CLAN) survey. 
Dublin: Department of Health and Children.  
Irish Prison Service (2000) Report of the steering group on prison-based drug-treatment 
services. Dublin: Department of Justice, Equality and Law Reform. 
Irish Prison Service (2003) Irish Prison Service Annual Report 2002. Dublin: Stationery 
Office. 
Keane R, Reaper-Reynolds S, Williams J and Wolfe E (2004) Understanding substances and 
substance use: a handbook for teachers. Dublin: South Western Area Health Board. 
Keating S, Coughlan S, Connell J, Sweeney B and Keenan E (2005) Hepatitis C viral 
clearance in an intravenous drug-using cohort in the Dublin area. Irish Journal of 
Medical Science, 174(1): 37–41. 
Kelleher C, Nic Gabhainn S, Friel S, Corrigan H, Nolan G, Sixsmith J et al. (2003) The 
national health & lifestyle surveys: survey of lifestyle, attitudes and nutrition (SLÁN) & 
the Irish health behaviour in school-aged children survey (HBSC). Galway: National 
University of Ireland. 
Kelly A, Carvalho M and Teljeur C (2003) Prevalence of opiate use in Ireland 2000–2001: a 
3-source capture recapture study. Dublin: Stationery Office. 
Kelly F, Long J and Lynn E (2005) Trends in treated problem drug use in the Health Service 
Executive Eastern Region, 1998 to 2002. Occasional Paper 16. Dublin: Health 
Research Board. 
Keogh E (1997) Illicit drug use & related criminal activity in the Dublin Metropolitan Area. 
Research Report No. 10/97. Dublin: An Garda Síochána. 
Lawless M and Corr C (2005) Drug use among the homeless population in Ireland: a report 
for the National Advisory Committee on Drugs. Dublin: Stationery Office. 
Long J, Allwright S, Barry J, Reaper-Reynolds S, Thornton L, Bradley F et al. (2001) 
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in 
entrants to Irish prisons: a national cross sectional survey. British Medical Journal, 
323: 1209–1213. 
Long J, Allwright S and Begley C (2003) Fear and denial: how prisoners cope with risk of or 
diagnosis with hepatitis C. Irish Journal of Medical Science, 172(2 Supplement): 27. 
Long J, Allwright S and Begley C (2004a) Prisoners’ views of injecting drug use and harm 
reduction in Irish prisons. International Journal of Drug Policy, 15(2): 139–149. 
Ireland – National Report 2004  137
Long J, Jackson T, Kidd M, Kelleher T and Sinclair H (2004b) Treatment demand for problem 
alcohol use in the South Eastern and Southern Health Board areas, 2000 to 2002. 
Occasional Paper 10. Dublin: Health Research Board. 
Long J, Lynn E and Keating J (2005a) Drug-related deaths in Ireland, 1990–2002. Overview 
1. Dublin: Health Research Board. 
Long J, Lynn E and Kelly F (2005b) Trends in treated problem drug use in Ireland, 1998 to 
2002. Occasional Paper 17. Dublin: Health Research Board. 
Lord Mayor's Commission (2005) The Lord Mayor's Commission on Crime and Policing. 
Dublin: The Lord Mayor's Office. 
Lyder A (2005) Pushers Out, Victoria: Trafford. 
MacGabhann L, Scheele A, Dunne T, Gallagher P, MacNeela P, Moore G et al. (2004) 
Mental health and addiction services and the management of dual diagnosis in 
Ireland. Dublin: Stationery Office. 
Mayock P (2001) Cocaine use in Ireland: an exploratory study. In Moran R, Dillon L, O'Brien 
M, Mayock P, Farrell E and Pike B (eds) A collection of papers on drug issues in 
Ireland. Dublin: Health Research Board. 80–152. 
McDowell M (2004a) Written Answer No. 16, Col. 1052. In Official Report of the 
Parliamentary Debates of the House of Oireachtas, Vol. 594, No. 4. Available at 
www.oireachtas-debates.gov.ie 
McDowell M (2004b) Written Answer No. 27, Col. 1061. In Official Report of the 
Parliamentary Debates of the House of Oireachtas, Vol. 594, No. 4. Available at 
www.oireachtas-debates.gov.ie 
Merchants Quay Ireland (2005) Annual Review 2004. Dublin: Merchants Quay Ireland. 
Methadone Prescribing Implementation Committee (2005) Review of the Methadone 
Treatment Protocol. Dublin: Department of Health and Children. 
Methadone Treatment Services Review Group (1998) Report of the methadone treatment 
services review group. Dublin: Department of Health and Children. 
Moore G, McCarthy P, MacNeela P, MacGabhann L, Philbin M and Proudfoot D (2004) A 
review of harm reduction approaches in Ireland and evidence from the international 
literature. Dublin: Stationery Office. 
Moran R, O’Brien M, Dillon L, Farrell E and Mayock P (2001) Overview of drug issues in 
Ireland 2000: a resource document. Dublin: Health Research Board. 
Morgan M (2004) An overview of scientific and other information on cannabis. Dublin: 
National Advisory Committee on Drugs. 
Murphy T, O'Mahony P and O'Shea M (1998) Ecstasy use among young Irish people – a 
comparative and interdisciplinary study. Cork: National University of Ireland. 
National Advisory Committee on Drugs (2003) An overview of cocaine use in Ireland. Dublin: 
Stationery Office. 
National Advisory Committee on Drugs & Drugs and Alcohol Information and Research Unit 
(2003). Drug use in Ireland & Northern Ireland: first results of the 2002/2003 drug 
prevalence survey. A summary of the methodology. National Advisory Committee on 
Drugs. Retrieved 23 October 2005 from 
http://www.nacd.ie/publications/Methodology5.doc 
National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit 
(2005) Drug use in Ireland and Northern Ireland: first results (revised) from the 
2002/2003 drug prevalence study. Bulletin 1. Dublin: National Advisory Committee on 
Drugs. 
National Immunisation Advisory Committee (2002) Immunisation guidelines for Ireland. 
Dublin: National Disease Surveillance Centre. 
Ireland – National Report 2004  138
North Inner City Drugs Task Force (2005) Changing track: a study informing a juvenile arrest 
referral pilot in the north inner city. Dublin: North Inner City Drugs Task Force. 
O'Mahony P (1996) Criminal chaos: seven crises in Irish criminal justice, Dublin: Round Hall 
Sweet & Maxwell. 
O'Mahony P (1997) Mountjoy prisoners: a sociological and criminological profile. Dublin: 
Stationery Office. 
O'Mahony P (2004) Drugs, crime and punishment: an overview of the Irish evidence. 
Administration, 52(2): 3–35. 
O'Reilly F, Reaper E and Redmond T (2005) "We're people too": views of drug users on 
health services. Dublin: The Mountjoy Street Family Practice, Union for Improved 
Services, Communication and Education, and the Participation and Practice of Rights 
Project. 
O'Sullivan P (2004) A study of the prevalence of blood-borne viral diseases in injecting drug 
users receiving methadone maintenance in the National Drug Treatment Centre at 
Trinity Court in Dublin. Thesis submitted for Membership of the Faculty of Public 
Health Medicine, Royal College of Physicians of Ireland. 
Oireachtas Joint Committee on Arts, Sport, Tourism, Community, Rural and Gaeltacht Affairs 
(2005) The treatment of cocaine addiction, with particular reference to the Irish 
experience. Dublin: Stationery Office. 
Oireachtas Joint Committee on Justice, Equality, Defence and Women's Rights (2005) 
Report on community policing. Dublin: Stationery Office. 
Quinlan (2003) International women: prison experiences in Ireland. In Lentin R and  Luibhéid 
E (eds) Women's movement: migrant women transforming Ireland. Selection of papers from 
a conference held in Trinity College Dublin, 20-1March 2003. 
 Revenue Commissioners (2003) Annual report 2002. Dublin: Stationery Office. 
Scully M, Geoghegan N, Corcoran P, Tiernan M and Keenan E (2004) Specialised drug 
liaison midwife services for pregnant opioid dependent women in Dublin, Ireland. 
Journal of substance abuse treatment, 26(1): 27–33. 
Smyth BP and O'Brien M (2004) Children attending addiction treatment services in Dublin, 
1990-1999. European Addiction Research, 10(2): 68–74. 
Smyth BP, Barry J and Keenan E (2005a) Irish injecting drug users and hepatitis C: the 
importance of the social context of injecting. International Journal of Epidemiology, 
34(1): 166–172. 
Smyth BP, Barry J, Lane A, Cotter M, O'Neill M, Quinn C et al. (2005b) In-patient treatment 
of opiate dependence: medium-term follow-up outcomes. British Journal of 
Psychiatry, 187: 360–365. 
Steering group for the mid-term review of the National Drugs Strategy (2005) Mid-term 
review of the National Drugs Strategy 2001–2008. Dublin: Department of Community, 
Rural and Gaeltacht Affairs. 
Tallaght Homeless Advice Unit (2004) Heroin – the mental roof over your head: links 
between homelessness and drug use. Dublin: National Advisory Committee on 
Drugs. 
TSA Consultancy (2005) The Next Step Initiative: research report on barriers affecting 
women in prostitution. Dublin: Ruhama. 
UISCE (Union for Improved Services, Communication and Education) (2003) Methadone: 
what’s the story? Dublin: Union for Improved Services, Communication and 
Education. 
Watters N and Byrne D (2004) The role of family support services in drug prevention. Dublin: 
Stationery Office. 
Ireland – National Report 2004  139
WHO (World Health Organization) (1977) Manual of the international statistical classification 
of diseases, injuries, and causes of death: volume 1, (Ninth revision). Geneva: World 
Health Organization. 
WHO (World Health Organization) (1992) International statistical classification of diseases 
and related health problems: volume 1, (Tenth revision). Geneva: World Health 
Organization. 
WHO (Europe) Health in Prisons Project and the Pompidou Group of the Council of Europe 
(2001) Prisons, drugs and society: a concensus statement on principles, policies and 
practices. Berne: World Health Organization. 
Working Group on treatment of under 18 year olds (2005) Report of the working group on 
treatment of under 18 year olds presenting to treatment services with serious drug 
problems. Dublin: Department of Health and Children. 
Zinberg NE (1984) Drug, set, and setting: the basis for controlled intoxicant use. New Haven: 
Yale University Press. 
 
 
 
14.2 List of Acts, Statutory Instruments and cases cited 
Children Act 2001. No. 24 of 2001.  
Creaven & anor v. Criminal Assets Bureau & ors [2004] IESC 92 (29 October 2004). 
Retrieved 27 October 2005 from http://www.bailii.org/ie/cases/IESC/2004/92.html 
Criminal Assets Bureau Act 1996. No. 31 of 1996.  
Criminal Justice Act 1994. No. 15 of 1994.  
Criminal Justice (Drug Trafficking) Act 1996. No. 29 of 1996.  
Criminal Justice (Joint Investigations Teams) Act 2004. No. 20 of 2004.  
Director of Public Prosecutions v. Peter Byrne (30 October 2003, Ref 26/2) 
European Arrest Warrants Act 2003. No. 45 of 2003.  
Garda Síochána Act 2005. No. 20 of 2005.  
Health Act 2004. No. 42 of 2004.  
Housing (Miscellaneous Provisions) Act 1997. No. 21 of 1997.  
Intoxicating Liquor Act 1988. No. 16 of 1988.  
Intoxicating Liquor Act 2004. No. 34 of 2004.  
Licensing (Combating Drug Abuse) Act 1997. No. 33 of 1997.  
Maritime Safety Act 2005. No. 11 of 2005.  
Prevention of Corruption (Amendment) Act 2001. No. 21 of 2001.  
Proceeds of Crime Act 1996. No. 76 of 1996.  
Proceeds of Crime (Amendment) Act 2005. No. 1 of 2005.  
Road Traffic Act 2004. No. 44 of 2004.  
Safety Health and Welfare at Work Act 2005. No. 10 of 2005.  
Statutory Instrument No. 510 of 2005. Medicinal Products (Prescription and Control of 
Supply) (Amendment) Regulations 2005.  
Statutory Instrument No. 707 of 2003. Infectious Diseases (Amendment) (No. 3) Regulations 
2003. 
Taxi Regulation Act 2003. No. 25 of 2003.  
 
 
Ireland – National Report 2004  140
14.3 List of Internet addresses 
http://www.oireachtas.ie 
http://www.oireachtas-debates.gov.ie 
http://www.healthpromotion.ie 
http://www.drugsinfo.ie 
http://www.taoiseach.ie 
http://www.pobail.ie 
http://www.dohc.ie 
http://www.hrb.ie 
http://www.ndc.hrb.ie 
http://www.mqi.ie 
http://www.nacd.ie 
http://www.hpsc.ie 
http://www.ndsc.ie 
http://www.hse.ie 
 
 
14.4 List of databases 
• Central Treatment List 
• Central Methadone Treatment List 
• Drug Trend Monitoring System (DTMS) 
• Hospital In-Patient Enquiry scheme (HIPE) 
• National Drug Treatment Reporting System (NDTRS) 
• National Psychiatric Inpatient Reporting System (NPIRS) 
Ireland – National Report 2004  141
15. Annexes 
15.1 List of tables  
Table 2.2.1   Lifetime, last-year and last-month prevalence of illegal drugs in Ireland, 2002/2003 
Table 2.2.2   Lifetime, last-year and last-month prevalence of cannabis in Ireland, 2002/2003 
Table 2.2.3   Lifetime, last-year and last-month prevalence of ecstasy in Ireland, 2002/2003 
Table 2.2.4   Lifetime, last-year and last-month prevalence of cocaine (including crack) in Ireland, 
2002/2003 
Table 2.3.1   Changes in the proportion of school-going children (15–16 years) in Ireland using drugs 
in the ESPAD surveys of 1995, 1999 and 2003 
Table 2.3.2   Illicit drug use in past 12 months by undergraduate full-time students (CLAN survey) 
compared to those aged 15–24 years in the general population, 2002/2003 
Table 2.4.1   Prevalence of illicit drug use in the homeless population in Ireland in 2003 
Table 4.3.1   Number (%) of cases treated for problem drug use, by treatment status, in Ireland, 1998–
2003 
Table 4.3.2   Number (%) of cases treated for problem drug use, by HSE area of residence, 1998–
2003 
Table 4.3.3   Main problem drug reported by cases treated for problem drug use, by HSE area of 
residence, 1998–2003 
Table 5.2.1  The past health board structure, present interim structure and the proposed future 
regional structure of the public health services in Ireland 
Table 5.2.2   Number and type of services providing treatment for problem drug use and number of 
cases treated (in brackets) in Ireland and reported to the NDTRS, 1998 to 2003 
Table 6.3.1   Uptake of blood-borne viral screening and prevalence and incidence of such infections in 
treated  heroin users (n=358) in the HSE South Western Area up to the end of 2001 
Table 6.3.2    Number of PCR-positive samples by genotype of selected hepatitis C antibody positive 
individuals attending five drug treatment centres in Dublin 
Table 8.3.1   Headline drug offences which became known to the gardaí in 2003 
Table 8.3.2   Non-headline drug offences where proceedings commenced in 2003 
Table 8.3.3   Comparative Garda Síochána studies on drug–crime linkages, 1997 and 2003 
Table 9.3.1   The number (%) of cases reported to the National Drug Treatment Reporting System 
who were referred by police, probation or court, 1998–2002 
Table 10.2.1   Perceived availability of substances: percentages among Irish students answering ‘Very 
easy’ or ‘Fairly easy’ in ESPAD Survey, average percentage among all ESPAD countries, 
and Ireland’s ranking against other ESPAD countries, 2003 
Table 10.2.2   Places where marijuana or hashish can be easily bought: percentages among Irish  
students in ESPAD Survey, and average percentage among all ESPAD countries, 2003 
Table 10.3.1   Number of seizures of specific drugs recorded in annual reports of Garda Síochána, 
1995–2003 
Table 10.3.2    Number of seizures of specific drugs recorded in annual reports of the Revenue 
Commissioners, 2000–2003  
Table 11.1.1   Gender differences in lifetime, last year and last month prevalence (%) for selected 
drugs among adult males and females (15–64 years) in 2002/2003 
Table 11.1.2   Trends in lifetime, last-year and last-month prevalence of cannabis use for adult males 
and females (18+ years) between 1998 and 2002 
Table 11.1.3   Trends in last-year prevalence of amphetamines, cocaine, ecstasy, heroin, LSD, magic 
mushrooms, and solvent use for adult males and females (18+ years) between 1998 and 
2002 
Table 11.1.4   Trends in lifetime and last-year prevalence of cannabis use for school-going boys and 
girls (10–17 years) between 1998 and 2002 
Ireland – National Report 2004  142
Table 11.1.5   Trends in lifetime prevalence of glue or solvent use for school-going boys and girls (10–
17 years) between 1998 and 2002 
Table 11.1.6   Trends in lifetime, last-year and last-month prevalence of cannabis use for school-going 
boys and girls (15–16 years) between 1999 and 2003 
Table 11.1.7   Trends in lifetime, last-year and last-month prevalence of inhalant use for school-going 
boys and girls (15–16 years) between 1999 and 2003 
Table 11.1.8    Median age new cases treated for problem drug use commenced using drugs, left 
school, injected and sought treatment, 1998–2003 
Table 11.1.9   Number (%) of new HIV cases in injecting drug users in Ireland, by gender, from 2000 
to 2004 
Table 11.1.10   Review of studies identifying risk factors for hepatitis C among drug users in Ireland 
Table 11.1.11   Males and females committed for drug offences under sentence, by age, 2002 
Table 11.1.12   Males and females committed to prison for drug offences, by sentence length, 2003 
 
 
15.2    List of figures 
Figure 6.2.1   Number of direct drug-related deaths in Ireland, by national and by European definition, 
reported by the CSO, 1990 to 2002 (unpublished data from the vital statistics) 
Figure 6.2.2   Number of direct drug-related deaths in Ireland, by national and by European definition 
and by place of death, reported by the CSO, 1990 to 2002 (unpublished data from the 
vital statistics) 
Figure 6.3.1   Number of new cases of HIV among injecting drug users, by year of diagnosis, reported 
in Ireland, 1986 to 2004 (adapted from Kelly and Clarke 2000; National Disease 
Surveillance Centre 2002, 2003, 2004; Health Protection Surveillance Centre 2005)  
Figure 6.4.1   Rate of psychiatric first admissions aged 16 years or over with a diagnosis of drug-
dependence (using the ICD-10 three character categories) per 100,000 of the population 
in Ireland and reported to the NPIRS, 1990 to 2003 
Figure 8.3.1  Trends in possession (s3 MDA), supply (s15 MDA) and total recorded drug 
offences,1993–2003 (from annual reports of An Garda Síochána 1993–2003) 
Figure 8.3.2   Selected MDA drug offences where proceedings commenced, 1983–2003 (Possession 
s3 and supply s15 offences excluded) (from annual reports of An Garda Síochána 1995–
2003) 
Figure 8.3.3   Recorded drug offences where criminal proceedings commenced, by drug type, 1995–
2003 (from annual reports of An Garda Síochána 1995–2003) 
Figure 8.3.4    Trends in drug-related prosecutions for a selection of drugs excluding cannabis from 
1995 to 2003 (from annual reports of An Garda Síochána 1995–2003) 
Figure 10.2.1   Trends in cannabis-related prosecutions by Garda region, 1995–2003 (from annual 
reports of An Garda Síochána 1995–2003) 
Figure 10.2.2   Trends in ecstasy-related prosecutions by Garda region, 1995–2003 (from annual 
reports of An Garda Síochána 1995–2003) 
Figure 10.2.3   Trends in heroin-related prosecutions in the Dublin Metropolitan Region, 1995–2003 
(from annual reports of An Garda Síochána 1995–2003) 
Figure 10.2.4  Trends in heroin-related prosecutions by Garda region outside the Dublin Metropolitan 
Region, 1995–2003  (from annual reports of An Garda Síochána 1995–2003) 
Figure 10.2.5   Trends in cocaine-related prosecutions in Dublin Metropolitan Region, 1995–2003 
(from annual reports of An Garda Síochána 1995–2003) 
Figure 10.2.6   Trends in cocaine-related prosecutions outside the Dublin Metropolitan Region, 1995–
2003 (from annual reports of An Garda Síochána 1995–2003) 
Figure 10.2.7   Trends in supply offences in Dublin Metropolitan Region, 1995–2003 (from annual 
reports of An Garda Síochána 1995–2003) 
Figure 10.2.8   Trends in supply offences outside Dublin Metropolitan Region, 1995–2003  (from 
annual reports of An Garda Síochána 1995–2003) 
 
Ireland – National Report 2004  143
Figure 10.3.1   Trends in the number of drug seizures for selected drugs 1995-2003 (from annual 
reports of An Garda Síochána 1995–2003) 
 Figure 10.3.2   Trends in the number of heroin, cocaine, ecstasy, amphetamines and LSD seizures 
1995–2003 (from annual reports of An Garda Síochána 1995–2003) 
Figure 11.1.1   Gender of direct drug-related deaths in Ireland, by national and by European definition, 
reported by the CSO, 1990 to 2002 (unpublished data from the vital statistics) 
Figure 11.1.2   Number of new cases treated for problem drug use, by gender, 1998–2003 
Figure 11.1.3   Number of new cases attending each service provider, by gender, 1998–2003 
Figure 11.1.4   Proportion of new cases attending each service provider, by gender, 1998–2003 
Figure 11.1.5   Number of new cases referred to drug treatment services, by source and gender, 
1998–2003 
Figure 11.1.6   Proportion of new cases referred to drug treatment services, by source and gender, 
1998–2003 
Figure 11.1.7   Age at which new cases commenced using their main problem drug use, by gender, 
1998–2003 
Figure 11.1.8   Age at which new cases were treated for problem drug use, by gender, 1998–2003 
Figure 11.1.9   Number of new cases, by main problem drug and gender, 1998–2003 
Figure 11.1.10   Proportion of new cases, by main problem drug and gender, 1998–2003 
Figure 11.1.11   Number of new cases who used more than one problem drug, by gender, 1998–2003 
Figure 11.1.12   Proportion of new cases who used more than one problem drug, by gender, 1998–
2003 
Figure 11.1.13   Proportion reporting additional problem drugs, by drug type and gender, 1998–2003  
Figure 11.1.14   Number of new cases reporting injecting drug use, by gender, 1998–2003 
Figure 11.1.15   Proportion of new cases reporting injecting drug use, by gender, 1998–2003 
Figure 11.1.16   Proportion of new cases living with each category of house companions, by gender, 
1998–2003 
Figure 11.1.17   Proportion of new cases living in each type of accommodation, by gender, 1998–2003 
Figure 11.1.18   Proportion of new cases by employment status and gender, 1998–2003 
Figure 11.1.19   Proportion of new cases by place of residence and gender, 1998–2003 
Figure 11.1.20   Persons prosecuted for drug offences, by gender, 1995–2003 (from annual reports of 
An Garda Síochána 1995–2003) 
Figure 11.1.21   Number of over-21-year-olds prosecuted for drug offences, by gender, 1995–2003 
(from annual reports of An Garda Síochána 1995–2003) 
Figure 11.1.22   Number of 17–20-year-olds prosecuted for drug offences, by gender, 1995–2003 
(from annual reports of An Garda Síochána 1995–2003) 
Figure 11.1.23   Number of under-17-year-olds prosecuted for drug offences, by gender, 1995–2003 
(from annual reports of An Garda Síochána 1995–2003) 
 
15.3 List of maps 
 
Ireland – National Report 2004  144
15.4 List of abbreviations 
AIDS   Acquired Immunodeficiency Syndrome 
AUDIT   Alcohol Use Disorder Identification Test Screening Instrument 
B&B   Bed and Breakfast (accommodation) 
BMK   Benzylmethylketone 
CDLE   Customs Drug Law Enforcement 
CE   Community Employment 
CLAN   College Lifestyle and Attitudinal National (survey) 
CPF   Community Policing Forum 
CSO   Central Statistics Office 
DART   Derry Arrest Referral Team 
DAST   Drug Abuse Screening Test 
DCRGA  Department of Community, Rural and Gaeltacht Affairs 
DMA   Dublin Metropolitan Area 
DMRD   Drug Misuse Research Division 
EMCDDA  European Monitoring Centre for Drugs and Drug Addiction 
ERHA   Eastern Regional Health Authority 
ESPAD  European School Survey Project on Alcohol and Other Drugs 
EWO   Educational Welfare Officer 
FÁS   Foras Áiseanna Saothair (Training and Employment Authority) 
FSL   Forensic Science Laboratory 
GMR   General Mortaility Register 
GNDU   Garda National Drugs Unit 
HCV   Hepatitis C Virus 
HRB   Health Research Board 
HIV   Human Immunodeficiency Virus 
HPU   Homeless Persons Unit 
HPU   Health Promotion Unit 
HSE   Health Service Executive 
ICD   International Classification of Diseases 
IDG   Inter-Departmental Group on Drugs 
IPRT   Irish Penal Reform Trust 
JPC   Joint Policing Committee 
KPI   Key Performance Indicator 
LDTF   Local Drugs Task Force 
LES   Local Employment Scheme 
MDA 1977  Misuse of Drugs Act 1977 
MDA   Methylenedioxyampethamine 
MDEA   Methylenediethanolamine 
MDMA   Methalenedioxymethamphetamine 
MDT   Mandatory Drugs Testing 
MQI   Merchants Quay Ireland 
NAC   National Assessment Committee 
NACD   National Advisory Committee on Drugs 
NDS   National Drugs Strategy 
NDST   National Drugs Strategy Team 
NDTRS  National Drug Treatment Reporting System 
NEWB   National Educational Welfare Board 
NPIRS   National Psychiatric Inpatient Reporting System 
NSP   National Service Plan 
PCR   Polymerase Chain Reaction 
PMK   Piperonylmethyltone 
RDTF   Regional Drugs Task Force 
RIS   Rehabiltation/Integration Service 
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RNA   Ribonucleic Acid 
SPHE   Social, Personal and Health Education 
SWAHB  South Western Area Health Board 
SCP   Sports Capital Programme 
TD   Teachta Dála (Member of Parliament) 
UISCE   Union for Improved Services, Communication and Education 
WHO   World Health Organization 
YPFSF  Young People’s Facilities and Services Fund 
 
 
 
 
 
